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Abstract  
This thesis describes the synthesis of natural and novel glucosinolates 1. 
O
HO
HO
HO
HO N
OSO3-S
R
K+
 1  
 Chapter 1 gives an overview of glucosinolates, from isolation and biosynthesis 
to previous chemical syntheses. Chapter 2 describes an improved method for 
the formation of thiohydroximate bonds and its application over a variey of 
substrates. Chapter 3 focuses on exploring new chemistry on intact 
glucoinolates and details oxidative chemistry on an alkene containing side chain 
glucosinolate.  Futhermore, the total synthesis of novel glucosinolates 150, 156 
and 161 is illustrated.  
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Chapter 4 describes a model study for the solid phase synthesis of 
glucosinolates. Finally experimental procedures for the compounds synthesised 
in the thesis are described in Chapter 5.  
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amu Atomic Mass units 
BAIB Bis(acetoxy)iodobenzene  
Bn  Benzyl 
bp boiling point 
CI Chemical ionisation 
DCM  Dichloromethane 
DMF N,N-Dimethylformamide 
DMP Dess Martin periodinane 
DMS Dimethyl sulfide 
DMSO Dimethyl sulfoxide 
EI Electron impact 
ESP  Epithiospecifier protein 
et al. Et alia (Latin), and others 
GST Glutathione S-transferase 
h  hours 
IBX 2-iodoxybenzoic acid  
ITC  isothiocyanate 
Min  minutes 
MNDO Modified neglect of differential overlap  
NCS N-Chlorosuccinimide 
NFKb  Nuclear factor kappa b 
NIS N-Iodosuccinimide  
nm  nanometres 
NMM N-Methylmorpholine 
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NMR Nuclear magnetic resonance 
NPG Nitrophenyl-β-D-glucoside  
NSP  Nitrile specifier protein 
NQO1 NADH quinone oxidoreductase 
PAPs 3-Phosphoadenosine 5’-phosphosulfate 
PTAS p-Toluenesulfonic acid 
TBAF Tetra-n-butylammonium fluoride  
TBS  tert-Butyldimethylsilyl chloride 
THF  Tetrahydrofuran 
TS  Transition state 
TEMPO  2,2,6,6-Tetramethylpiperidine N-oxide 
radical 
UDPG  Uridine-5’-diphosphate glucose 
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1 
Introduction 
1.1 Glucosinolates 
Glucosinolates are a family of natural products found in all Cruciferae, including 
Brassica vegetables (Brassica Oleracea) such as Brussels sprouts, broccoli and 
oilseed rape, as well as mustard, horseradish and rocket. These secondary 
metabolites have the general structure of Type 1 (Figure 1) containing a 
thioglucose unit attached to a β-thiohydroximate bond that is O-sulfated. 
Additionally, attached to the carbon of the thiohydroximate moiety lies a side 
chain varying as an aliphatic, aromatic or indole group.  
O
HO
HO
HO
HO N
OSO3-S
R
K+
Examples of R
Aromatic
Indole
Aliphatic
N
H
Type 1
 
Figure 1: General glucosinolate structure of Type 1 with examples of side chains. 
To date, there have been approximately 150 naturally occurring glucosinolates 
isolated1 with the first reported in 1831 by Robiquet and Boutron.2 It was 
Gadamer3 in 1897 who proposed the first, but erroneous, isomeric structure, 
whereby the side chain would be linked to nitrogen and the sulfate directly 
attached to the carbon of the thiohydroximate. However, this would be later 
revised by Ettlinger and Lundeen4 in 1957 to give the currently accepted 
structure (Figure 2) whereby the β-thioglucose unit is connected to a 
thiohydroximate moiety and the sulfate is attached to the nitrogen with the Z-
stereochemistry. 
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N
R S
OSO3-
Glucose
Gadamer, 1897
N
-O3SO S
R
Glucose
Ettlinger and Lundeen, 1957  
Figure 2: Ettlinger and Lundeen proposed the first correct glucosinolate structural formulae. 
The nature of the variable side chain, R, is dependant upon the amino acid 
used in the early stages of the biosynthesis. 
1.2 Biosynthesis of glucosinolates 
Glucosinolates are biosynthesised in three distinct stages; side chain 
elongation, formation of the glycone moiety and then secondary side chain 
modification.5 
In the initial side chain elongation, the appropriate α-amino acid undergoes a 
transamination reaction to generate the corresponding α-keto acid (Scheme 1). 
This is followed by an aldol reaction with acetyl CoA. A dehydration, rehydration 
sequence, followed by oxidation and then decarboxylation occurs. Finally a 
second transamination takes place to recover the elongated amino acid 
functionality.5 
H
C COOHR
NH2
C COOHR
O
C OHR
CH2COOH
COOH
CHR
CCOOH
COOH
HO
H
CH2
CO
R
COOH
H
C COOH
H2
C
NH2
R
(repeat)
1st transamination
2nd transamination [O]
-CO2
Acetyl CoA
dehydration
rehydration
CoASH
 
Scheme 1: Initial side chain elongation. 
The substrate can be subjected to this cycle a number of times, adding another 
carbon atom with each iteration. For example methionine 2, which is used as a 
precursor for aliphatic glucosinolates, can be converted to homomethionine 3 
and then to dihomomethionine 4 and so forth using this biosynthetic cycle, 
(Scheme 2). 
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O
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NH2
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2 3 4  
Scheme 2: An example of chain extension.  
Labelling experiments have been used to probe this biosynthetic pathway. The 
most recent study by Graser6 in 2000 used isotopically enriched [1,2-13C2]-
acetate and universally labelled [U-13C]-methionine that were incorporated into 
Eruca sativa (more commonly known as ‘rocket’) in a feeding study.  In turn this 
led to the isolation of desulfoglucosinolates 5 and 6 from the leaves, where 13C-
NMR analysis was used to establish isotope enrichments, which were found at 
the corresponding positions as summarised in Scheme 3. 
S CHOOH
NH2
O
HO !
N
!
! S
OH
GlucoseS
S
N OH
GlucoseS
[1,2-13C2]-acetate
[U-13C]-methionine
5
6  
Scheme 3: a) Incorporation of [1,2-13C2]-acetate showed enhancements of the 13C-NMR signals for C-1 
and C-2 of 5; b) Incorporation of  [U-13C]-methionine showed enhancements of the 13C-NMR 
signals for the C-3,4,5 and 6 of 6. 
The second stage of the biosynthesis involves the formation of the aglycone 
moiety and is initiated by cytochome P450 oxidation of the amino acid precursor 
to give an N-hydroxyl amino acid. Little data is available regarding these steps 
due to the instability of the intermediates involved, although it is proposed that 
the oxime is initially converted to an aci-nitro compound, which is an acceptor 
for a thiol donor. The identity of the sulfur donor has recently been shown to be  
GSH, the reduced form of the tripetide of glutamic acid, cysteine and glycine.7 A 
C-S lyase enzyme then cleaves the cysteine adduct to give the 
thiohydroximate, which undergoes S-thioglucosylation by a soluble 
UDPG:thiohydroximate glucosyltransferase to yield the desulfoglucosinolate. 
The second stage of the biosynthesis concludes with sulfation by a 3’-
Introduction 
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phosphoadenosine 5’-phosphosulphate (PAPS) dependent enzyme to yield the 
complete glucosinolate5 (Scheme 4). 
R
H
C COOH
NH2
R
H
C COOH
NH2OH
R CH
NOH
R CH
N+-O OH
SH
CR
N OH
S
CR
N OH
Glucose S
CR
N OSO3-
Glucose
aldoxime aci-nitro compound
     (thio acceptor)
NADPH 
+ O2
S-alkyl-thiohydroximate
(PAPS)
UDP-Gluc
P450
GSH
S
H2
C C CO2H
NH2C
N OH
R
R'
 
Scheme 4: Second stage of glucosinolate biosynthesis. 
In individual cases the biosynthesis continues with secondary side-chain 
modifications such as methylation, oxidation and hydrolysis. It is by these 
modifications that such a diverse range of glucosinolates is formed8 (Scheme 
5). For example the thiomethyl glucosinolate 7, can be oxidised to give the S-
oxygenated glucosinolate, which in turn is converted to the hydroxylalkyl 
glucosinolate, 8. Alternatively thiomethyl glucosinolate undergoes methylsulfide 
elimination to give the alkenyl glucosinolate, 10, which can be derivatised 
further to a hydroxyalkenyl glucosinolate, 11. In further biosynthetic 
modifications the hydroxylalkyl side chain is esterified by the benzoate 
hydrolysing enzyme (BZO) to afford benzoyloxy glucosinolate, 9. 
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N OSO3-
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N OSO3-
S-Glc
O N OSO3-
S-GlcHO
N OSO3-
S-GlcBzO
N OSO3-
S-Glc
N OSO3-
S-Glc
OH
S-oxygenated glucosolate
7
8 9
10 11
BZO
 
Scheme 5: Secondary side chain modifications.8 
1.3 Enzymatic hydrolysis of glucosinolates 
Myrosinase catalyses the hydrolysis of glucosinolates when plants are 
damaged, for example by harvesting, freezing, thawing or chewing. By this 
process the glucosinolate 1 is cleaved at the thioglycoside linkage9 (Scheme 6). 
This releases the aglycone 12, a thiohydroximate-O-sulfonate, which readily 
undergoes Lossen rearrangement, in a non-enzymatic step, to form the 
corresponding isothiocyanate.  
O
HO
HO
HO
HO N
OSO3-S
R
O
HO
HO
HO
HO OH
N
-O3SO
R-S
myrosinase
Lossen-type 
rearrangement R-N=C=S
121  
Scheme 6: Hydrolysis of glucosinolate by myrosinase. 
The mode by which myrosinase hydrolyses glucosinolates is very similar to the 
hydrolysis of O-glycosides by β-glycosidase enzymes. However unlike β-
glycosidase, myrosinase does not require a glutamate residue in order to 
protonate the departing aglycone as the glucosinolate aglycone is a good 
leaving group. Myrosinase has been shown only to hydrolyse those O-
glycosides with good leaving groups such as p-NPG (p-nitrophenyl-β-D-
glucoside) and o-NPG.10 In myrosinase the catalytic glutamate is replaced by 
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glutamine and it is believed that this leads to a more favourable interaction with 
the sulfate of the glucosinolate.11 The glutamine is positioned in order to deliver 
a water molecule for the hydrolysis of the glycosyl-enzyme intermediate. 
Although the myrosinase binding site has a preference for the sugar and sulfate 
group a wide variety of side chains are clearly tolerated (Figure 3). 
O
HO
HO
HO
HO N
OSO3-S
R
O NH2
O O-
O
HO
HO
HO
HO N
OSO3--S
R
O NH2
O O
O
HO
HO
HO
HO
O NH2
O O
O
HO
HO
HO
HO
O NH3+
O O-
H
O HOH
-RNCS
-SO4 2-
R-N=C=S
SO42-
 
Figure 3: Proposed mechanism for glucosinolate hydrolysis by myrosinase.10 
The myrosinase catalysed glucosinolate hydrolysis can be modified by the 
presence of other proteins. For example, if specifier proteins are present then 
the formation of the isothiocyanate is impeded.  Two such proteins have been 
identified to date; the epithiospecifer protein (ESP) from Abradidopsis thaliana 
and the nitrile-specifer protein from Pieris rapae.12 They do not share any 
sequence similarity, however both have been shown to encourage the 
formation of nitriles. The defining reason for this change in product profile is not 
yet known, however the outcome of the rearrangement is also largely 
dependent on pH, temperature and the presence of ferrous ions.13  
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O
HO
HO
HO
HO N
OSO3-S
R
R=H
R=OHmyrosinase
myrosinase
ESP/Fe+
N C S
H
N C S
OH
O
H
N
S
CN
R
S
R = OH, H
R = OH, H
 
Scheme 7: The outcome of glucosinolate breakdown is dependant on conditions as well as side chain 
functionality. 
In selected cases, such as indole or hydroxylalkenyl side chains, the initially 
produced isothiocyanate can undergo further rearrangements to give cyclic 
(Scheme 7) or dimeric by-products (Scheme 8), due to the inherent reactivity of 
the isothiocyanate intermediate. There do not appear to be any enzymes 
involved in these reactions and the products emerge as a result of the inherent 
instability of the initially formed isothiocyanate.  
O
HO
HO
HO
HO N
OSO3-S
N R
R
N
R
N C S
N+
R
N
R
N
R
OH
N
R
Iminium ion Carbinol
SCN-
H2O
dimerisation
H+
CH2O
 
Scheme 8: Indole isothiocyanates can undergo breakdown by rearrangements to give dimeric 
compounds. 
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1.4 Biological activity of glucosinolates 
Glucosinolates and their breakdown components have many important roles 
within nature. The earliest report of glucosinolates, or more precisely their 
isothiocyanate breakdown products, acting as a natural pesticide emerged in 
1967 from Drobnica et al.14 Following this account there has been a lack of 
research in the area, properly establishing good structure-activity 
relationships.15  Despite the limited examples, phenethyl isothiocyanate 13 is 
known to be a feeding deterrent for snails (Phsella spp.), caddisflies 
(Hesperophylax designatus and Limnephilus spp.) and amphipods (Gammanus 
pseudolimnaeus).16 
N C S
13  
In some specialised cases pests, such as the diamond-back moth (Plutella 
xylostella),17 have evolved to use glucosinolates found on the leaf surface as a 
stimulus for oviposition.18 This is a process whereby pests use glucosinolates 
as a signalling agent and then burrow down into the root via the stem of the 
plants to lay eggs near the root. Upon hatching the larvae will eat the root of the 
plant at a large cost to crop yields and therefore impact significantly on 
commercial return. 
The antifungal and antimicrobial activity of glucosinolates and isothiocyanates 
are also widely known. For example phenethyl isothiocyanate and 4-
methylsulfonylbutyl isothiocyanate have been reported to inhibit the growth of 
Staphylococcus aureus and Penicillium glaucum.19 Studies have also shown 
that glucosinolates induce a significant suppression of soil-borne pathogens 
and inhibit weed seed germination20 which suggests a role in agriculture as a 
green manure. 
By far the most widely recognisable aspect of glucosinolates are their 
breakdown products, which give the sharp, bitter and distinctive taste to foods 
such as broccoli or mustard. However a regular intake of brassica vegetables, 
for example as little as 10 g of broccoli per day, has been reported to lower the 
incidence of lung, prostate and colon cancer.21 This appears to be due to the 
Introduction 
 21 
presence of the glucosinolate, glucoraphanin 14, which is abundant in broccoli, 
and breaks down to give the isothiocyanate sulforaphane 15 (Scheme 9).  
O
HO
HO
HO
HO N
OSO3-S
SO
S
O
N C S
14
15
 
Scheme 9: Glucoraphanin 14 hydrolysis to generate sulforaphane 15, a putative chemoprotective 22,23  
Greater health benefits have been shown to come from the consumption of raw 
as opposed to cooked vegetables.24 Cooking has a detrimental effect on the 
levels of myrosinase present and by consequence the level of glucosinolate 
breakdown products.  
The mode by which the glucosinolate isothiocyanates exert their chemo 
protective properties appears to be via a signalling pathway, involving nuclear 
factor kappa b (NFKb) whereby isothiocyanates act as external stimuli. This 
leads to increased expression of antioxidant and detoxification processes 
induced by the phase II enzymes glutathione-S-transferase (GST) and 
NAD(P)H: quinine oxidoreductase 1 (NQO1).24 Increased levels of phase II 
enzymes then lead to increased protection against other carcinogenic species.  
As discussed above, specifer proteins can impede the formation of 
isothiocyanates in favour of nitriles.  Studies have been conducted in order to 
assess the ecological functions of plant specifer proteins, such as ESP or NSP. 
Due to the complexity of the glucosinolate-myrosinase system and the 
difference in volatility and reactivity, it has proven difficult to assess the function 
of isolated glucosinolate hydrolysis products.25 However, more recent artificial 
diet studies of the larvae of the generalist pest Spodoptera littoralis  have 
suggested that nitriles do not act as a deterrent to feeding,25 highlighting that 
there are differences in activity between the breakdown products produced.  
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1.5 Epithiospecifier protein (ESP)  
In the presence of ESP, glucosinolates have been reported to favour nitrile 
formation upon breakdown. However, upon metabolism of alkenyl 
glucosinolates the sulfur of the thioglycosidic bond undergoes an intramolecular 
reaction, to give an unusual thiirane motif 16 which has been verified, by 
labelling experiments.26 The exact mechanism for this thiirane formation is 
unknown, although it has been hypothesised that its formation progresses via a 
radical mechanism,27 due to the 1:1 ratio of enantiomers formed (Scheme 
10),28,29 and that it is comparable to the reaction catalysed by isopencillin-N 
synthase.12 However another study involving the exclusion of oxygen and 
addition of radical scavengers did not affect the absolute or relative amounts of 
epithionitrile formed suggests that radicals may not actually be involved.12 
N
-S OSO3-
N
S OSO3-
Fen
N
N N
S-Fen
NS
SO42-
S-Fen
S-Fen
16  
Scheme 10: Proposed mechanism for ESP-catalysed reaction.27 
The mode by which ESP promotes nitrile formation is still unclear and a debate 
as to whether these proteins are co-factors or true enzymes is ongoing.  As yet 
no other natural or synthetic compound has been reported to serve as a 
substrate for ESP and the instability of the aglycone intermediate does not allow 
for rigorous kinetic studies.12 Nonetheless, studies performed on an optimal 
assay of myrosinase combined with ESP by Burow et al.,12 failed to observe 
any ESP activity when the two proteins were spatially separated by dialysis 
membranes, implying that the two proteins need to be in close proximity. In 
addition, ESP attached to a resin bound antibody was used to investigate a 
stable interaction between ESP and myrosinase. However it was found that 
when ESP was eluted from the resin, myrosinase activity was not detected.  
The study investigated whether ESP was a co-factor of myrosinase or a 
separate enzyme, by monitoring the ratio of epithionitrile to isothiocyanate 
formed from an alkyl glucosinolate. It was found that myrosinase activity was 
increased by the addition of L-ascorbate, and consequently there was a 
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decrease in the epithionitrile to isothiocyanate ratio. This contradicts a proposal 
that ESP is acting as an allosteric co-factor,30 therefore it seems likely that ESP 
is an enzyme but one that rapidly intercepts the unstable intermediate as its 
substrate (Figure 4).  
 
 
 
 
Figure 4: a) Model of the putative allosteric interaction b) without ESP c) and in close proximity for the 
intervention of the reactive intermediate. 
1.6 Previous syntheses of glucosinolates 
The first glucosinolate synthesis by Ettlinger and Lundeen in 1957 used an 
‘electrophilic’ sugar approach.4 By this approach, glucosinolate 1 is synthesised 
via the intermediate thiohydroximate 17 following sulfation and deprotection of 
the acetyl protecting groups. In turn, 17 is generated by the coupling of 18 with 
thiohydroxamic acid 19 (Scheme 11).  
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Scheme 11: Retrosynthetic analysis of ‘electrophilic’ sugar approach to glucosinolate synthesis. 
Until recently, this was the only example of this method which suffered from 
poor coupling yields of 18 and 19.4 In 2011, Rollin et al.,31 revisited this 
approach and developed a milder technique which improved the low yields by 
employing a ‘nucleophilic’ sugar. The authors found that it was possible to 
synthesise aliphatic side chains by lactone ring opening, which can be 
converted efficiently to bis-O-silylated hydroxamic acids, 20. Upon treatment 
with triflic anhydride this can progress, via a nitrile oxide, to an efficient coupling 
with thioglucose to obtain a thiohydroximate – the precursor to glucosinolates 
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(Scheme 12b).  This method was successful for a range of substrates as well as 
for aromatic side chains via the per-silylation of preformed hydroxamic acids.  
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Scheme 12: A. Ettlinger & Ludeen method. Reagents and conditions a) i CS2, ii. NH2OH⋅HCl, 0°C, 33% 
b) 18, KOH, 6 h, rt, 47%; B. Rollin method. Reagents and conditions a)i. HONH3Cl, KOH, 
MeOH ii. TBSCl, imidazole, DMF b) i. Tf2O, Et3N, DCM, 0°C ii. 21, Et3N, DCM. 
The most common method used for the synthesis of glucosinolates is that of 
Benn32 (Scheme 13) reported over forty years ago. It has been the most widely 
utilised.33 This robust method constructs the intact glucosinolate 1 from an 
thiohydroximate 17, which in turn derives from the coupling of tetra-O-acetyl 
thioglucopyranose 21, a nucleophilic sugar, and an oximyl chloride 22. 
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Scheme 13: Retrosynthetic analysis of Benn.32 
The sugar unit 21 can be readily accessed from glucose, an inexpensive and 
readily available starting material, by a route devised by Cerny et al.34 (Scheme 
14). 
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Scheme 14: Retrosynthetic analysis of 2,3,4,6-tetra-O-acetyl-1-thio-D-glucopyranose 21. 
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For fragment 22, there are thee main synthetic approaches reported for the 
synthesis of glucosinolates (Scheme 15). These are the aldoxime, nitronate or 
nitroalkene pathways, which are all detailed in the following sections.  
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Scheme 15: Three retrosynthetic routes toward the intermediate oximyl chloride 22.33 
1.7 The aldoxime pathway for glucosinolate synthesis 
Benn’s pioneering work on the synthesis of many natural glucosinolates 
including; glucoapparin, gluconasturtin, glucoputranjivin, glucosinalbin, 
glucoaubrietin, glucocochlearin32,33,35-41 used the aldoxime pathway. The key 
step for this method requires the chlorination of an oxime, synthesised from the 
corresponding aldehyde, using electrophilic chlorinating agents (Scheme 16). 
Chlorine gas42 and NCS43 are often employed. One advantage of this route is 
that the starting alcohols, aldehydes or even oximes are commercially available. 
However there have been reports of low yields40 of thiohydroximate formation 
and difficulty in purifying the oximyl chlorides, which has led to the development 
of complementary routes. 
 
Introduction 
 26 
O
AcO
AcO
AcO
AcO SN
OH N OH
Cla b
c d
N
OH
O
AcO
AcO
AcO
AcO S N
OSO3- O
HO
HO
HO
HO S N
OSO3-
23  
Scheme 16: Aldoxime in the synthesis of glucotropaeolin 23.35 Reagents and conditions a) Cl2, CHCl3, 
48%; b) acetylated thioglucose, NEt3, Et2O, 81%; c) Py⋅SO3, 17%, d) NH3/MeOH, 100%.  
1.8 The nitronate pathway towards glucosinolate synthesis 
Methodology emerged in 1954 by Copenhaveur whereby a thiohydroximate is 
formed by using base induced condensation of primary nitroalkanes with thiols 
(Scheme 17).44  
NO2
SH N
S
OH
a
 
Scheme 17: The original Copenhaveur conditions. 44 Reagents and conditions a) tri-n-butylamine, reflux 
Benn later developed these conditions to explore their application towards 
glucosinolates.45 The original synthetic studies proved unsuccessful as they 
required harsh conditions, which were likely to deprotect the thioglucose moiety, 
and thus proved low yielding. However they observed that there was an 
intermediate nitronate anion, which could be formed under a range of milder 
conditions (Scheme 18). This nitronate has proven widely applicable in the area 
of glucosinolate synthesis. 
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Scheme 18: Benn’s milder conditions.45 Reagents and conditions a) NEt3, THF, 56% and 28%. 
During the coupling of the two fragments, 24 and 21, formation of the unnatural 
E isomer, 26, was observed, however this was found to be labile and it could be 
converted to the natural Z isomer, 25, by the addition of acid (Scheme 18). In 
more recent studies,48 as detailed in Scheme 19, the key stage of the reaction 
requires nucleophilic chlorination of the nitronate intermedate. Various 
techniques have been reported to achieve this for glucosinolates including dry 
HCl46 and thionyl or lithium chloride.40,47 This pathway has been particularly 
favoured in the synthesis of glucosinolates, such as sinigrin 27,48 which contain 
alkene functionality in order to circumvent the possibility of alkene halogenation 
(Scheme 19). 
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Scheme 19: An example of the nitronate pathway in the synthesis of sinigrin.48 Reagents and conditions 
a) NaNO2, urea, DMSO; b) NaOEt; c) LiCl-HCl; d) acetylated thioglucose, NEt3; e) py⋅SO3; f) 
NH3/MeOH. 
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1.9 Nitroalkene pathway towards glucosinolate synthesis 
In 1994 Kulkarni developed an alternative method for the formation of 
hydroximyl chlorides 29 via nitroalkene precursors 28 (Scheme 20).49 
Ar NO2 Ar
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Scheme 20: Kulkarni methodology. Reagents and conditions a) TiCl4, Et3SiH, CH2Cl2, rt, 1 h, 76%. 
Realising the potential in this methodology Rollin et al., applied it to the 
preparation of a range of glucosinolates bearing aryl alkyl and indolymethyl 
functionalities.50 They found that the approach had the advantage of a shorter 
reaction pathway than the nitronate method and that it was applicable to a wider 
range of substrates including indoles, such as 30, which had previously proven 
troublesome in glucosinolate syntheses. An example of this method is detailed 
in Scheme 21. 51   
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Scheme 21: An example of the nitroalkene route in the synthesis of glucobrassicin.51 Reagents and 
conditions a) i. CH3NO2, AcONH4; ii) Ac2O, DMAP; b) TiCl4, Et3SiH, CHCl2; c) 21, NEt3; d) 
py⋅SO3, pyridine; e) MeOK, MeOH. 
1.10 The synthesis of novel and unnatural glucosinolates 
The synthesis of novel and unnatural glucosinolates play a vital role in 
understanding the many biological aspects of these natural products. For 
example Rollin et al., synthesised sugar motifs, deoxygenated at various 
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positions (31-34, Figure 5), and screened them against natural glucotropaeolin 
35 and glucobrassicin 36 in order to probe the activity of myrosinase.52 During 
this study it was found the C-2 deoxyglucose (31, Figure 5) showed a significant  
decrease in inhibition. This was suggested to be due to two factors; i) the 
absence of a C-2 hydroxyl in 31 disturbs favourable alignment of the sugar 
moiety in the binding site. This effect was also apparent for the C-6 
deoxygenated glucose analogue 34; and ii) C-2 being close to the glycoside 
bond will impact on the polarisation required for inducing nucleophilic attack at 
the anomeric carbon.   
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Figure 5: Deoxygenated sugar analogues synthesised by Rollin et al.52 
2-Deoxy-2-fluoroglucotropaeolin 37 (Figure 6) was synthesised and proved 
successful in inhibiting myrosinase, however this substrate was found to 
undergo rapid Lossen rearrangement.53 Therefore the sulfide functionality was 
removed in order to prepare a non-hydrolysable substrate, C-glucotropaeolin, 
38 (Figure 6).54 It was anticipated that in doing so, information regarding 
substrate positioning, conformation and binding in the active site might be 
obtained with the use of X-ray data. Unfortunately this substrate did not bind to 
the enzyme, suggesting that the sulfide is essential for binding to 
myrosinase.54,55 This led to further developments by Rollin and co-workers in 
the synthesis of the first carbo-glucosinolate, 39 (Figure 6), whereby the endo-
oxygen was replaced by a methylene group.56 This analogue was found to be 
an inhibitor of myrosinase.   
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Figure 6: Modified structures of glucopaeolin; 2-deoxy-2-fluoroglucotropaeolin 37, C-glucotropaeolin 38, 
carbo-glucotropaeolin 39.53-56 
To date the only structural change tolerated at the anomeric centre and to 
undergo enzymatic hydrolysis by myrosinase has been that of 
selenoglucosinolate 40 in Figure 7.57 Breakdown products were analysed by 
‘trapping’ the volatile breakdown products in reactions with piperidine where 
adducts such as 41 were observed. 
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Figure 7: Selenoglucosinolate 40 and trapped adduct 41. 
Finally, a ‘pseudo-glucosinolate’ 42 has also been synthesised by Rollin and co-
workers58 that possesses an α-thioglycosidic linkage instead of the naturally 
occurring β-thioglycoside bond. 
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1.11 The synthesis of isotopically labelled glucosinolates  
Isotopically labelled glucosinolates have provided vital information regarding the 
biosynthesis (Section 1.2) and metabolism of glucosinolates.59 For example 
plant metabolism has been probed in feeding experiments with isotopically 
labelled precursors. In this way the labelled compounds are introduced into the 
living plant and their metabolites can then be traced, either by following the 
radioactivity by scintillation counting of purified extracts or with stable isotopes, 
or by analytical methods such as LC-MS or NMR spectroscopy. For example in 
1977 Luthy and Benn used 2-[1-14C]-propenyl glucosinolate to demonstrate the 
conversion to 3-thiocyanato [3-14C]-propenyl glucosinolate where the aglycone 
43 is believed to undergo a rearrangement as illustrated in Scheme 22.60 
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Scheme 22: SN2’ rearrangement of sinigrin aglycone 43. 
More recently Rossiter et al.,61 used (E)-2-[2,3-2H2]-propenyl glucosinolate to 
study the enzymatic hydrolysis of sinigrin. Sinigrin 27, is a widely documented62 
alkene glucosinolate isolated from broccoli and Brussel sprouts. During this 
study Rossiter et al.,61 were able to confirm the rearrangement of the 
thiohydroximate moiety (Scheme 22) and demonstrated by 2H-NMR that the 
deuterium atoms were retained and emerged at the double bond terminus of 44 
in an SN2’ type rearrangement. 
Isotopically labelled glucosinolates have also been used to answer questions 
regarding metabolism of glucosinolates in humans. For example, the 
chemoprotective properties of glucosinolate breakdown products such as 
sulforaphane, are well documented63 and the issue of human exposure is 
complex. As previously discussed  (Section 1.3) myrosinase levels, affected by 
processes such as cooking or chewing, will in turn affect the level of 
isothiocyanates produced and therefore have an effect on the level of 
chemoprotective activity. In order to gain an insight into human exposure levels 
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to isothiocyanates, stable isotope enriched glucosinolates have been 
synthesised to search for new biomarkers and to be used as internal standards 
for LC-MS.64  
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Figure 8: [Phenyl-2H5]-gluconaturtiin 45 and its metabolites.64 
Previous work within the Botting group has reported the synthesis of [phenyl-
2H5]-gluconasturtiin 45 and its metabolites (Figure 8).65 In order to search for 
new biomarkers a study was performed whereby labelled and unlabelled 
compounds were fed to rats and the isotopically enriched products were used to 
identify metabolites by a difference of 5 amu using LC-MS. Additionally these 
isotopically labelled compounds have also been employed as internal LC-MS 
references compounds in various studies, including a study on the analysis of 
blood plasma following dietary studies in order to quantify glucosinolate 
exposure.66 
1.12 Aims of research 
This programme of research set out to develop new methods for the synthesis 
of novel and natural glucosinolates by developing improved methodologies. A 
key area to be addressed was the formation of the thiohydroximate bond, a 
current synthetic hurdle, which is time consuming and generally gives products 
in low yield (Scheme 23).40 
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Scheme 23: Thiohydroximate 17 assembly by coupling of thioglucose 21 and oximyl chloride 22. 
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Development of new methodology such as side chain functional group 
conversions was of particular interest, as this would introduce improved 
techniques in the area of introducing isotope labels into glucosinolates. For 
example, the establishment of chemical transformations that could be 
successfully performed at a late stage in glucosinolate assembly, using 
commercially available isotopically labelled starting materials, would allow 
access to desirable labelled glucosinolates via less expensive and more 
efficient methods (Scheme 24). 
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Scheme 24: Schematic of novel approach to introduce labelled side chains from a common intermediate. 
A successful programme would also allow the synthesis of novel glucosinolates, 
which could then be used to explore biological questions, such as the ESP 
mechanism (Section 1.5). Therefore at the outset it was important to establish a 
method to allow the synthesis of gluosinolates, containing alkene side chains. In 
addition synthetic challenges, such as glucosinolate-thiohydroximate 
protections, were explored to allow for intact-glucosinolate chemistry to be fully 
investigated.  
Strategies regarding purification and handling of glucosinolates need to be 
considered, e.g. during the sulfation step. Thus another objective explored  
alternative counter ions for sulfation, particulary cyclohexylammonium, to 
improve stability and processability (Figure 9).  
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Figure 9: Cyclohexylammonium is an example of an organic counter ion for glucosinolate salts. 
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An alternative approach for simplifying glucosinolate preparation and 
purification, involved exploring a solid phase synthesis of glucosinolates 
(Scheme 25). This offers particular benefit at the sulfation and final deprotection 
stages where the products are often difficult to handle. In this programme a 
solution phase model study with a resin mimetic was explored as a prelude to 
attempting an on resin synthesis. Solid phase synthesis of glucosinolates has 
never previously been reported. 
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Scheme 25: Proposed method for the solid phase synthesis of glucosinolates. 
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2 
Optimising glucosinolate synthesis 
2.1 Introduction and background 
In order to improve on previous total syntheses of glucosinolates, it was 
necessary to establish a synthesis of a representative example of the 
glucosinolate family in the laboratory. To this end a total synthesis of but-3-enyl 
glucosinolate 46 was planned. 
O
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HO
HO S N
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46  
A number of factors make but-3-enyl glucosinolate an interesting target. It had 
previously been prepared in low yields and the efficiency of the synthesis 
remained unsatisfactory.67  Secondly it is known to be a substrate for ESP 
breakdown. Access to the natural product would allow the role of ESP to be 
addressed in more depth (Section 1.5). Finally, the alkene functionality should 
enable further chemistry to be developed on intact glucosinolates in order to 
prepare novel entities (Section 1.12) a strategy that has been relatively 
unexplored to date. 
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2.2 Results and Discussion  
The approach taken explored retrosynthetic disconnections as previously 
described by Benn32 (Scheme 26). This involved the coupling of β-thioglucose 
21 and the oximyl chloride 48. Following this it was envisaged that 
thiohydroximate 47 would be converted to the glucosinolate 46 by O-suflation 
and removal of the acetate protecting groups. 
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Scheme 26: Retrosynthesis of 46 via the Benn approach.32 
2.3 Synthesis of β -thioglucose 21 
The synthesis of β-thioglucose followed the route developed by Cerny et al.34 
Thus starting from D-glucose a one-pot acetylation using HBr (45% in acetic 
acid) and acetic anhydride gave rise to the peracetylated glucose 49. This 
intermediate was not isolated, instead addition of a further 3.3 equivalents of 
HBr (45% in acetic acid) promoted C-1 bromination. The product was secured 
by extraction into ether and then recrystallisation from diethyl ether. This 
provided 18 in an excellent yield (85%) and the reaction was carried out on a 
50 g scale. 
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Scheme 27: Reagents and conditions a) HBr (45% in acetic acid), acetic anhydride, 24 h, 85%. 
Although the C-2 acetate group is likely to be involved in neighbouring group 
participation giving rise to the β-anomer, it has been observed that the β-
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bromide will equilibrate under the reaction conditions to give the more 
thermodynamically stable α-anomer 18 (Scheme 28). 
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Scheme 28: The proposed mechanism for bromination. 
The α-anomer is thermodynamically more favoured than the β-anomer due to 
anomeric stabilisation. This stereoelectronic effect is a result of the lone pair of 
the pyranose oxygen being able to donate into the antibonding orbital (σ*) of the 
C-Br bond. This is only possible due to the overlap of the two orbitals and is not 
achievable in the β-anomer where the orbitals are essentially at right angles to 
each other (Figure 10a).68 Also with the bromide in the equatorial position an 
additional electrostatic repulsion occurs between the bromine and the endo 
oxygen, which is relaxed with the bromide in the axial position (Figure 10b) thus 
disfavouring the β-anomer. 
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Figure 10: a) Anomeric effect comparing the α-anomer and β-anomer. b) Electrostatic repulsion 
comparing the α-anomer and β-anomer. 
Introduction of the sulfur was then required. Displacement of the bromide of 18 
was accomplished with thiourea, in an SN2-type reaction to give 50. The 
resulting salt (50) was purified via recrystallisation from acetone and was 
recovered in good yield (71%). In contrast to 18, the anomeric stereochemistry 
of intermediate 50 favoured the β-anomer, although coupling constants could 
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not be measured at this point to assign stereochemistry, as the H-1 signal 
overlapped with those from H-2 and H-4. 
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Scheme 29: Reagents and conditions a) Thiourea, acetone, reflux, 15 mins, 71%.;b) sodium metabisulfite, 
DCM: water, reflux, 20 mins, 76%.  
Finally, in order to obtain β-thioglucose 21, the hydrolysis of thiourea 50 was 
performed (Scheme 29). Treatment with sodium metabisulfite in a biphasic 
system at reflux provided the product in an excellent yield (76%). The product 
21 was crystallised from methanol and the β-stereochemistry was confirmed by 
a distinctive doublet at 4.49 ppm and with a 3J coupling constant of 9.1 Hz 
consistent with H-1 being in the axial position. 
2.4 Synthesis of the oximyl chloride fragment 
The discussion in Chapter 1 outlined that three independent routes have been 
explored for the formation of oximyl chlorides; a nitroalkane, nitroalkene or an 
aldoxime approach. The nitroalkene route used for the synthesis of sinigrin 2750 
was first explored. 
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2.4.1 Synthesis of oximyl chloride via Nitroalkene route 
The desired nitroalkene 54 was approached in two different ways (Scheme 30). 
In each case the integrity of the material was confirmed by 1H and 13C NMR and 
was consistent for both methods. 
OH Br NO2
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Scheme 30: Reagents and conditions a) CBr4, PPh3, DCM, 0 °C, 4 h, 48%; b) HMPA, 130-195 °C, 2 h, 
73%; c) NaNO2, DMF, rt, 4 h, 37%. 
The first used penten-1-ol 51 that was brominated, used carbon tetrabromide 
and triphenylphosphine to generate intermediate 53, a reaction which proceeds 
in a moderate yield (48%). The second method developed by Meyer et al.,69 
started from 1,5-dibromopentane 52 to give 5-bromopentene 53 in an E2 
elimination reaction. In situ distillation allowed recovery of the desired product in 
good yield (73%) and high purity. This method proved the more practical for 
greater accessibility to the desired bromide on a gram scale.  
Nitration using sodium nitrite was favoured over the use of silver nitrite due to its 
lower cost and lower toxicity. The resultant nitro compound 54 was generated in 
a moderate yield (37%).  Perhaps the low yield is due to the ambident nature of 
the nitrite anion nucleophile, which can either react via nitrogen or oxygen, 
although none of the O-alkylated product 55 was observed (Scheme 31). 
53
54NaNO2 Br
NO2
ONO
55  
Scheme 31:  Ambident nucleophile has the potential to give two products from the nitration reaction. 
It was not possible to improve the yield of the nitration step and thus access to 
significant quantities for further investigation was particularly limited. Therefore 
the alternative aldoxime pathway was explored. 
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2.4.2 Synthesis of oximyl chloride via aldoxime pathway 
The availability of straight chain alkenes with an aldehyde functionality is limited 
and the few compounds that are of this class, available from commericial 
suppliers, are expensive. Therefore it was envisaged that oxidation of the more 
readily available alcohols would prove to be more viable (Scheme 32).  
a b
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Scheme 32: Reagents and conditions a) IBX, DCM, 50 °C, 48 h, quant; b) NH2OH⋅HCl, NaOAc, MeCN : 
H2O, 16 h, 73%.  
There are of course numerous methods available for the oxidation of an alcohol 
to an aldehyde.70 In this case methods involving TEMPO were first 
explored.71,72, However these methods proved largely unsuccessful. IBX,73 the 
precursor to the well-known Dess-Martin periodinane (DMP) was then explored. 
This gave a quantitative conversation of the alcohol to the aldehyde, showing 
the distinctive formyl proton signal at 9.72 ppm in the 1H NMR spectrum. An 
added advantage of this method is the low solubility of IBX and its reduced by-
product (Figure 11) in organic solvents, allowing the reagent residue to be 
filtered off once the reaction was complete. Further purification of the aldehyde 
was not required after work up. 
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Figure 11: Structures of TEMPO and IBX. 
Although IBX is relatively easy to synthesise, large amounts were required for 
scale up. Batch syntheses of 50 g were undertaken for IBX but this proved time 
consuming and costly for the amount of reagent required to secure the 
aldehyde on a desirable scale. This was a bottle-neck particulary as an early 
stage step and thus an alternative method was sought. 
It was found that a more cost-effective Claisen rearrangement, could be used to 
convert commercially available allyl vinyl ether 58 to the desired aldehyde 56 in 
   Chapter 2 
 41 
quantitative yields by heating in a sealed tube (Scheme 33). This also had the 
benefit that the product 56 did not require further purification after the reaction. 
a
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Scheme 33: Claisen rearrangement of allyl vinyl ether 58. Reagents and conditions a) Sealed tube, 
150 °C, 16 h, quant. 
With aldehyde 56 in hand, conversion to the desired oxime intermediate 57 was 
then required.  This was achieved using hydroxylamine hydrochloride in a 
biphasic solution of acetonitrile and water, and generated the desired product in  
high yield (73%).  The oxime was isolated as a 1:1 mixture of E:Z isomers, 
readily identifiable by the two signals of the oxime protons, in the 1H-NMR 
spectrum at 7.43 and 6.72 ppm, as well as two oxime resonances in the 13C- 
NMR spectrum at 149.8 and 149.4 ppm. A separation of the geometric isomers 
was not attempted as the E and Z oximes both proceed via the common 
intermediate 59 during the coupling reaction (Scheme 34). 
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Scheme 34: E and Z oximes progress via the nitrile oxide 59 during oximyl chloride formation.  
For the conversion of oxime 57 to the oximyl chloride 48 a variety of methods 
have been used. These have included the use of chlorine gas42 or an 
alternative ‘Cl+’ source such as NCS.43 A previous synthesis of isotopically 
labelled 4-butenyl glucosinolate by Rossiter74 used NCS and achieved a yield of 
19% for the thiohydroximate product. As this was a key stage in our synthesis 
of glucosinolates, we sought to develop an alternative and more reliable 
protocol to effect this transformation. 
After repeating Rossiter’s74 method (Scheme 35) it was observed that the 
intermediate oximyl chloride was low yielding and proved difficult to purify and 
then to characterise. It became apparent that, due to the instability of the oximyl 
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chloride, a ‘one-pot’ coupled synthesis from oxime 57 to thiohydroximate 47 
would be advantageous, to avoid handling of the sensitive oximyl chloride 48. 
NHO N
Cl
HO
57 48
a
 
Scheme 35: Chlorination was attempted using NCS. 
2.5 An improved one-pot coupling protocol 
There is evidence that the coupling of the oximyl chloride and β-thioglucose 
occurs via a nitrile oxide intermediate 59 (Scheme 34).46 It was noted that a 
mild method for the formation of nitrile oxides had been reported by Engberts et 
al., in 1998,75  although its use in glucosinolate synthesis had not been 
explored. This method simply used sodium hypochlorite (NaOCl) treatment to 
efficiently oxidise the oxime to a nitrile oxide for cycloaddition to the alkene. The 
reaction with styrene is illustrated in Scheme 36. 
NHO ONN O
-
NaOCl
 
Scheme 36: Engberts formation of nitrile oxides using sodium hypochlorite. 
The aldoxime route is not generally used in the synthesis of glucosinolates 
bearing alkene side chains due to the possibility of alkene chlorination. 
Although NaOCl is an electrophilic source of chlorine it was however found in a 
preliminary study with oxime 57, that chlorination of the terminal alkene did not 
occur (Scheme 37) and the process might be suitable in the development of a 
‘one-pot’ procedure.  
NaOClNHO N
Cl
HO
NHO
m/z ES+ [M+H]+ 134 136
Not observed
Cl
 
Scheme 37: Preliminary analytical study: Oxime 57 treated with a NaOCl : DCM biphasic solution. Mass 
spectra  of product. A m/z (ES+) of 134 was observed consistent with production of 48. 
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An attempt was made to carry out a one-pot process however a strongly 
exothermic reaction occurred and only the dimeric sugar 60 was isolated as 
evidenced by mass spectrometry. Such a structure is consistent with a disulfide 
bond formation although this was never securely identified.  
O
AcO
AcO
AcO
OAc
S S
O
OAc
OAcAcO
AcO
60  
In order to investigate and overcome oxidative dimerisation, it was necessary to 
prepare the oximyl chloride 48 independently and then add the resulting 
solution directly to the β-thioglucose 21. This was achieved by simply shaking a 
solution of oxime in DCM with commercially available laboratory NaOCl in a 
separting funnel. The use of DCM as the solvent is advantageous as a range of 
oximes are readily soluble and conveniently, it is denser than the NaOCl 
solution and the lower layer can be added directly to the β-thioglucose 21 
coupling reaction. Addition of the NaOCl to a solution with oxime and DCM 
results in a strong blue colour indicating the formation of a nitroso intermediate, 
most probably 61 (Scheme 38) as well as transient dimeric intermediate 62. The 
strong blue absorbance at 660 nm is most probably due to a N=O, π-πΨ,electron 
transition.46 
NHO
R
N
R
O
ClH
N
ClR
OH N+
O-
R
N
SR
OH
Glucose
oximyl 
chloride
R = Aliphatic, aromatic and indole sidechains
HS-GlucoseNEt3
nitroso
N+ N+
O-
CHRCl-O
ClRHC
61
62  
Scheme 38: Proposed mechanism for thiohydroximate formation.76 
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After the blue colour had dissipated the DCM fraction containing the oximyl 
chloride was then added directly to a stirred solution of β-thioglucose 21. It was 
not necessary to dry or purify the oximyl chloride in any way before addition.  
Also during optimisation it was noted that the order of addition was key to a 
successful outcome for the reaction. It was observed that addition of 
triethylamine to the β-thioglucose component before the oximyl chloride led 
exclusively to the formation of the disulfide dimeric sugar 60. Also it was 
presumed that early addition of base to the oximyl chloride would generated the 
nitrile oxide 59 which in turn could lead to unwanted by-products. Such by-
products could be 1,3-dipolar cycloaddition adducts such as furoxans 63, 
(Scheme 39a) or tricyclic adducts such as 64, (Scheme 39b) although, none of 
these products were isolated.  
N OH
N+O-
NEt3
N+O-
N+
O
N
O-
63
N OH
N+O-
N+-O
O
N
O
N
NEt3
64
a
b
 
Scheme 39: Origin of putative dimeric products. 
For the most efficient outcome the sugar 21 and oximyl chloride 48 are 
combined before the addition of triethylamine. Also during optimisation it was 
observed that both the desired adduct and β-thioglucose co-eluted on flash 
chromatography making it difficult to isolate the product in high purity. This 
issue was addressed by lowering the amount of β-thioglucose to 0.6 
equivalents, which improved the conversion with no unreacted starting material 
being observed by 1H-NMR spectrum. Finally, increased yields were obtained 
when an excess of both base (3 eq) and sodium hypochlorite (5 eq) were used 
in the respective steps.  
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Scheme 40: Reagents and condtions  a) NaOCl, NEt3, DCM, 3 h, 63%.  
Following the formation of the intermediate nitrile oxide, the nucleophile, in this 
case β-thioglucose, attacks the nitrile oxide to generate the desired β-
thiohydroximate bond (Scheme 40). This gave rise to the Z-isomer exclusively, 
consistent with the previous literature of glucosinolate coupling.32 The formation 
of the Z-thiohydroximate is stereoelectronically favoured as the incoming 
nucleophile and the nitrogen lone pair will result in an antiperiplanar 
arrangement analogous to the atomic rearrangement that takes place during 
1,3-dipolar cycloadditions of nitrile oxides.  A debate regarding the mechanism 
of nucleophillic addition to nitrile oxides has led to conflicting computational 
studies regarding whether the reaction proceeds via a stepwise or concerted 
mechanism. The first report was by Sharma and Aggarwal, 76 which showed the 
progression via a stepwise addition based on semiempirical MNDO 
calculations. By this mechanism the reaction is reported to progress via two 
discrete transition states, TS1 and TS2, as shown in Scheme 41.77 
R C N+ O-
H3C OH
NC
O
R
O
H
H3C
NC
O
R
O
H
H3C
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O
R
O
H
H3C
N
OHH3CO
R
TS1
TS2
Intermediate
 
Scheme 41: Proposed non-concerted mechanism of Sharma and Aggarwal77 deduced by semiempirical 
MNDO calculations. 
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By contrast, Hegarty et al. using ab initio calculations78 suggest an 
asynchronous concerted process, whereby proton transfer to the oxygen begins 
at the transition state and progresses without any further energy barrier, 
(Scheme 42). Despite the dispute in the status of the transitions state both 
methods are in agreement that Z-selectivity will be favoured as the 
stereochemical outcome of thiohydroximate formation.  
C N O-R N
O
R
Nu H
Nu
H
N
OHNu
R
 
Scheme 42: Proposed concerted mechanism via ab initio calculations.78 
2D NMR spectroscopy was used to confirm the formation of a new C-S bond, 
showing a HMBC correlations between H-1 (5.01 ppm) in the 1H-NMR spectrum 
and thiohydroximate carbon (156.9 ppm) in the 13C-NMR spectrum. 
In addition it was also found that the product crystallised and a suitable crystal 
was submitted for X-ray crystallographic analysis (Figure 12). The resulting 
structure confirmed the Z-stereochemistry of the thiohydroximate moiety with a 
S-C=N-O torsion angle of -1.0°.  
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Figure 12: X-Ray data of two distinct conformers of 47 within the unit cell showing the Z stereochemistry 
of the thiohydroximate moiety. 
2.6 Viability of coupling on other analogues 
The applicability of this new thiohydroximate bond formation was explored with 
a variety of substrates in order to assess its generality in glucosinolate 
synthesis. This new procedure proved to be highly efficient with all of the 
oximes that were studied, giving improved yields over previous two-step 
methods as detailed in Table 1. Entry 1, this gave a 76% yield and is the 
precursor to gluconasturtiin, which had been made before in the Botting 
laboratory in a 61% yield, over two steps via the standard method involving 
isolation of the oximyl chloride.79 Similarly it was also prepared by McLeod in 
69% yield.46  The oxime of octanal (Entry 2) was coupled to give heptyl 
glucosinolate, previously preformed in 61% yield over two steps.33 This could be 
improved to a 78% isolated yield. Good yields were also obtained with both 
alkenyl and alkynyl side chains (Entries 3 and 4). In previous syntheses of 
glucosinolates, with unsaturated side chains, the oximyl chlorides were 
prepared via nucleophilic chlorination due as the presence of the alkene in the 
side chain which was anticipated to be problematic for electrophillic methods.33 
However, it is striking that but-4-enyl oxime could be obtained in 63% yield 
(Entry 3), compared to only 13% with the nitroalkane protocol over two steps.67  
O
AcO
AcO
AcO
AcO S N
OH
47
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Entries 5 and 6 are aromatic oxime components for novel glucosinolate 
structures. The final oxime (Entry 7) gives a β-thiohydroximate with a TBS-
protected alcohol in the side chain. This was found to be stable under the 
reaction conditions, and coupled in an excellent yield. 
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Entry Oxime Product Product number Yield 
 
1 
 
O
AcO
AcO
AcO
AcO S N
OH
 
 
65 
 
76% 
 
2 
 
O
AcO
AcO
AcO
AcO S N
OH
5
 
 
66 
 
78% 
 
3 
 
 
O
AcO
AcO
AcO
AcO S N
OH
 
 
47 
 
63% 
 
4 
 
 
O
AcO
AcO
AcO
AcO S N
OH
 
 
67 
 
77% 
 
5 
 
 
O
AcO
AcO
AcO
AcO S N
OH
Br  
 
68 
 
92% 
 
6 
 
 
O
AcO
AcO
AcO
AcO S N
OH
N  
 
69 
 
65% 
 
7 
 
 
O
AcO
AcO
AcO
AcO S N
OH
OTBS
 
 
70 
 
83% 
Table 1: Range of oximes coupled to β thioglucose by NaOCl method. Yields are of purified products. 
N OH
N OH
N OH
N OH
N OH
Br
N OH
N
OTBS
N OH
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2.7 Attempted synthesis of indole glucosinolate 
One of the most challenging side chains to prepare in the glucosinolate family is 
that of the indole moiety.81 In order to test the viability of such substrates in this 
one-pot oxidative method, a synthesis of 73 using indole-oxime 72 was 
explored. The oxime 72 was readily prepared from commercially available 
indole-aldehyde 71, as illustrated in Scheme 43. 
N
H
N
OH
O
AcO
AcO
AcO
AcO S N
OH
N
H
O
7271
a
73
N
H
 
Scheme 43: Reagents and conditions a) NH2OH⋅HCl, NaOAc, MeCN : H2O, 16 h. 52% b) NaOCl, NEt3, 
DCM. 
The coupling reaction failed to yield the desired indole thiohydroximate 73 
under our conditions and only a dimeric sugar product was generated as well as 
unreacted oxime 72. It was thought, due to the recovery of the oxime that poor 
solubility of 72 may be the cause of the unsuccessful outcome. The reaction 
was therefore explored using a range of solvents. Although a solvent change 
from DCM to ethyl acetate increased the solubility of oxime 72 there was no 
evidence for the formation of the desired indole hydroximate, 73.  
2.8.1 Attempted synthesis of N-glycoside glucosinolates 
Only a few examples are known of glucosinolates that have alternative 
heteroatoms to sulfur at the anomeric centre, Section 1.10. It was decided to 
explore the synthesis of this linkage with nitrogen to generate the aminoxide 
moiety 74 using the new methodology. In addition to probing the scope of the 
reaction, these products would clearly be of biological interest as potential 
substrate analogues to test their ability to undergo enzymatic hydrolysis with 
myrosinase.  
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In order to generate the amidoxime analogues of glucosinolate 77 a suitable 
amino sugar 75 was required which could be coupled with 3-phenylpropiopal 
oxime 76  (Scheme 44). The amino sugar 75 has been prepared previously 
from bromide 18, an intermediate used for the synthesis of β-thioglucose 21.  
O
HO
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HO
HO NH N
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NH2
N OH O
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AcO NH N
OH
18 75 76
77
78  
Scheme 44: Proposed synthesis of amidoxime analogue of glucosinolates. 
The requisite amino sugar 75 was prepared by heating 18 with sodium azide in 
a sealed tube in acetone and water (Scheme 45). The desired azide 79 was 
generated in good (69%) yield. The β-anomer was formed exclusively as 
indicated by a coupling constant of 9.0 Hz at 4.68 ppm in the 1H spectrum. This 
suggests a process which progresses via neighbouring group participation 
involving the C-2 acetate moiety. The next step in the process involved 
reducing the azide via a Staudinger 82 reaction. Such a reduction on 79 was 
however inconclusive. Although the mass spectrum indicated an ion of m/z 348 
(ES+), consistent with the desired product, it was not possible to purify. 
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Therefore a hydrogenation, using the H-Cube apparatus was selected for direct 
reduction of the azide using a 10% palladium on carbon cartridge (10% Pd/C). 
18 75
O
AcO
AcO
AcO
OAc
Br
O
AcO
AcO
AcO
OAc
N3
O
AcO
AcO
AcO
OAc
NH2
79
a b
 
Scheme 45: Reagents and conditions a) NaN3, sealed tube, 16 h, 69%; b) H-Cube, 10% Pd/C 30 min, 
quant. 
The H-Cube has the benefit of performing the hydrogenation under flow 
conditions and the active palladium catalyst is contained in a pre-packed 
cartridge. The equipment eliminates the requirement for handling flammable 
powdered palladium on carbon (Figure 13). 
 
 
 
 
 
 
  
 
 
 
The method proved successful and allowed reduction of the azide to the amine 
to take place in a quantitative yield in a 30 minute run with no need for 
purification.  
     
H2 
A 
B 
C 
D 
A  - A solution of the rectants are pumped 
into H-Cube with a continuous flow. 
B – Hydrogen gas is produced in situ from 
the electrolysis of water. 
C – The catalyst is contained within a pre-
packed cartridge within the reaction 
chamber. The pressure and temperature  of 
the reaction chamber can be altered as 
required. 
D – Hydrogenated product is pumped 
through the system to an awaiting 
collection vessel. 
 
Figure 13: Schematic of H-Cube equipment. 
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Scheme 46: Reagents and conditions a) NaOCl, NEt3, DCM. 
With this amino sugar 75 in hand attempts were made to couple with 3-
phenylpropional oxime 76 using the method described in Section 2.5. However 
the reaction did not however go to completion as determined by the 1H NMR 
spectra. The 1H NMR of the product (Figure 14a) showed the starting amino 
sugar as well as a second sugar derivative (<10%). These products co-elute by 
flash chromatography and it was not possible to separate them for 
characterisation. In order to confirm the presence of the coupled amine, a D2O 
shake was performed. This resulted in the disappearance of the NH signal (6.20 
ppm) in the 1H-NMR spectrum as well as a change from a doublet of doublets to 
a doublet at 4.62 ppm with a 3J coupling of 9.0 Hz, for the H-1 proton (Figure 
14). 
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Figure 14: Putative presence of 77 by 1H-NMR analysis. Overlay of 1H-NMRs a) crude 77 ;b) D2O shake. 
A sample of the reaction mixture was submitted to electrospray mass 
spectrometry and a m/z (ES+) 517 [M+Na]+, consistent with the desired product, 
as well as m/z (ES+) 348 [M+H]+ for unreacted 75  were observed.  
In an attempt to improve upon the preliminary result and to drive the reaction to 
completion a screen of different conditions was undertaken. This involved 
increasing the equivalents of oxime, NaOCl and base. Also a variety of 
alternative oximes were screened. In addition to this the reaction was 
preformed at various temperatures. Despite this the reaction could not be 
pushed towards completion.  
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2.9 Conclusions  
In summary a new coupling method for β-thiohydroximate bond formation has 
been developed for the glucosinolate family of natural products using 
inexpensive and readily available NaOCl as the chlorinating agent. The method 
exploited a known oxidation of oximes but used this activation protocol for 
glucosinolate coupling. It proved very effective over a range of substrates. This 
simplified one-step procedure is straightforward to carry out, rapid and it gives 
good to excellent yields over a range of substrates. The method is undoubtedly 
an improvement on existing protocols, and should be the choice for future 
synthetic routes to glucosinolates.  
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3 
Exploring Glucosinolate chemistry 
3.1 Introduction and background  
Our interest in a combinatorial approach to the synthesis of new glucosinolates 
is two fold. The first is that little is known in the literature regarding the chemistry 
of intact glucosinolates. The second is that access to a variety of substrates 
would be highly desirable in order to evaluate glucosinolates in the presence of 
the epithiospecifier protein (ESP). As discussed in Section 1.5, ESP acts in 
concert with the enzyme myrosinase to convert glucosinolates, containing 
terminal alkenes, to thiirane breakdown products (Scheme 47). 
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Scheme 47: Breakdown pathways of glucosinolates. 
It is proposed that a Wittig reaction could be used to introduce a range of 
alternative alkene side chains from aldehydes (Scheme 48). However in order 
to achieve this, a novel glucosinolate, one that contains an aldehyde side chain, 
such as 81, would be required.  
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Scheme 48: Proposed synthetic of novel alkene containing glucosinolates 80 via Wittig olefination of 
aldehyde 81. 
In addition to Wittig chemistry, an aldehyde would also be a useful synthetic 
intermediate to allow access to a variety of novel glucosinolates analogues, for 
example, amines of type 82 (Scheme 49).  As previously outlined in Section 
1.12 advancing the area of intact glucosinolate chemistry would open up the 
possibility of preparing libraries of novel glucosinolates from a common 
intermediate, such as 81.  In particular it is proposed that this would offer an 
alternative more cost effective method for achieving isotopically labelled 
glucosinolates.  
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Scheme 49: Proposed synthetic pathway towards amine side chain glucosinolate 82 from 81. 
Two complementary routes were envisaged that offer potential access to the 
desired aldehyde 81, as illustrated in Scheme 50. The first route involved the 
oxidation of the terminal alcohol side chain in 83 and the second would utilise 
oxidative cleavage of a terminal alkene 84. Common to both routes is the 
requirement for oxime protection, a previously unexplored area in glucosinolate 
chemistry.  
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Scheme 50: Two retrosynthesis approaches to the aldehyde side chain 81. 
With respect to a study of ESP a range of substrates would be required in order 
to probe the stereochemical outcome of the generated thiiranes (section 1.5) 
and to explore structure activity relationships of the enzymes.  To do this 
constrained ring systems and elongated substrates, such as those illustrated in 
Figure 15, were envisaged as potential synthetic targets.  
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Figure 15: Target compounds for mechanism and enzyme probes of ESP. 
The reaction catalysed by ESP is reported to follow a radical mechanism 
(Scheme 51).29,83,84 Therefore, it was rationalised that the incorporation of side 
chains containing cyclopropane rings could act as mechanistic probes since 
these are known to ring open on contact with radicals.85 It was anticipated that 
rearrangement products could inform upon the ESP breakdown mechanism of 
glucosinolate, as represented in Scheme 51.  
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Scheme 51: The proposed breakdown of a cyclopropane side chains of radical intermediates. 
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3.2 Results and discussion 
3.2.1 Alternative synthesis of β -thioglucose 21 
β-Thioglucose 21, is required for both approaches as it represents the sugar 
unit for each of the desired glucosinolates. Previously β-thioglucose 21 has 
been synthesised using a one-pot method (Scheme 52). However large scale 
(>50 g) preparation is limited due to the expense and safety issues concerning 
larger quantities of hydrobromic acid. A relatively large quantity of hydrobromic 
acid would be required to complete both synthetic pathways, therefore an 
alternative more practical protocol was sought. 
OAcO
AcO
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HO
HO
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D-Glucose 18
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Scheme 52: Reagents and conditions a) HBr (45% in acetic acid), 24 h, 85%. 
The process was separated into two steps as detailed in Scheme 53. In doing 
so peracetylated glucose 49 is formed independent of the hydrobromic acid 
step.  The key advantage being that the overall volume of hydrobromic acid 
required is significantly reduced. 
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Scheme 53: Reagents and conditions a) Acetic anhydride, sodium acetate, 4 h 87%; b) 45% HBr in acetic 
acid, DCM, 3 h, 63%. 
Acetylation of D-glucose was explored on a small scale in a number of ways, 
most simply by treatment with acetic anhydride and pyridine86 or acetic 
anhydride and iodine.87  For scale up (>50 g), the former would require the use 
of large quantities of anhydrous pyridine. Also iodine, which is used as a 
catalyst, proved to be difficult to remove on a small scale and required column 
chromatography therefore on a larger scale this would become a more 
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significant problem. Therefore, a protocol using acetic anhydride and sodium 
acetate was selected for scale up.88 
In the event, a slurry of D-glucose and sodium acetate in acetic anhydride was 
heated to reflux until the solution was clear, before pouring into an ice-water 
slurry.  It was found that after 3 h stirring, a white solid had precipitated, and 
was isolated by filtration. The product was then recrystallised from ethanol to 
generate a white crystalline solid of the peracylated product, 49. 1H NMR data 
indicated this to be a 1:9 ratio of α and β anomers of 49. It was not necessary to 
separate the diastereomers at this stage. By this method, 49 could be obtained 
reliably in batches of 200 g.  
Peracetylated 49, was then progressed to 18 via anomeric bromination. This 
was achieved using HBr (45% in acetic acid). It was found that using an 
aqueous work up, washing with sodium hydrogen carbonate solution, could 
purify the crude product 18. Upon concentration of the combined organic 
fractions a golden oil was generated, which was then recrystallised from diethyl 
ether to furnish 18 in good yield (63%).  The α-anomer was formed exclusively. 
1H-NMR spectroscopy indicated a coupling constant of 4.0 Hz at 4.83 ppm for 
H-1 indicating a vicinal gauche relationship between the C-1 and C-2 
hydrogens. This stereochemical preference is due to the instability of the β-
anomer that equilibrates to the α-anomer during the reaction. It was found that 
the two steps could be performed sequentially allowing the process to be 
completed in 8 h rather than the 24 h required for the previous one-pot reaction. 
a b
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Scheme 54: Reagents and conditions a) Thiourea, acetone, 3 h, 71%; b) Sodium metabisulfite, 20 min, 
reflux, 76%. 
The glycosyl bromide 18, was then converted to thiourea 50 in high yield (71% 
as already discussed in Section 2.3.  Finally, β-thioglucose 21 was generated 
by the hydrolysis of 50 with sodium metabisulfite in a biphasic system to give 21 
in excellent yield (76%) (Scheme 54).  
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3.3 Routes towards an aldehyde terminated side chain  
It was envisaged that β-thioglucose 21 would be coupled to the two respective 
oximes, via Method 1 and Method 2 (Scheme 55) in order to obtain target 
aldehyde 81.  
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Scheme 55: Two proposed pathways to aldehyde 81. 
3.4 Method 1 : Via a terminal alcohol oxidation 
It was envisaged that oximyl chloride 87 could be generated from butane-1,4-
diol 86, as illustrated in Scheme 56. This would require a number of functional 
group transformations. The oxime requires protection of its hydroxyl group and 
it is necessary that the selected protecting group can be removed orthogonally 
with respect to the acetate esters of the sugar unit. Another obvious 
consideration is that following coupling with 21 to generate the thiohydroximate 
intermediate 88 a further protecting group will be required to enable a Wittig 
olefination to take place. Thiohydroximate protection had not been attempted in 
the glucosinolate literature and would need to be explored. In the final stages, 
this approach would require deprotection of the side chain alcohol and selection 
of a suitable mild oxidation method to generate the desired aldehyde 81.  
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Scheme 56: Proposed synthetic pathway towards intermediate aldehyde 81. 
3.4.1 Synthesis of oxime fragment 92 
Butane-1,4-diol 86 was mono-protected using the classical strategy of tert-
butyldimethylsilyl chloride and imidazole (Scheme 57). The silyl protecting 
group was selected as it can be removed under mild conditions in the presence 
of a variety of functional groups including acetate esters.  
a
86
OHHO OHTBSO
89  
Scheme 57: Reagents and conditions a) TBS-Cl, imidazole, 16 h, 75%. 
The inexpensive diol is kept in excess of the tert-butyldimethylsiyl chloride and 
gave rise to predominately the mono-protected silyl ether. The product could be 
readily purified by column chromatography. 
Two methods were explored for the oxidation of alcohol 89. The first involved a 
modified Parikh-Doering oxidation89 using pyridine⋅sulfur trioxide complex, 
DMSO and Hünig’s base. This furnished the desired aldehyde 83 in excellent 
yield (83%) (Scheme 58).  
a
89
OHTBSO O
TBSO
90  
Scheme 58: a) DIPEA, py⋅SO3, 2 h, DMSO : DCM, 83%. 
This reaction progresses firstly by DMSO reacting with pyridine.sulfur trioxide 
complex to form the reactive intermediate 91, which then undergoes 
nucleophilic attack from the alcohol oxygen (Scheme 59). Deprotonation of N-
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N-diisopropylethylamine generates a sulfur ylide, which in turn triggers an 
intramolecular 1,4-hydrogen transfer and fragmentation to give the desired 
aldehyde with dimethyl sulfide as a by-product. 
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Scheme 59: Proposed mechanism for Parikh-Doering oxidation. 
As large quantities (< 10 g) of aldehyde 90 were required an alternative method 
avoiding the use of toxic pyridine⋅sulfur trioxide complex was explored; an 
Anelli oxidation.90 It was found in practise that this method, which utilised 
TEMPO and NaOCl, could readily and rapidly generate 90, in high yield (74%).  
a
89
OHTBSO O
TBSO
90  
Scheme 60: Reagents and conditions: a) TEMPO, NaOCl, DCM, NaBr, 20 min, 74%. 
With aldehyde 90 in hand, the next step required the conversion to oxime 91. In 
the event this involved the use of hydroxylamine hydrochloride and sodium 
acetate. The oxime was isolated as a 1:1 mixture of E:Z isomers that were 
clearly identifiable by 1H NMR, with two diagnostic triplets at 7.47 ppm and 6.72 
ppm. 
O
TBSO NTBSO OH
90 92
a
 
Scheme 61: Reagents and conditions: a) NH2OH⋅HCl, NaOAc, MeCN : H2O, 8 h, 77%. 
This stereochemical mixture was not separated, as the geometric isomers are 
each converted to a common intermediate during the coupling process, as 
discussed in Section 2.4.2. 
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3.4.2 Thiohydroximate formation for Method 1 
The two fragments, β-thioglucose 21 and oxime 92, were coupled using the 
NaOCl methodology described in Chapter 2. This gave the novel 
thiohydroximate 70 in excellent yield (83%), as illustrated in Scheme 62. 
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Scheme 62 : Reagents and conditions a) NaOCl, NEt3, DCM, 3 h, 83%.  
To allow for a greater range of chemistry to be performed on the intact 
glucosinolate, the thiohydroximate hydroxyl required protection. To date, very 
little is known in the literature regarding protections of this type.91 The 
glucosinolate systems are known to undergo the Lossen rearrangement upon 
enzymatic hydrolysis,92 thus care had to be taken in the selection of a protecting 
group not to promote such a rearrangement (Scheme 63).  
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Scheme 63: Proposed mechanism for Lossen type rearrangement breakdown of glucosinolates. 
The use of 2,2-dimethoxypropane has previously been reported93 for oximes 
however it had not been applied to the thiohydroximate functionality found in 
glucosinolates. In the event, the protection of the thiohydroximate, 70, was 
achieved in a high yield (91%) with the use of 2,2-dimethoxypropane and a 
catalytic amount of p-toluenesulfonic acid (PTSA). 
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Scheme 64: Reagents and conditions a) 2,2,dimethoxypropane, PTSA, rt, 16 h, 91%. 
In order to progress with the synthesis the reaction was scaled up, from 200 mg 
to 5.0 g. It was observed by 1H NMR that breakdown of 70 occurred if a non-
linear scale up of solvents were used for the increased quantity of substrate. 
Following 2D NMR spectroscopy the major breakdown product was identified to 
be 94. This reaction on a larger scale had to be carried out on a larger volume 
(16g/litre). 
O
AcO
AcO
AcO
AcO S
O
94  
With protected thiohydroximate 92 in hand the silyl protecting group was now 
removed using tetra-n-butylammonium fluoride (TBAF). It was found that if this 
reaction was performed at room temperature the exclusive product was 95 but it 
was generated in low yield (36%). This is consistent with an intermolecular 
acetate migration promoted by generation of the intermediate alkoxylate anion 
(Scheme 65). 
a
O
AcO
AcO
AcO
AcO N
OS
OTBS
O
O
AcO
AcO
AcO
AcO N
OHS
OAc
93 95  
Scheme 65: Reagents and Conditions a) TBAF, THF, 3 h, 36%. 
At lower temperature (0 °C) silyl group deprotection using TBAF generated 
alcohol 96 in an excellent yield (80%).  
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Scheme 66: Reagents and conditions a) TBAF, THF, 0 °C, 2 h, 80%. 
3.4.3 Oxidation of the alcohol side chain 
Oxidation of alcohol 96 to aldehyde 97 was required. As the substrate is 
decorated with several sensitive functional groups, mild oxidation conditions 
were explored.  
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Scheme 67: Oxidation of terminal alcohol 96 to aldehyde 97. See Table 2 for reagents. 
A range of mild oxidation methods are available in the literature94 for such a 
transformation although on this system many of these proved to be either 
unsuccessful or low yielding, as summarised in Table 2.  
Entry General conditions Observation 
1 DMP  98 
2 DMP/pH 7 buffer Starting material 96 recovered 
3 DMP/NaHCO3 Starting material 96 recovered 
4 IBX Starting material 96 recovered 
5 BAIB/TEMPO/DCM Aldehyde 97 (22%) 
6 IBX/Tempo Aldehyde 97 (99%) 
Table 2: Summary of results for conditions of 96 to 97 oxidation. 
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For example the Dess–Martin periodinane, DMP,95 (Entry 1) proved to be too 
acidic and resulted in deprotection of the thiohydroximate moiety to afford 98. 
O
AcO
AcO
AcO
AcO N
OHS
OH
98  
Attempts were made to generate a neutral system with the use of a buffer at pH 
7 (Entry 2) and also a more basic set of conditions (Entry 3). However in both 
cases this led only to the recovery of starting material 96.   
IBX, the precursor to DMP and a mild oxidising agent, is also known to convert 
alcohols to aldehydes.96 In addition IBX has the advantage of being sparingly 
soluble in a range of solvents and is readily removed by filtration on work up. 
Unfortunately treatment of alcohol 96 with IBX (Entry 4) also failed to give 
aldehyde 97 after 24 h at reflux and only starting material was recovered. 
2,2,6,6-Tetramethyl piperidin-1-yloxyl (TEMPO) is known to oxidise alcohols 
with the use of co-oxidants such as BAIB,97 Entry 5. These conditions proved 
successful on this system and the desired aldehyde was isolated but only in a 
modest yield (22%). 
Encouraged by this reaction (Entry 5), a range of conditions involving TEMPO 
and hypervalent iodine compounds were screened. It was found that alcohol 96 
could be reacted with IBX and a catalytic amount of TEMPO (Entry 6) after 3 h 
at reflux to access aldehyde 97 in excellent yield (99%) (Scheme 68).   
O
AcO
AcO
AcO
AcO N
OS
OH
O
O
AcO
AcO
AcO
AcO N
OS
O
O
96 97
a
 
Scheme 68: Reagents and conditions a) IBX, cat. TEMPO, DCM, 3 h, 99%. 
   Chapter 3 
 68 
The reaction most probably progresses with the alcohol moiety of the 
glucosinolate side chain reacting with TEMPO. The resultant adduct 101 can 
then undergo a 1,5-hydrogen transfer to give the aldehyde and the reduced 
TEMPO, 100. The active TEMPO 99 can then be regenerated by oxidation with 
IBX.  
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Scheme 69: Proposed mechanism for IBX/TEMPO oxidation. 
To our knowledge the use of IBX as a co-oxidant for TEMPO is a novel 
oxidation technique, that has not previously been reported in the literature. It is 
presented as a mild, novel technique for oxidation of alcohols in complex 
molecular systems. 
In summary this synthesis gave the desired aldehyde 97 in eight linear steps. 
The synthesis required column chromatography in six of the seven steps and 
was found to be time consuming in generating material. A more expedient route 
to the aldehyde was explored alongside this method. 
3.5 Side chain modifications after sulfations on Method 1 
Forming the aldehyde 103 at a later stage in the synthesis would reduce the 
number of independent modifications required to form each glucosinolate in a 
collection, as summarised in Scheme 70.  
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Scheme 70: Proposed pathway for novel glucosinolate synthesis via late stage intermediate 103. 
With intermediate thiohydroximate 70 in hand, 104 was generated by a sulfation 
using pyridine⋅sulfur trioxide complex in good yield (68%) (Scheme 71). 
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Scheme 71: Reagents and conditions a) py⋅SO3, pyridine, DCM, 16 h, 68%. 
Deprotection of 104 was attempted using TBAF, however this proved to be 
unsuccessful and the desired primary alcohol could not be isolated. It was 
proposed that this may be due to the polar nature of 102 that renders it water 
soluble during work up. In order to prevent this, Dowex-50W resin that can be 
filtered directly was explored98 as a deprotection method, however in practise, 
this also failed to generate the desired alcohol 102.  
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Scheme 72: Attempts to cleave silyl ether were unsuccessful with TBAF and Dowex-50W resin. 
The polar nature of this compound as its potassium salt was clearly making the 
product difficult to isolate and at this stage the approach was abandoned.  
3.6 Formation of aldehyde via alkene side chain oxidation 
Alkene oxidation offerred an alternative strategy to 81. Such an approach 
required the formation of the thiohydroximate intermediate 47 carrying a 
terminal alkene side chain. This approach would arise from the coupling of 21 
and 48 (Scheme 73). It was anticipated that protection of thiohydroximate 47 
would enable a wider range of transformations to be performed for structural 
diversification. The final steps in the synthesis would require the oxidation of the 
terminal alkene 47 to aldehyde 81. Such an alkene cleavage is a novel strategy 
on an intact glucosinolate and required detailed investigation. 
O
AcO
AcO
AcO
AcO SHNHO
Cl
P= protecting group
O
O
AcO
AcO
AcO
AcO N
OHS
O
AcO
AcO
AcO
AcO N
OPS
O
56
48
21
47 81
 
Scheme 73: Proposed synthesis of aldehyde 81 via terminal alkene oxidation. 
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3.6.1 Formation of thiohydroximate 47 
In order to explore terminal alkene oxidation the coupling of pent-4-enal oxime 
57 and β-thioglucose 21 was required (Scheme 74). This synthesis has been 
described, in detail, in Section 2.5. In practise the reaction was performed in 
10 g batches of 52 and proved a reliable method for access to terminal alkene 
47. 
O O N
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Scheme 74: Reagents and conditions a) Sealed tube, 160 °C, 16 h, quant; b) NH2OH⋅HCl, NaOAc, 
MeCN : H2O, 73%; c) NaOCl, 21, NEt3, DCM, 63%. 
3.6.2 Investigating novel thiohydroximate protections 
Following the success of the protection stategy for thiohydroximate 70, the 
acetal protecting group was selected for thiohydroximate 47 (Scheme 75). It 
was found that treatment of 47 with dimethoxypropane and PTSA generated 
105 in good yields (77%). 
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Scheme 75: Reagents and conditions a) Dimethylmethoxy propane,  pTSA, DCM, 16 h, 77%. 
Other protecting groups were investigated at this stage. Silyl groups were 
selected to protect the free hydroxyl of 47 and thus 47 was treated with TBSCl 
and TBDPSCl. The two silyl protections of 47 proved straightforward, as 
illustrated in Scheme 76 and gave the corresponding protected 
thiohydroximates, 106 and 107, in excellent yields (92% and 87% respectively).  
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Scheme 76: Novel thiohydroximate protecting groups. Reagents and conditions a) TBSCl, imidazole, 
DCM, 3 h, 0 °C, 92%; b) TBDPSCl, imidazole, DCM, 4 h, 0 °C, 87%. 
3.7 Novel oxidation chemistry on intact glucosinolates 
With the thiohydroximate protection strategies in place a number of oxidation 
methods were now explored. General methods for the oxidation of an alkene to 
an aldehyde are illustrated in Scheme 77. These include functional group 
interconversions such as hydroboration and then oxidation, ozonolysis or 
dihydoxylation followed by oxidative fragmentation. To date, these reaction 
conditions have not been explored on glucosinolate systems and thus they 
merited further investigation. 
O
AcO
AcO
AcO
AcO N
OS
O
O
AcO
AcO
AcO
AcO N
OS
O
O
Hydroboration
ozonolysis
dihydroxylation
oxidation
oxidative fragmentaion
n
105  
Scheme 77: General strategies for the conversion of the terminal alkene to an aldehyde. 
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3.7.1 Hydroboration oxidation of the terminal alkene side chain. 
Hydroboration of 105 will clearly retain all carbons of the side chain and 
generated the homologated alcohol 108 (Scheme 78). However, this 
transformation was screened in order to probe the viability of such a 
transformation on an intact glucosinolate.  
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Scheme 78: Proposed hydroboration of alkene side chain glucosinolate.  
The method was of particular interest as it had potential to be adapted, via the 
use of hydroboration-amination, to generate novel amines,99 such as 109 
(Scheme 79). 
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Scheme 79: Proposed hydroboration-amination of glucosinolate 105 to amine 109. 
In the event the alkene was treated with borane⋅tetrahydrofuran complex 
followed by a hydrogen peroxide/sodium hydroxide oxidative work up. Upon 
work up, the crude 1H NMR spectroscopy did not indicate any residual alkene 
functionality. However the acetate protecting groups had been removed as 
evidenced by a characteristic shift of the sugar protons from 5.50-4.04 ppm, up 
field, to the region of 4.20-3.50 ppm. This is likely to be due to the sodium 
hydroxide employed during the oxidative work up. It was concluded that these 
reaction conditions are too harsh to be performed on intact glucosinolates and 
other methods were explored. 
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3.7.2 Studies towards aldehyde 97 via epoxide 110 
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Scheme 80: Proposed pathway towards aldehyde 97 via epoxide 110. 
Epoxides can offer an indirect precursor to an aldehyde. This would require 
three steps. Epoxide 110 could also serve as a versatile intermediate for further 
functionalisation (Scheme 81).  
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Scheme 81: Examples of proposed transformations of the epoxide functionality of 110.100 
The Prilezhaev reaction,101 utilises m-chloroperoxybenzoic acid (mCPBA), 111 
(Figure 16) to form epoxides from electron-rich alkenes. 
OO
O H
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111 112  
Figure 16: Structure of mCPBA 105 and by-product m-chlorobenzoic acid 106.  
Reaction of mCPBA with alkene 105 resulted in the loss of the thiohydroximate 
protecting group. This could be due to the formation of m-chlorobenzoic acid as 
a by-product 112, which could clearly promote thiohydroximate deprotection 
(Scheme 82).  
   Chapter 3 
 75 
105
O
AcO
AcO
AcO
AcO N
OS
O
O
AcO
AcO
AcO
AcO N
O+S
O
H O
AcO
AcO
AcO
AcO N
OHSH+
H2O
47  
Scheme 82: The proposed mechanism of deprotection of 105.  
Dimethyldioxirane (DMDO) 113, has found use as an alternative reagent for 
epoxidation and it gives rise to acetone as a by-product, Scheme 83.102 Thus a 
suitable preparation of DMDO was explored. It was found that formation of 113, 
using sodium bicarbonate and Oxone, was time consuming as it rapidly 
degraded over a 24 h time period even upon storage at -20 °C.  
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Scheme 83: DMDO synthesis. Reagents and conditions a) NaHCO3, H2O, ‘oxone’ 4 h. 
Therefore an alternative procedure whereby the DMDO was formed in situ103 
proved more practical. However, epoxide 110 was only formed in low yield 
(31%) and attempts to improve the yield were unsuccessful (Scheme 84). 
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Scheme 84: Reagents and conditions a) Oxone, acetone : water, NaHCO3, 16 h, 31%. 
With a small quantity of epoxide 110 available an attempt was made to open 
the epoxide under acidic conditions to form diol 114 (Scheme 85). Although a 
range of acids and concentrations were explored, it was found that the 
glucosinolate decomposed into a multitude of unidentifiable by-products.  
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Scheme 85: The proposed synthetic pathway towards aldehyde 97 from epoxide 114.  
Therefore, although diol 114 was not formed, a novel epoxide containing 
glucosinolate 110 was prepared in this study. This may prove to be a useful 
intermediate for further investigations in intact glucosinolate chemistry. 
3.7.3 Studies towards aldehyde 97 via a dihydroxylation 
pathway  
Aldehyde 97 could clearly be formed by the oxidative fragmentation of diol 114. 
In order to form the desired diol, oxidation of alkene 105 with potassium 
permanganate, was explored (Scheme 86).  
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Scheme 86: Dihydroxylation of alkene 105. Reagents and conditions a) KMnO4, MgSO4, EtOH, H2O, 16 h, 
45%. 
This proved successful and diol 114, could be isolated in a modest yield (45%). 
The remainder of the material was recovered as a mixture of the starting alkene 
105 and the unprotected thiohydroximate alkene 47. Further optimisation of the 
reaction was explored by varying the equivalents of the reagents used, as well 
as altering the ratio of solvents. However this did not lead to any further 
improvement in the yield obtained.  
Magnesium sulfate was added to the reaction to precipitate magnesium 
hydroxide. However this reagent system was still too acidic and resulted in the 
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loss of the thiohydoximate protecting group. In order to prevent the loss of the 
protecting group a phosphate buffer (pH 7) was explored. However the buffered 
reaction failed to yield any of the desired diol 114 and only starting material 105 
was recovered.  
In order to improve the oxidation an alternative method was sought. Sharpless  
et al.,104 have reported dihydroxylation of alkenes using ruthenium (III) chloride 
and sodium metaperiodate. Ruthenium tetroxide 115 the active oxidant, is 
generated in situ, and a co-oxidant is added to recycle the ruthenium and 
regenerate the active species (Scheme 87).  
8 Ru3+ (aq) + 5 IO4- (aq) + 12 H2O 8 RuO4 + 5 I- (aq) + 24 H+ (aq)
115  
Scheme 87: Oxidation of Ru3+ with periodate to form active species 115. 
This system was explored and was promising with no alkene remaining as 
judged by 1H NMR, although deprotection of the oxime had occurred. This 
system was then buffered at pH 7 using a phosphate buffer, however this again 
only led to the recovery of starting material 105.  
At this stage it was clear that a change in protecting group strategy was 
required due to the propensity of 105 to undergo acetyl cleavage. Therefore, 
the TBS protected thiohydroximate 106 was selected, because the silyl ether 
(described in Section 3.6.2) offers a less labile protection under the acidic 
reaction conditions. 
Oxidation with RuO4 did not remove the protecting group but there was an 
apparent intermolecular migration of an acetate group from the sugar motif to 
give 116 in low yields (13%) (Scheme 88). Once again, an attempt was made to 
buffer the reaction with a phosphate buffer and also to run the reaction at a 
lower temperature to overcome this migration but in both cases only starting 
materials were recovered. 
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Scheme 88: Reagents and conditions a) RuCl3, NaIO4, MeCN : H2O, 6 h 13%. 
Potassium permanganate  proved to be the best reagent as diol 117 could be 
isolated in modest yields (48%) (Scheme 89). Upon optimisation it was found 
that by altering the order of addition and the ratio of solvents from 2:1 to 3.5:0.5 
ethanol:water, the yield could be significantly increased from 48 to 99% 
(Scheme 89). 
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Scheme 89: Reagents and conditions a) KMnO4, MgSO4, EtOH, water, 16 h, 99%. 
Having established access to the vicinal diol 117, oxidative cleavage to the 
required aldehyde 118 was required (Scheme 90).  A range of conditions was 
explored (Scheme 90) to identify suitable conditions for this oxidative cleavage. 
These are illustrated in Table 3. 
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Scheme 90: Oxidative fragmentation of the vicinal diol would lead to aldehyde 118. 
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Entry Reagent system  Observation 
1 NaIO4 no aldehyde 118 
2 Pb(OAc)4 aldehyde 118 (6 %) 
3 NaOCl Decomposition of 117  
4 NIS 117 recovered 
5 IBX/DMSO  Aldehyde 118 (4%) 
6 DMP Aldehyde 118 (trace) 
Table 3: Reaction conditions screened for the oxidative cleavage of 117. 
The use of sodium metaperiodate is generally the reagent of choice105 for the 
oxidative cleavage of 1,2-diols. However on treatment of 117 (Entry 1) with 
sodium metaperiodate the diol was consumed but did not yield the desired 
aldehyde 118. Instead the reaction gave a polar product consistent with over-
oxidation to carboxylic acid 119 (Scheme 91).  
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Scheme 91: Proposed over-oxidation of diol 117 to acid 119. 
Aldehyde 118 could be isolated in a low yield (6%) with the use of lead 
tetraacetate106 (Entry 2), however it was found to degrade quickly even upon 
storage at -20 °C. The majority of the material from this reaction had 
decomposed into a range of unidentifiable by-products. Similarly the use of 
sodium hypochlorite107 (Entry 3) also led to decomposition of the starting 
material. N-Iodosuccinimide (NIS)108 has been reported for glycol bond 
cleavage by McDonald et al., however in our hands (Entry 4) only starting 
material was recovered. 
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Scheme 92: Reagents and conditions a) IBX, DCM, 4 h, 4%. 
An IBX and DMSO system (Entry 5)  had previously been reported by Frigerio 
et al., for the cleavage of 1,2 diols.109 This reaction progresses with the IBX 
reacting with DMSO in situ and is detailed in Scheme 93. 
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Scheme 93: Proposed mechanism for IBX oxidative diol fragmentation. 
With the use of IBX and DMSO (Entry 5), it was found that diol 117 was 
converted to aldehyde 118 in a low yield (4%). Analysis revealed that the 
majority of the recovered product was unreacted starting material.  
Reports by Dess and Martin110 have shown that the Dess-Martin periodionane 
DMP, more commonly used for oxidation, can also cleave glycol bonds.111 The 
use of DMP on an intact glucosinolate previously led to decomposition (detailed 
in Section 3.4.3). This was also observed when attempting to cleave diol 111 
with DMP. The breakdown of the glucosinolate may be occurring due to the 
release of acetic acid as the DMP degrades prior to the reaction. Therefore an 
attempt was made to circumvent this by forming DMP in situ. To do this, acetic 
anhydride was reacted with excess IBX in order to generate DMP before the 
addition of diol 111 (Scheme 94). 
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Scheme 94: In situ formation of DMP prior to glycol cleavage. Reagents and conditions a) IBX, acetic 
acid, 117. 
Upon work up the desired aldehyde 118 was isolated, but in a trace amount 
only, with significant recovery of the starting diol 117. 
To conclude, dihydroxlyation is shown to occur in good yields to generate novel 
glucosinolate diol 117, an intermediate that could be used for further research. 
Limited success however was made in the oxidative cleavage reaction to the 
aldehyde. It was thought a more direct approach would be necessary, therefore 
ozonolysis was explored. 
3.7.4 Synthesis of aldehyde 97 via ozonolysis  
Ozonolysis would offer a single step transformation of alkene 105 to furnish 
aldehyde 97 (Scheme 95).  
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Scheme 95: Ozonolysis of  105 to aldehyde 97. 
This is expected to progress first with 1,3 dipolar cycloaddition of the alkene 
and ozone to obtain the molozonide intermediate 120 (Scheme 96). This is an 
unstable intermediate that will undergo a retro 1,3 cycloaddition to furnish a 
aldehyde and a carbonyl oxide.113 The aldehyde will then adopt the orientation 
required to allow a further 1,3 cycloaddition to give trioxolane 121 which, on 
reductive work up with triphenylphosphine or dimethyl sulfide (DMS), should 
produce the desired aldehyde.  
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Scheme 96: Criegees ozonolysis mechanism.112 
First attempts at ozonolysis proved to be successful but low yielding (10%) 
when triphenyphosphine was used for the reductive work up. The difficulty was 
the removal of the triphenylphosphine oxide by-product 122. Also it was not 
clear how stable aldehyde 97 was and repeated chromatography may have led 
to degradation and loss of material. 
P O
 
122 
Two alternative reductive work up procedures were employed in order to 
circumvent the purification issues described. The first explored the use of solid-
supported triphenylphosphine, which would allow the by-products to be filtered 
from the crude reaction mixture. The second used DMS in the work up 
procedure, which would give rise to dimethyl sulfoxide (DMSO) as an alternative 
by-product to triphenylphosphine. 
The solid phase resin did improve the recovery of the desired aldehyde, 
however, although the isolated yields were still low (22%). The low level of 
recovery could not justify the significant cost involved in using this solid phase 
reagent. Similarly, a change to DMS on work up did make purification easier 
however the aldehyde was recovered in low conversion (22-26%). Therefore 
further optimisation of this approach was required. 
The low isolated yields may be due to poor side chain stability leading to 
product breakdown.  A large excess of base, typically potassium carbonate, is 
used in ozonolysis as ozone reacts with DCM to give HCl.113 There are 
concerns too regarding the stability of the glucosinolates (Section 3.4.3) and 
thus the use of base in ozonolysis maybe contributing towards decomposition. 
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This led to an investigation of a new ozonolysis system in which no base would 
be required. An acetone/water system reported by Schiaffo et al.,114  suggested 
that the reaction would proceed via ozonolysis intermediate 123 reacting with 
water to form 124, which in turn will break down to generate the desired 
aldehyde with loss of hydrogen peroxide (Scheme 97). Such a hypothesis 
suggests that the reaction does not progress via the trioxolane 114, as in the 
Criegee mechanism, and that there is no requirement for a reductive work up.  
R
O
R
O
O
O+
R
O- H2O HOO OH O
RH2O2
123 124  
Scheme 97: Proposed mechanism for acetone/water ozonolysis. 
The reaction was performed at 0 °C and gave the desired aldehyde in low 
conversion (13%).  The major product was β-thioglucose 21, arising from 
hydrolytic cleavage of the thiohydroximate bond during the reaction (Scheme 
98).   
O
AcO
AcO
AcO
AcO N
OS
O O
AcO
AcO
AcO
AcO SH
105
21
 
Scheme 98: Oxidative fragmentation occurring across thiohydroximate bond of 105 resulted in formation 
of 21. 
An attempt was made to circumvent this breakdown by lowering the reaction 
temperature to -40 °C, however no improvement was noted and once again 
cleavage across the thiohydroximate bond occurred.  
An alternative base-free ozonolysis system reported by Dussault et al.115 used 
N-oxides such as N-methylmorpholine N-oxide (NMO), as illustrated in Scheme 
99. Upon break down of the molozonide 120, the intermediate 123 reacts with 
the NMO to give 125. This intermediate undergoes loss of oxygen and 
reduction of the N-oxide to give the aldehyde and NMM (Scheme 99).  
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Scheme 99: Proposed mechanism for NMO ozonolysis.117 
It was clear that anhydrous conditions were required and the reaction benefited 
from the use of 4 Å molecular sieves. Optimisation, as illustrated in Table 4, 
also found that this method required ten equivalents of NMO (Entry 3 and 4) as 
three equivalents (Entry 1) gave only a 10% yield of the desired aldehyde 97.  
Entry NMO 
equivalents 
Time (h) Conversion to 
97 by 1H NMR 
1 3 1 > 10% 
2 5 1 32 % 
3 10 1 56 % 
4 10 5 30 % 
 
Table 4: Optimisation results for NMO assisted ozonolysis on alkene 97.  
Increasing the reaction time from 1 h to 5 h (Entry 3 and 4) led to a lower yield 
of aldehyde 97. This was partially due to the breakdown of the aldehyde in 
solution as well as its previously observed instability on both silica or alumina. 
Attempts to use the crude aldehyde 97 directly in subsequent reactions were 
unsuccessful however it was found that an aqueous work up gave reasonable 
recovery. This could now be explored in Wittig reactions. 
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3.8 Ozonolysis of potassium salt 126  
Another strategy explored ozonolysis on the potassium salt 126. This had the 
advantage that it would shorten the synthetic sequence to access a range of 
novel glucosinolates (Scheme 100).  
O
AcO
AcO
AcO
AcO N
OSO3-K+S
O
AcO
AcO
AcO
AcO N
OSO3-K+S
O
R1
R2
R1
R3
R1
R4
Deprotection to 
final glucosinolates
126
127  
Scheme 100: Proposed pathway to novel glucosinolates via late stage intermediate 127. 
Ozonolysis of the potassium salt 126 in DCM did not give a reaction (Scheme 
101). This was most probably due to the insolubility of 126 in DCM. Additionally 
if methanol was used as a co-solvent with DCM (1 : 9, MeOH : DCM) for the 
ozonlysis of 126 then 1H NMR analysis of the reaction product showed the loss 
of the alkene protons, but no aldehyde proton. 
O
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AcO N
OSO3-K+S
O
AcO
AcO
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AcO N
OSO3-K+S
O
126 127
O3
 
Scheme 101: Putative conversion of aldehyde 127 via oxidative cleavage 126. 
A hemiacetal, of type 128 (Scheme 102), may be forming therefore a 1H NMR 
study was undertaken. As salt 126 is only sparingly soluble in both chloroform 
and methanol, analogue 97 was used in the 1H NMR study. A distinctive 
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aldehyde peak at 9.85 ppm was observed when only deuterated chloroform 
was used. However the 1H NMR of 97 recorded in methanol (Figure 17), 
indicated a disappearance of the aldehyde peak, and the emergence of the 
distinctive methyl hemiacetal at 3.31 ppm, Scheme 102 as well as an additional 
proton signal in the region of 5.40-5.37 ppm corresponding to the hemiacetal 
methine proton.  
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97 128  
Scheme 102: Hemiacetate 128 formation on the addition of MeOH to aldehyde 97.  
 
Figure 17: Overlays of 1H NMR a) aldehyde 97 in chloroform b) aldehyde 97 in methanol  
Although it appears that the desired aldehyde is forming on reaction of ozone 
with potassium salt 126, it appears then to be reacting with methanol to form a 
hemiacetal of 127. Further work in this area is required.  
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In order to increase the solubility of 126 in organic solvents, a change of 
counterion was envisaged. In the event, sulfation was achieved using 
pyridine⋅sulfur trioxide complex and the reaction was quenched using an 
aqueous cyclohexylamine solution to furnish 129 in high yield (72%). 
O
AcO
AcO
AcO
AcO N
OHS
O
AcO
AcO
AcO
AcO N
OSO3-S +NH3
12947
a
 
 Scheme 103: Reagents and conditions: a) Py⋅SO3, pyridine, 16 h, 72%. 
It was found that 129 generated good crystals and this allowed a suitable 
crystal to be submitted for X-ray structure analysis. The resultant structure is 
shown in Figure 18.  To our knowledge this is the only reported example of an 
X-ray crystal structure for a sulfated glucosinolate. 
 
 
 
 
Figure 18:The resultant X-ray crystal structure of glucosinolate 129 as a cyclohexylammonium salt. 
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Preliminary ozonolysis studies on 129 to 130 indicated that only starting 
material was recovered. Further investigations are clearly warranted as this 
would shorten the synthetic pathway towards a collection of novel alkenes.  
O
AcO
AcO
AcO
AcO N
OSO3-S +NH3
O
AcO
AcO
AcO
AcO N
OSO3-S
O
+NH3
129 130  
Scheme 104: Preliminary ozonolysis studies on 129 were unsuccessful. 
3.9 Conclusions on the oxidation of the alkene side chain. 
In order to access aldehyde 97 from alkene 105 a variety of methods were 
utilised. It was found that hydroboration was not suitable on glucosinolates due 
to harsh work up conditions. Epoxidation of 105 generated novel intermediate 
110, which was explored as a point of divergence, however this failed to ring 
open to give the desired diol. Dihydroxylation was achieved, to obtain novel diol 
117, however oxidative cleavage to generate aldehyde 118 was only achieved 
in low yields. Ozonolysis was found to mediate the desired transformation to 
aldehyde 97, in a good yield (56%).  
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3.10 Using aldehyde 97 to form alkene side chains 
3.10.1 Wittig reaction 
It was envisaged that a Wittig reaction116 could be performed on aldehyde 97, in 
order to install the desired alkene functionality. It is clear that a range of alkene-
containing glucosinolate analogues could be synthesised via this method if it 
proved to be successful. In order to probe the viability of the Wittig strategy, 
benzyltriphenylphosphonium bromide was selected in the first instance 
(Scheme 105). 
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Scheme 105: Reagents and conditions a) nBuLi, Ph3P+CH2PhBr-, THF, 4 h, 30%; b) Dowex-50W, MeOH, 
5 h, 98%. 
Aldehyde 97 was reacted accordingly with benzyltriphenylphosphonium 
bromide and n-butyllithium in THF to generate the target alkene 131. This 
reaction proved to be successful and alkene 131 was isolated in a 30% yield. 
The alkene was obtained as a mixture of E:Z isomers. It was not possible to 
separate the diastereomers at this stage by column chromatography.   
To investigate the synthetic strategy further the diastereomeric mixture of 131 
was progressed through to the next stage. Removal of the acetal group of 131 
would require acidic conditions. It was found that Dowex-50W resin, which was 
readily removed by filtration, could be used to generate the thiohydroximate 132 
in excellent yields (98%). Previous studies had found sulfation of the 
thiohydroximate to be troublesome on a small scale therefore sulfation of 132 
was not attempted. 
A second example, one that would furnish the aliphatic side chain 133, was now 
explored. For this butyltriphenylphosphonium bromide was selected, and alkene 
133 was recovered in a 28% yield (Scheme 106). 
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Scheme 106: Reagents and conditions a) nBuLi, Ph3P+BuBr- THF, 2 h, 28%. 
To conclude, Wittig chemistry was shown to successfully install alkene 
functionality from aldehyde 97. However due to the relatively modest yields, 
further optimisation is required before a compound collection can be generated. 
3.10.2 A one-pot ozonolysis-Wittig reaction  
A one-pot ozonolysis-Wittig reaction that would furnish 134 from 106 was 
explored. If successful this would allow the direct conversion from 106 to 134, 
without the requirement to isolate the unstable aldehyde (Scheme 107). This 
procedure had previously been reported by Montgomery and co-workers117 and 
utilised stablised ylides. 
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Scheme 107: One-pot, ozonolysis-Wittig. Reagents and conditions a) i. O3/O2, -78 °C, PPh3; ii. 
Ph3P=CHCO2Et 35% (over two steps); b) Dowex-50W resin, MeOH, 2 h, 96% . 
In the event the reaction proved to be low yielding (35%) and 1H NMR 
suggested that deprotection of the thiohydroximate had partially occurred. 
Therefore the product was subjected to deprotection to convert 134 to 135 with 
the use of Dowex-50W resin.  
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Attempts were made to optimise the yield achieved by the one-pot procedure. 
This involved investigating the reductive work up to use DMS. In addition a 
variety of reaction times were explored however no improvement was noted. 
In summary the one-pot method generated the thiohydroximate alkenes in a 
35% yield in one step compared to 17% over two steps from Section 3.10.1.  
3.11 Additional mechanism probes for ESP 
3.11.1 Cycloaddition reactions on alkene glucosinolates 
Cycloadditions to alkenes are well documented for the production of ring 
systems, such as 136 and 137.  By exploring cycloaddition reactions118 on an 
alkene containing glucosinolate such as 105, it was envisaged that a variety of 
novel side chains could be synthesised.  
R
R
R" R"
R"R"
N+ O-R"
O
N
R
R"
137136  
Scheme 108: Examples of cycloaddtion products on an alkene. 
3.11.1.1 The use of Diels-Alder chemistry on alkene 106 
As a ring containing glucosinolate such as 138 would be of particular interest to 
an ESP study (Section 1.5), a Diels-Alder reaction119 between alkene 105 and a 
variety of dienes was explored (Scheme 109). 
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Scheme 109: Diels-Alder chemistry on glucosinolate side chains. 
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Although there is a lack of commercially available dienes, 2,3-
dimethylbutadiene and dimethoxybutadiene are readily available and they were 
reacted with the alkenyl glucosinolate 105 (Figure 19). 
OMeMeO
dimethylbutadiene dimethoxybutadine  
Figure 19: Dimethylbutadiene and dimethoxybutadiene. 
Both of these dienes failed to yield Diels-Alder products even after screening a 
range of solvents, extended reaction times and temperature. Cyclopentadiene 
was also explored as it is generally a good diene in Diels-Alder reactions. In 
order to use cyclopentadiene it must be cracked from the commercially 
available dimeric form, and this was carried out following a literature method.120 
After cracking the diene, it was reacted immediately with 105 but again there 
was no conversion to the desired cycloaddition product.  
3.11.1.2  The use of 1,3 dipolar cycloadditions on alkene 105 
As discussed in Section 2.5, nitronates can be formed from the corresponding 
oxime with the use of NaOCl. Engberts and co-workers75 orginally used this 
methodology for generating nitrile oxides for 1,3-dipolar cycloadditions. Clearly  
a 1,3-dipolar cycloaddition of alkene 106 would generate a dihydroisoxazole 
core side chain and give access to a novel class of glucosinolate side chains. In 
the event oxime 76 was converted to the corresponding nitrile N-oxide via the 
oximyl chloride and this was immediately reacted with 106 and triethylamine in 
DCM. This produced 139 in an excellent yield (89%) and as a 1:1 mixture of 
diastereomers (Scheme 110). 
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Scheme 110: Reagents and conditions a) Oxime 76, NaOCl, NEt3, DCM, 3 h, 89%. 
The regiochemistry predicted for this reaction was first confirmed via COSY 
couplings showing Hx coupling to the diastereotopic HY protons (Figure 20a). 
Further to this an HMBC coupling from the carbon of the imine bond to the 
carbon with a pair of diastereotopic protons was also observed (Figure 20b).  
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Figure 20: a) COSY correlations; b) HMBC correlations. 
This is the first example of this sort of reaction on an intact glucosinolate. 
Clearly intermediate 139 could be used to expand into a range of novel 
glucosinolates (Scheme 111). For example, work by Curran121,122,123 
demonstrated the high yielding reduction of dihydroisoxazole rings with Raney 
nickel give to  keto-alcohol 140. Following olefination to 142 this would lead to a 
novel glucosinolate. 
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Scheme 111: Proposed conversion of 139 to 142.  
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3.12 Synthesis of glucosinolates containing ring side chains 
The original approach of Benn32 (as discussed in Section 1.6) was now 
explored to construct novel ring systems. The commercially available aldehyde 
143 was converted to the corresponding oxime 144 as summarised in Scheme 
112. This oxime was then successfully coupled to β-thioglucose to obtain 
thiohydroximate 145 in a good yield (61%) over the two steps (Scheme 112). 
a b
O N O
AcO
AcO
AcO
AcO N
OHS
OH
143 144
145  
Scheme 112: Reagents and conditions a) NH2OH·HCl, NaOAc, MeCN, H2O, 16 h; b) NaOCl, NEt3, DCM, 
3 h, 61% (over 2 steps) 
The thiohydroximate 145 was isolated as an inseparable mixture of the 
diastereoisomers of 145a and 145b (Figure 21). 
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Figure 21: Diastereomers of 145. 
Sulfation of 145 was explored using pyridine⋅sulfur trioxide complex and 
quenching with potassium hydrogen carbonate however this proved 
unsuccessful. The reaction was repeated using cyclohexylammonium as an 
alternative counter ion, however this also failed to yield sulfated 146 (Scheme 
113). 
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Scheme 113: Sulfation failed to yield desired product 146 as a potassium or cyclohexylammonium salt. 
Oxime 148 was prepared as shown in Scheme 114. This was obtained by 
coupling the oxime generated from aldehyde 147 with β-thioglucose 21 to 
obtain thiohydroximate 148 in good yield (69%). The 1H NMR was relatively 
complex consistent with a mixture of diastereomers. Sulfation of 148 to 149 was 
successfully achieved as a potassium salt (Scheme 114).  
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Scheme 114: Reagents and conditions a) i. NH2OH·HCl, NaOAc, MeCN, H2O, 16 h; ii. 21, NaOCl, NEt3, 
DCM, 69% (over 2 steps); b) Py⋅SO3, pyridine, 16 h, 48%. 
This also led to a mixture of diastereomers as indicated by 13C NMR spectra 
with multiple signals for the thiohydroximate. There are four possible 
diastereomers for 149 (Figure 22). The structural integrity of 149 was however 
confirmed with the use of 2D NMR and mass spectrometry. 
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Figure 22: Diastereomers of 149. 
The use of potassium carbonate in methanol facilitated acetate cleavage and 
provided 150 in excellent yield (Scheme 115).  
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Scheme 115: Reagents and conditions a) K2CO3, MeOH, 16 h, 88%. 
3.13 The total synthesis of novel glucosinolates  
It was anticipated that novel elongated side chains with a terminal alkene 
functionality could be obtained using the Benn synthesis32 (Scheme 116). 
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Scheme 116: Proposed pathway for the formation of elongated side chains. 
Aldehyde 152 was accessed by the oxidative fragmentation of commercially 
available diol 151 in an excellent yield (92%) (Scheme 117).  The aldehyde 152 
was then converted to the desired oxime 153 using hydroxylamine 
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hydrochloride. The reaction was conducted in a biphasic system, and this 
generated 153 as a 1:1 mixture of E:Z isomers. 
OH
HO
O N
HO
151 152 153
a b
 
Scheme 117: Reagents and conditions a) NaIO4, 3 h, 92%; b) NH2OH·HCl, NaOAc, MeCN, H2O, 16 h, 
78%. 
Coupling of the oxime to the protected thioglucose 21 was achieved using the 
NaOCl method outlined in Section 2.5 to generate 154. This reaction was 
straightforward and gave 154 in an excellent yield (71%) (Scheme 118).  
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Scheme 118: Reagents and conditions a) NaOCl, NEt3, DCM, 3 h, 71%. 
The glucosinolate was a crystalline solid and it was subject to X-ray structure 
analysis.  The structure of 154 showed two distinct conformers in the solid state 
with different orientations of the alkene moiety (Figure 23). A similar disorder 
was apparent in the structure of 129 (Figure 23). 
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Figure 23: X-ray crystal structure of 154 showing two distinct conformers around the terminal alkene. 
With alkene 154 in hand, sulfation with pyridine sulfur trioxide complex using a 
potassium counter ion was achieved to give 155 in good yield (59%) (Scheme 
119). Deacetylation was successfully achieved using potassium carbonate in 
methanol, to furnish the desired glucosinolate in high yield (73%) (Scheme 
119).  
154
O
AcO
AcO
AcO
AcO N
OHS
O
AcO
AcO
AcO
AcO N
OSO3- K+S
O
HO
HO
HO
HO N
OSO3- K+S
155 156
a b
 
Scheme 119: Reagents and conditions a) Py·SO3, pyridine, DCM, 16 h, 59%; b) K2CO3, methanol, 24 h, 
73%. 
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The synthesis of 157 was undertaken in an effort to prepare a glucosinolate 
analogue with a mid chain double bond.   
157
O
AcO
AcO
AcO
AcO S N
OH
 
Oxime 159 was prepared in an excellent yield (83%) by reacting commercially 
available, Z-alkeneic aldehyde 158 with hydroxylamine hydrochloride. Using the 
one-pot coupling technique now developed in this thesis, oxime 159 was 
coupled to thioglucose, generating 157, in an excellent yield (85%) (Scheme 
120). 
a b
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Scheme 120: Reagents and conditions a) NH2OH·HCl, NaOAc, MeCN : H2O, rt, 16 h, 83%; b) NaOCl 
NEt3, DCM, 4 h, 85%. 
With thiohydroximate 157 in hand sulfation was carried out to generate the  
cyclohexylammonium salt 160. A variety of methods were attempted to purify 
the sulfate 160 at this stage, however these were found to be time consuming 
and gave low isolation yields. Sulfation of thiohydroximate 157 was repeated 
and a cyclohexylammonium salt used as a counter ion. This gave 160 as a pale 
yellow solid. Deprotection was undertaken using potassium carbonate in 
methanol and this furnished the glucosinolate 161 as a cyclohexylammonium 
salt in excellent yield (81%) (Scheme 121). 
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Scheme 121: Reagents and conditions a) Py⋅SO3, pyridine, 5% cyclohexylamine in water, 16 h, 75%; b) 
K2CO3, MeOH, 24 h, 81%.  
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3.14 Conclusions  
Three novel glucosinolates, 150, 156, 161, have been prepared in good yields 
(Figure 24).  
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156  
Figure 24: Total synthesis of 150, 156 and 161 has been completed 
This involved using our NaOCl coupling strategy and also suflation and then 
mild conditions for per-acetate ester hydrolysis. This route allows for practical 
access to a range of novel glucosinolates and should find utility in the future. 
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4 
Towards the solid phase synthesis of a glucosinolate 
4.1 Background and introduction 
Merrifield124 introduced the concept of solid phase synthesis in 1963 when he 
described a technique for reacting amines and carboxylic acids together with 
one covalently linked to an insoluble solid matrix.125  By physically separating 
the reactants from the unwanted reagents and by-products the need to use 
flash chromatography is removed and replaced with a simple filtration and 
washing procedure. Initially solid phase synthesis was developed primarily for 
use in peptide synthesis, and indeed, the first use by Merrifield124 involved the 
synthesis of the tetrapeptide Leu-Ala-Gly-Val 162. 
O
NH2 O
N
H
OH
N
O
N
H
OH
162  
4.2 Components of a solid phase reagent 
Solid phase reagents can be divided into two key components. There is the 
insoluble matrix which forms the backbone of the resin and then there is the 
linker to which the substrate is covalently attached (Figure 25). Finally the 
substrate is likely to have other functionality attached to allow further 
modifications to be performed. The properties of the resin, for example 
solubility, can be tuned via alterations to each of these components.  
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Figure 25: Solid phase synthesis: schematic of substrate attached to matrix. 
4.2.1 The matrix backbone 
Classically the matrix backbone is insoluble in the reaction medium and is 
required to be sufficiently stable to allow for agitation and filtration.124,125 In 
addition it must also have appropriate functionality to allow attachment directly 
to the substrate or, more commonly, via a linker.  Merrifield investigated many 
polymers in his initial studies of matrices but found that modified polystyrene 
(PS) (Figure 26) was most successful in achieving the desired porous gel 
structure required for reagent diffusion. 
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Figure 26: Structure of polystyrene (PS). 
More recently controlled pore glass (CPG) was introduced an alternative 
matrix.125 Unlike PS it has wide solvent compatibility, as it does not require 
swelling prior to use. However, CPG systems based on a silica network, have 
the disadvantage of not being compatible with silyl protecting groups as 
deprotection, typically with a fluoride ion source, leads to breakdown of the 
matrix. Therefore the use of this matrix is not favoured in carbohydrate 
synthesis.125   
 
 
matrix linker 
FG 
 substrate 
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4.2.2 The linker component 
The linker component can be used to tune the reactivity and physical properties 
of the backbone of the resin. For example the incorporation of poly(ethylene 
glycol) (PEG), 163, linkers improves the compatibility of the PS-based systems 
in polar solvents due to the improved swelling characteristics of the PEG side 
chain.129 
O OHHO n
163  
The linker also plays a vital role in the cleavage conditions required for removal 
of the substrate from the resin. Typically linkers can be cleaved via acid,128 
base,129 oxidation,130 reduction,131 photolysis132 or alkene metathesis133 
depending on their design (Figure 27).  Therefore it is possible to select a 
linker/resin system whereby the cleavage conditions are orthogonal to those of 
the protecting groups or the functionality contained within the substrate.  
O R
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S R
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O R
Acid (TFA)
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Reduction (LiAlH4)
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O O
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Hydrogenation (Raney-Nickel)
oxidation (SmI2)
NO2
R
Photolysis (320 nm)
 
Figure 27: Various solid phase synthesis linkers that have been developed with their cleavage 
conditions.129-133 
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4.3 Alternatives to classical solid phase reagents 
Research focused on finding supported reagents is an emerging field in the 
area of solid phase research. Recently the use of highly fluorinated tags, Figure 
28, for the development of fluorous solid phase extraction (FSPE) has become 
fashionable.134 
SH
F2C(F2C)4F3C
NH2
CF3(CF2)6CF2
Si H
F2C(F2C)4F3C  
Figure 28: Examples of fluorous reagents. 
This technique has been successful in many recently reported syntheses of 
complex motifs. These include library synthesis of bioactive heterocycles137 
such as hydantoins and thiohydantoins 164 (Scheme 122a), as well as natural 
product-like scaffolds such as spirooxindoles136 165 (Scheme 122b). 
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Scheme 122: Examples of FSPE in synthesis. 
The advantage of FSPE is in the ease of purification. This is due to the 
specialist cartridge systems, on which the tagged FSPE molecules are retained. 
A change in solvent gradient can then be used to elute the tagged substrate, as 
illustrated in Figure 35. Currently the major limitation for this methodology is the 
high cost of both the reagent tags and the specialist purification scavenger 
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systems, but they have found increasing utility in the synthesis of high value 
products.  
 
 
 
 
 
4.4 Carbohydrates on solid phase 
The first example of solid phase carbohydrate synthesis was reported in 1971 
by Frechet et al.132 Frechet described the synthesis of disaccharide, 166 and 
used a novel poly [p-(1-propen-3-ol-1yl) styrene] resin, which allowed cleavage 
by ozonolysis. 
O
R1O
R2O
R2O
OR
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O
OCH2CHOR
2O
R2O
R2O
166  
Since this pioneering publication various synthetic strategies have been 
reported for attaching carbohydrate substrates to resins. In early work, 
Gagnaire136 explored the use of an ester linkage to the C-6 hydroxyl group for 
the formation of disaccharide 167, as shown in Scheme 123a. Subsequently the 
synthesis of gentiotetraose137 168 utilised a benzoyl propionate linker that could 
be cleaved under mild conditions with hydrazine acetate, Scheme 123b. 
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Figure 29: Schematic of fluorous solid phase extraction. 
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Scheme 123: Reagents and conditions A. a) i. pyridine ii. PhCOCl, pyridine iii. hydrazinium acetate, 
pyridine, AcOH, 50 °C, b) i. Hg(CN)2, 85%. B. a) hydrazinium acetate, 50°C 
Frechet and co-workers138 developed an alternative pathway using the resin 
bound boronic acid (Scheme 124). This method allowed selective preparation 
for the  β-anomer as it had previously been reported that glycosylation preferred 
formation of α-anomer linkages.139 
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Scheme 124: Boronic acid pathway. Reagents and conditions a) dehydration  b) Hg(CN)2 
An alternative and notable strategy was introduced by Guthrie and co-
workers140  involving a novel concept by performing a co-polymerisation of 169 
with styrene in order to gain covalent resin attachment while also crucially 
forming the polymeric scaffold (Scheme 125). 
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Scheme 125: Guthrie strategy for copolymerisation.140 
Automation has revolutionised the synthesis of bioactive carbohydrates 
enabling their exploration as novel candidates in the drug discovery process. 
Current market leaders in this class include acarbose 170 (Figure 36) a Type II 
diabetes drug first synthesised by Shibata et al.141 A further example is heparin 
171 (Figure 30), an injectable anticoagulant, which was first prepared by Sinaÿ 
et al.142 
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Figure 30: Therapeutic sugars made on solid phase. 
4.5 Glucosinolates on solid phase  
Glucosinolates are thioglycosides but they have an additional sulfate moiety, a 
structural feature that presents a difficulty in their purification and isolation 
during synthesis. It was envisaged that it may be possible to ease purification, 
in particular through the latter stages of their synthesis, by developing a solid 
phase synthesis of a glucosinolate. Such an approach has never been reported.   
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4.6 Model study 
4.6.1 Resin selection 
Before using solid phase reagents a solution phase model study was required 
to investigate the potential suitability of the chemical transformations involved. 
Merrifield resin with its high loading capacity, compatibility and broad range of 
possible reaction conditions, durability and low price143 made it the ideal resin 
for the synthesis. In order to mimic this resin a solution phase study used the 
benzyl group as it shares the same chemical reactivity characteristics of the 
resin (Figure 31).  
Benzyl group Merrifield Resin  
Figure 31: Benzyl group and Merrifield resin. 
4.6.2 Selecting a position for resin attachment  
It was attractive to consider attaching the resin to the sugar moiety instead of 
through the side chain of the glucosinolate (Figure 32). 
O
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C-4
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C-2
 
Figure 32: Schematic of potential resin attachment points. 
This has the potential for the synthesis of a range of glucosinolates on the solid 
phase using the sugar unit as a common motif. The C-2 hydroxyl group was not 
considered as the attachment point as its location may interfere with 
neighbouring group participation, a feature that is required to control the 
stereochemical outcome during manipulations at the anomeric centre (Section 
2.3). It would also be challenging to obtain selectivity at the C-6 hydroxyl 
without the use of elaborate protecting group manipulations prior to resin 
attachment, therefore this position was not selected. The C-3 and C-4 hydroxyls 
emerged as candidates, however the C-3 hydroxyl looked most promising as 
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this could be selectively attached via the use of diacetone glucose, an 
inexpensive and readily available starting material (Scheme 126). 
O
HO
O
HO
HO OH
R
O
O
O
O
O
HO
diacetone glucose
R = Benzyl (solution phase model study)
    = Merrifield resin (solid phase synthesis)  
Scheme 126: Proposed benzylation/resin attachment on the C-3 hydroxyl. 
4.6.3 Solution phase model study. 
The synthesis began with the protection of the C-3-hydroxyl group of diacetone 
glucose as a benzyl ether (Scheme 127). Removal of the acetal groups should 
result in spontaneous cyclisation to give the pyranose ring form of 173. 
Protection of 173 would then generate the key intermediate, 174. There are 
many routes available for the formation of β-thioglucose 175 and these 
approaches have been discussed previously in Section 2.3 and will be revisited 
in the context of this study. The route progresses with the coupling of the oximyl 
chloride and the resin bound thioglucose 175, via the NaOCl method developed 
in this thesis (Section 2.5). The intermediate thiohydroximate requires to be 
sulfated to intermediate 176 and then the acetyl esters hydrolysed in the 
presence of the benzyl group in an orthogonal strategy to obtain the resin 
bound glucosinolate. Finally, benzyl deprotection strategies144 will be screened 
to identify appropriate conditions for the release the final glucosinolate 1.  
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Scheme 127: Proposed glucosinolate synthesis on the solid phase. 
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4.7 Results and discussion 
4.7.1 Synthesis of 3-O-benzyl-1,2,4,6-tetra-O-acetyl glucose, 177 
O
O
O
O
O
HO
O
O
O
O
O
BnO
Diacetone glucose
a
177
172  
Scheme 128: Reagents and conditions a) NaH, BnBr, DMF, 3 h, 0 °C, 78%. 
Kojima et al.,145 have recently reported that the C-3 hydroxyl group of diacetone 
glucose can be selectively functionalised. They used this for the attachment 
point for a FSPE reagent 178 for the total synthesis of cucurbitoside A, 179 
(Figure 33). 
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C8F17
FSPE reagent 178 179  
Figure 33: FSPE reagent 178 used for the synthesis of curcubioside 179.145 
In the event successful benzylation was achieved with the use of sodium 
hydride and benzyl bromide in DMF146 and the ether was isolated in a good 
yield (78%) after further purification by column chromatography (Scheme 129).   
OHO
BnO
OH
OH
OH
O
O
O
O
O
BnO
a
177 173  
Scheme 129: Reagents and conditions a) Dowex-50W, water, 16 h, 80 °C, 95%. 
Previous attempts within the research group at St Andrews to remove the 
acetonide groups with trifluoroacetic acid proved problematic due to the polar 
nature of the product, which made purification difficult. Dowex-50W resin had 
previously been reported to cleave acetonide groups, therefore it was selected 
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for this deprotection147 (Scheme 129). The resin has the advantage that it 
allows a straightforward filtration on work up. In our hands this gave an 
excellent yield (95%) of 3-benzylglucose 173 in a 2:3 ratio of α:β anomers and a 
purity of greater than 95% (by 1H NMR, Figure 34) was achieved. No further 
purification was required following concentration of the filtrate.  
 
 
OHO
BnO
OH
OH
OH
173  
 
 
 
 
Figure 34: 1H-NMR of the 173 after Dowex-50W treatment of 177. Characteristic protons at 5.10 ppm (1H, 
d, J 3.7 Hz, CH-1α) and 4.53 ppm (1H, d, J 8.6 Hz, CH-1β). 
Although this reagent system might not be suitable for a solid phase approach, 
it was necessary for this model study to obtain a reference sample of the 
desired product in good quantity. On the solid phase the reagent roles will be 
reversed, therefore the use of aqueous acid would be compatible with the 
glucose motif attached to the solid support.  
Upon deprotection, rearrangement of the furanose, form of the sugar to the 
pyrano glucose form occurs (Scheme 130).148 Although both furanose and 
glucopyranose are possible, the 6-membered ring is favoured 
thermodynamically due to lower torsional strain.149  
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Scheme 130: Proposed mechanism for ring opening of 177. 
The final step towards key intermediate 174 required acetylation of the four 
remaining free hydroxyl groups of 173 (Scheme 131). The acetate protecting 
group was selected as it could be orthogonally deprotected relative to the resin, 
and its use has been previously documented in a related system (Section 2.3). 
A variety of acetylation conditions have been reported, for example acetic 
anhydride and iodine or acetic anhydride and pyridine. Previous work within the 
group on related substrates has however shown these methods to be 
unsuccessful, low yielding or difficult to purify. Instead the desired reaction has 
been achieved in moderate yield (54%) with the use of acetic anhydride and 
sodium acetate . The main advantage of this method was that the by-products 
are water soluble, therefore 174 could be purified readily by pouring into an 
ice/water slurry. The desired peracetylated product 174, precipitated as a pale 
yellow solid. It was purified by recrystallisation from ethanol.  
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Scheme 131: Reagents and conditions a) Acetic anhydride, sodium acetate, 110 °C, 54%. 
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4.7.2 The synthesis of thioglucose, 175  
The acetylated sugar 174 occupies a branch point in the synthesis as illustrated 
in Scheme 132. 
OAcO
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Br
Method 1
Method 2
Method 3174 181
175182  
Scheme 132: Proposed pathways for 175 synthesis. 
Three different methods were explored for the conversion of 174 to the β-
thioglucose 175. Method 1 explored a progression via the trichloroacetamide 
intermediate 181 and Method 2 via bromination at C-1 to give 182.  Finally 
Method 3 investigated direct formation of β-thioglucose 175 from tetra-acetyl 
glucose 174.  
4.7.2.1 Method 1  - via a trichloroacetamide. 
Selective deprotection of the anomeric acetyl group was required prior to the 
formation of the trichloroacetamide intermediate, 181. A range of conditions for 
such a selective hydrolysis have previously been reported including amide 
formation with hydrazine acetate150 or benzylamine.151 
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Scheme 133: Schmidt donor synthesis. Reagents and conditions a) Benzylamine, THF, 16 h, rt; b) 
trichloroacetonitrile, DBU, DCM, 16 h. 
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This can be difficult to achieve when the anomeric centre is not orthogonally 
protected with respect to the other positions. However this method exploits the 
slightly higher reactivity at the anomeric position, as the leaving group is a 
hemiacetal rather than an alcohol (Scheme 134).152 
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Scheme 134: Anomeric deprotection of 174. 
Selective deacetylation used benzylamine in THF was explore because it had 
been shown previously within the research group153 to be efficent.  However, in 
the event, the hemiacetal 183 proved difficult to purify as the amide co-product 
184, co-eluted during purification by flash chromatography. After failed attempts 
to purify the product by recrystallisation it was decided to progress the crude 
material though to the next step and purify after reaction with 
trichloroacetonitrile. Clearly on the solid phase this purification would not be 
necessary, as the sugar will remain attached to the solid support. The 
trichloroacetonitrile donor, also known as a Schmidt donor,154 was then 
explored. Althought crude product analysis suggested that this reaction had 
been successful but with a low conversion, it appeared that a diasteriomeric 
mixture had been produced. As it would not be possible separate these 
diastereomers on solid phase, a concern was that this would introduce 
diastereomers of the thioglucose product (Scheme 135). This method was not 
developed any further. 
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Scheme 135: Diastereomeric mixture of 181 may lead to diastereomeric mixture of 175. 
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4.7.2.2 Method 2 –via bromination of intermediate 181 
Method 2 envisaged a route toward thioglucose 175 via the brominated 
intermediate 182 (Scheme 136). 
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174 182 175  
Scheme 136: One-pot bromination of 174. 
The major advantage of this approach is that α-bromination of carbohydrates is 
a well-documented method.155 The desired C-1 β-anomer of 175 can be 
generated with good stereochemical control from reaction of 182 with thiourea. 
The stereochemical control arises from neighbouring group participation of the 
C-2 acetate (Section 2.3). 
At the outset bromination was explored with the use of hydrogen bromide (45% 
v/v in acetic acid) using the one-pot method, as described Section 2.3. It was 
found, upon analysis of the 1H-NMR spectrum, that the benzyl group of the C-3 
hydroxyl had been cleaved during the reaction. This was most likely due to the 
acidic conditions of the reaction (Scheme 137) and an alternative method was 
sought.  
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Scheme 137: Proposed mechanism for debenzylation of 174. 
The Appel reaction156,157 has previously been reported for bromination and 
offered a method of bromination under milder condtions, Scheme 138. Initial 
deacetylation of the anomeric centre to generate 183 was required before 
bromination could be attempted. In the event, the deacetylation was achieved 
by the use of benzylamine however the isolation of hemiacetal 183 proved 
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difficult and therefore it was used as a crude product in order to progress to the 
bromination. 
a
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Scheme 138: Reagents and conditions a) CBr4, PPh3, 5 h, 22%. 
The reaction is reported to progress by formation of the 
bromotriphenylphosphonium tribromomethanide 185 upon reaction of 
triphenylphosphine and carbon tetrabromide (Scheme 139). The anomeric 
hydroxyl of 183 acts as a nucleophile and attacks the reactive intermediate 185, 
displacing bromide and forming phosphonium oxide 186. Anomeric 
displacement results in the loss of triphenylphosphine oxide to generate 187, 
which can then undergo nucleophilic attack by bromide to obtain the β-anomer 
of 182. This will then equilibrate to the more thermodynamically stable α-
anomer. 
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Scheme 139: Proposed mechanism for Appel bromination of 183 to give 182.  
The yield of 182α  was disappointingly low (22%) and it was also found to 
rapidly decompose.  Due to this a full analysis could not be obtained however 
the 1H NMR (Figure 35) was consistent with desired structure. An attempt was 
made to optimise this method purifying 183 by column chromatography. 
Additionally alterations were made to reagent equivalents and alternative 
   Chapter 4 
 119 
purifications of 182 were attempted without success. The poor recovery created 
a bottle-neck in available material at an early stage of the synthesis therefore it 
was decided to explore an alternative method toward β-thioglucose 175.  
  
Figure 35: 1H NMR of 182. Anomeric proton at  6.57 ppm (1H, d, J 3.5 Hz, CH-1). 
4.7.2.3 Method 3 – a one-pot thioglycosylation 
Method 3 involved using the fully protected pyranose 174 and converting it to 
175 via an intermediate thiourea 188.157 
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Scheme 140: Reagents and conditions a) Thiourea, BF3⋅OEt2, MeCN, 2 h; b) sodium metabisulfite, water,  
62% (over 2 steps). 
This direct route was preferred as it would eliminate three steps from the 
synthesis compared to Method 1 and Method 2.  
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A recent report by Chiara et al.,158 on a similar substrate showed that the sulfur 
could be installed into the anomeric position without prior deacetylation 
(Scheme 141). This would be an advantage as deprotection to generate 183 
proved to be problematic during purification in the previous approaches 
(Section 4.7.2.1 and 4.7.2.2). 
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Scheme 141: Reagents and conditions a) Thiourea, BF3•OEt2, MeCN, 80 °C, 94%. 
The method required isolating the intermediate 188 before an additional 
hydrolysis step to generate 175.  In our hands it was found that it was possible 
to react 174 with thiourea at reflux for 15 min before performing a hydrolysis 
with sodium metabisulfite. Only the β-anomer was obtained which is indicative 
of a process involving neighbouring group participation in the formation of 
intermediate 189, followed by an SN2 reaction with thiourea to generate 188, 
Scheme 142. Finally hydrolysis, with sodium metabisulfite, gave β-thioglucose 
175 in a 62% yield (Scheme 140).  
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Scheme 142: Mechanistic rational for the stereochemical outcome for β-thioglucose 175. 
The stereochemistry was assigned via 1H NMR spectroscopy. The product had 
a 3JHH coupling of 9.4 Hz for the H-1 at the anomeric centre, which is consistent 
with β-thioglucose 175. Recrystallisation of this material was not straightforward 
and it was found that purification required column chromatography.  
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Figure 36: 1H NMR of 3Bn-thioglucose, 175. Anomeric proton at 5.13 ppm (1H, dd, J 10.1, 9.4 Hz, CH-1). 
To our knowledge this is the first model system which has been used to achieve 
orthogonally protected thioglucose and clearly this substrate may have wider 
applications than glucosinolate synthesis. For example, Fiore et al.,159 have 
recently reported the synthesis of S-glycosyl amino acids. It is anticipated that 
the use of resin bound 175 could lead to a rapid synthesis of highly polar 
structures, such as 190, without the need for time consuming purification. 
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4.7.3  Formation of glucosinolates 
With β-thioglucose 175 in hand the next stage in the formation of a 
glucosinolate was to couple with an oxime of choice (Scheme 143). Thus the 
intermediate thiohydroximate 191 would then be required to undergo sulfation 
to obtain 192 as a potassium salt. It is at this stage that a solid phase synthesis 
would be most beneficial as previous syntheses of glucosinolates have found 
this product difficult to purify as they are often isolated with an excess of 
potassium salts. Salt 193 would then be generated after deacetylation. Finally in 
order to realise the desired glucosinolate 194 a variety of debenzylation 
methods will need to be explored.  
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Scheme 143: Propose synthesis for glucosinolate 194. 
4.7.4 Formation of thiohydroximate bond  
In the event oxime 57 was selected as it was readily prepared in good yield as 
discussed in Section 2.4.2. Thiohydroximate 195 was generated by the novel 
coupling methodology developed in Section 2.5 and this was achieved in a 
excellent yield (86%) (Scheme 144). 
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Scheme 144: Reagents and conditions a) NaOCl, DCM, NEt3, 5 h, 86%. 
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Sulfation was performed using the pyridine⋅sulfur trioxide complex by the 
method already described in Section 3.12. Electrospray mass spectrometry was 
used to confirm product formation and this method showing the desired mass 
peak at m/z (ES-) 588.  
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Scheme 145 Reagents and conditions a) Py⋅SO3, pyridine, 2M KHCO3, DCM, 16 h. 
The 1H NMR of 196 was however difficult to interpret due to an excess of 
potassium salts and attempts to further purify this material were not successful. 
Therefore it was felt that a change in the counter ion may be advantageous in 
order to help purify the glucosinolate at this stage. Therefore a sulfation was 
performed, but this time using a cyclohexylammonium as the counterion, 197 
(Scheme 146). Sulfate 197 was obtained in a moderate but workable yield 
(53%) and allowed investigations into the final deprotections stages of the 
model synthesis. 
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Scheme 146: Reagents and conditions a) Py⋅SO3, pyridine, 5 % aq cyclohexylamine solution, DCM, 16 h, 
53%. 
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4.7.5 Deprotection of 197 
A deacetylation using potassium carbonate in methanol was attempted. It was 
observed by 1H NMR and mass spectrometry analysis that a mixture of partially 
deprotected material had formed, whereby one acetate moiety remained. 
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Scheme 147: Reagents and conditions a) K2CO3, MeOH. 
2D NMR spectroscopy techniques were used to investigate at which position 
the acetate group was located however the results were not definitive. 
Extending the reaction time to drive the hydrolysis to completion was explored, 
however it was found that even after 6 days a mixture remained. Attempts were 
made to separate the desired compound 198 from the mixture using reverse 
phase chromatography however without success.  
Zemplen conditions, of sodium metal in methanol,160 proved too harsh and gave 
a range of decomposed by-products. Therefore in order to progress further, 
investigations in the deprotection of the acetate esters would need to be 
explored. 
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4.8  Conclusion 
Diacetone glucose was successfully protected as its a benzyl ether 177 at C-3, 
as a mimic for Merrifield’s resin. It was found that 177 be could readily 
converted to 173 in excellent yield with the use of Dowex resin. Acetylation was 
achieved with acetic anhydride and sodium acetate to obtain workable quanities 
of 174.  
Various methods were explored at this stage in order to generate 2-Bn-
thioglucose 175. Successful methods used a one-pot thioglycosylation-
hydrolysis system to achieve 175 in good yield (62%) over the two steps. 
Coupling between 175 and 57 was achieved in good yields using the NaOCl  
method previously developed in this thesis, as detailed in Section 2.5.  In the 
end deprotections proved to be problematic. The use of potassium carbonate 
suggested that one acetate remained intact. It was not possible to determine at 
exactly which position the acetate remained.  
It is clear that there are now prospects for a solid phase synthesis of 
glucosinolates after optimisation of the late stage deprotection methodology. 
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5 
Applications of synthesised glucosinolates 
In summary a new coupling method for β-thiohydroximate bond formation has 
been developed for the glucosinolate family of natural products using 
inexpensive and readily available NaOCl as the chlorinating agent. The method 
proved very effective over a range of substrates exploiting the oxidative 
activation of oximes for glucosinolate coupling. This simplified one-step 
procedure is straightforward to carry out, rapid and it gives good to excellent 
yields over a range of substrates. It is envisaged that this methodology could 
prove highly useful in the formation of isotopically labeled natural and novel 
glucosinolates, as detailed in Scheme 148. The method is undoubtedly an 
improvement over existing protocols, and should be the first choice for the 
synthesis of glucosinolates to gain efficient access to materials for further 
biological, metabolism and enzymatic studies. 
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Scheme 148: Alternative route towards [Phenyl-2H5]-gluconaturtiin 
This thesis has also developed a novel concept of using the side chain 
functionality of glucosinolates to synthesis novel and natural glucosinolates. 
Further developments of this methodology could include the synthesis of 
labelled glucosinolates by side chain modifications. For example the synthesis 
of a terminal alkene labelled sidechain glucosinolate, as detailed in Scheme 
149, could be obtained via the Wittig reaction of aldehyde 97 and an isotopically 
   Chapter 5 
 127 
labelled Wittig salt. In turn, it is envisaged that such an analogue could be used 
in biological studies to gain further insight into the ESP mechanism by 
monitoring the breakdown products produce by analytical techniques such as 
LCMS and NMR spectroscopy. 
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Scheme 149: Wittig chemistry would allow isotopically label to be installed at terminal alkene. 
Additionally aldehyde 97 could also allow access to cyclpropane side chain 
glucosinolate (Scheme 150). As discussed in Section 3.1 this would allow the 
proposed radical mechanism of ESP to be explored by monitoring the 
metabolites produced. 
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Scheme 150: Wittig reaction on 97 could be used to obtain ESP mechanism probe. 
The intermediate aldehyde 97 could be used to synthesis novel amine 
glucosinolates via the reductive amination of aldehyde 97 and a desired amine. 
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Scheme 151: Reductive amination on intermdiate 97 would allow access to amine containing 
glucosinolates. 
The three novel glucosinolates, 150, 156, 161, synthesed in Chapter 3 would 
offer the opportunity for insight into the ESP mechanism. Little is known about 
the  structural activity relationship of ESP therefore bulky substrates, such as 
150, and elongated sidechains, such as 156 and 161 would allow a substrate 
profile of the ESP-myrosinase system to be developed. 
O
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OSO3- +NH3
161
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HO N
OSO3-K+S
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O
HO
HO
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HO N
OSO3- K+S
156  
Novel glucosinolate such as the 1,3-dipolar intermediate 139 would not only 
allow further chemical transformations to be explored but also insight into the 
tolerlance of the myrosinase hydrolysis. 
O
AcO
AcO
AcO
AcO N
OTBSS
O
NR
139  
Finally, the transfer of the chemistry developed in Chapter 4 to solid support 
would allow for rapid access to glucosinolates which are immobilized thereby 
overcoming the difficulties associated with their high polarity. A further 
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implementation of the solid supported synthesis would be their use on the solid 
support as biological probe upon identification of a suitable biocompatible linker.  
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6 
Experimental  
General considerations: 
Materials were obtained from commercial suppliers and were used without 
further purification unless otherwise noted. All moisture and air-sensitive 
reactions were carried out under an atmosphere of nitrogen, which had been 
dried via passage through a Drierite column, using oven or flame dried 
glassware. 
Melting points were determined using an Electrothermal melting point apparatus 
and are uncorrected. 
Microanalysis was carried out by the University of St Andrews microanalytical 
laboratory on a Carlo Erba EA1110 CHNS analyser.  
IR spectra were recorded as either: nujol mulls or liquid flims between sodium 
chloride discs; as potassium bromide pellets unless otherwise stated on a  
Perkin Elmer GX FT-IR instrument. Absorption maxima are given in 
wavenumbers (cm-1) relative to a polystyrene standard.  
1H NMR spectra were recorded using a Bruker Avance 300 at 300 MHz, Bruker 
Avance II 400 (400 MHz) or Bruker Avance 500  (500 MHz) spectrometers. 13C 
NMR spectra were recorded using a Bruker Avance 300 (75 MHz), Bruker 
Avance 400 (100 MHz) or Bruker Avance 500 (125 MHz) spectrometers  using 
a DEPT-Q pulse sequence. 1H and 13C NMR spectra were referenced to 
deuterochloroform (CDCl3), d4-methanol or D2O. NMR spectra are described in 
parts per million (ppm) downfield shift from TMS and are reported consecutively 
as position (δH or δC), relative intergral, multiplicity (s=singlet, br s=broad 
singlet, d = doublet, br d = broad doublet, dd = doublet of doublets and 
assignment. Coupling constants (J) are recorded to 0.1 Hz and identical 
coupling constants averaged. 
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Low resolution and high resolution chemical isonisation (CI) mass spectra were 
recorded on a Micromass GCT spectrometer with methane as the ionisation 
gas. Electrospray (ES) spectra were recorded using a Micromass LCT 
operating in positive or negative  mode from solutions of acetonitrile, methanol 
or water. 
Preparative flash column chromatography was performed with Apollo Scientific 
silica gel 60 (40-63 micron grade) under a positive pressure of air. Thin layer 
chromatography was performed on Merck silica gel 60 F254 glass plates backed, 
and visualised using UV light, 10% H2SO4 in ethanol stain or alkaline potassium 
permanganate stain. 
NaOCl refers to sodium hypochlorite solution. (wt/mL at 20 °C 1.24 -1.26g) 
Ozone experiments were performed using a Fisher Technology OZ/500/5 
ozone generator.  
Specific optical rotations were measure using a Perkin Elmer Model 341 
polarimeter, in cells with a path length of 1 dm. The light source was maintained 
at 589 nm. The concentration (c) is expressed in g/100 mL. Specific rotations 
are denoted as 
! 
"[ ]D
T  and are given in implied units of 10-1 deg cm2 g-1 (T = 
ambient temperature in °C). 
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6.2 Experimental procedures 
2,3,4,6-Tetra-O-acetyl-α-D-glucopyranosyl bromide,161 18  
O
OAc
AcO
AcO
OAc
Br12
3
4 5
6
 
Method 1: Hydrogen bromide (45% w/w in acetic acid, 60 mL, 237.6 mmol, 1.1 
eq) was added dropwise to a solution of D-glucose (39.0 g, 216.0 mmol, 1.0 eq) 
in acetic anhydride (150 mL) at 0 °C. After 4 h further hydrogen bromide (45% 
w/w in acetic acid, 180 mL, 712.8 mmol, 3.3 eq) was added dropwise at 0 °C. 
The reaction mixture was allowed to warm to room temperature and stirred for 
16 h. The reaction mixture was taken up in DCM (300 mL) and poured into 
ice/water (500 mL). The layers were separated and the organic layer was 
washed with an ice/saturated sodium hydrogen carbonate solution (600 mL). 
The organic phase was separated and washed with saturated sodium hydrogen 
carbonate solution (600 mL). After effervesence had ceased the organic layer 
was separated, dried over magnesium sulfate and solvent removed under 
reduced pressure. The resulting oil was crystallised from diethyl ether to give 18 
as a crystalline solid (75.4 g, 85%):  
Method 2: Hydrogen bromide (45% w/w in acetic acid, 36.3 mL 140.1 mmol, 1.1 
eq) was added dropwise to a solution of (S)-1,2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl (50.0 g, 128.0 mmol, 1.0 eq) in DCM (20 mL) under a nitrogen 
atmosphere and at 0 °C. Following addition and 1 h of stirring at 0 °C the 
solution was allowed to warm to room temperature and was stirred for a further 
2 h. The solution was poured into water (ca. 300 mL) and the organic layer 
separated before being washed repeatedly (5 × 200 mL) with saturated sodium 
hydrogen carbonate solution until the organic layer was neutral at pH 7. The 
organic fraction was dried over magnesium sulfate before the solvent was 
removed under reduced pressure to obtain a golden oil which was crystallised 
from diethyl ether to give 18 (33.2 g, 63%) as a colourless crystalline solid.  
Data was consistent for both methods: 
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mp 86-87 oC. [lit 88-89 °C] 163; νmax (nujol)/cm-1 2960 (CH), 1740 (CO), 609 (C-
Br); δH (300 MHz, CDCl3) 6.59 (1H, d, J 4.0 Hz, CH-1), 5.55 (1H, dd, J  10.4, 
10.4 Hz, CH-3), 5.19-5.10 (1H, m, CH-4), 4.83 (1H, dd, J 10.4, 4.0 Hz, CH-2), 
4.34-4.25 (2H, m, CH2-6), 4.14-4.08 (1H, m, CH-5), 2.09, 2.08, 2.04, 2.02 (12H, 
4 x s, CH3C(O)O); δC (75 MHz, CDCl3) 170.9, 170.3, 170.2, 169.9, (4 × 
CH3C(O)O), 86.9 (C-1), 72.5 (C-5), 70.9 (C-3), 70.6 (C-2), 67.5 (C-4) 61.4 (C-
6), 21.1 21.0 (2C), 20.9 (4 × CH3C(O)O); m/z (ES+) 435 (98%, [M+Na]+, 81Br), 
433 (100%, [M+Na]+, 79Br) . 
S (2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) isothiouronium 
bromide,162 50 
12
3
4 5
6
O
OAc
AcO
AcO
OAc
S
NH2
NH2
Br
 
Thiourea (6.86 g, 90.1 mmol, 1.0 eq) was added in one portion to a solution of 
2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 18 (37.0 g, 90.1 mmol, 1.0 
eq) in dry acetone (100 mL), and the solution heated under reflux. After 15 min 
the reaction was first cooled to room temperature, then to 0 °C. The resulting 
precipitate was filtered and recrystallised from acetone to give 50 as a 
crystalline solid (31.2 g, 71%): mp 200-204 °C dec [lit164  205 °C]; νmax 
(nujol)/cm-1 3320 (NH), 1750 (CO), 1655 (NH); δH (300 MHz, D2O) 5.40-5.09 
(4H, m, CH-1,2,3,4), 4.34-4.26 (2H, m, CH2-6), 4.18-4.07 (1H, m, CH-5), 2.01, 
1.99, 1.97, 1.94 (12H, 4 × s, CH3C(O)O); δC (75 MHz, D2O) 171.7, 171.0, 170.5, 
170.3 (4 × CH3C(O)O), 79.2 (C-1), 73.9 (C-5), 71.4 (C-3), 67.2 (C-2), 65.7 (C-
4), 59.9 (C-6), 18.2, 18.1 (2C), 18.0 (4 × CH3C(O)O). 
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2,3,4,6-Tetra-O-acetyl-1-thio-β-D-glucopyranose,163 21 
12
3
4 5
6
O
OAc
AcO
AcO
OAc
SH
 
Potassium metabisulfite (1.15 g, 6.0 mmol, 1.0 eq) was added to water (75 mL) 
and the resulting solution was heated, with stirring, to 75 °C. DCM (100 mL) 
was added and then 50 (3.0 g, 6.0 mmol, 1.0 eq), and the biphasic mixture 
heated under reflux for 20 min. Upon cooling, the organic layer was separated, 
washed with water (3 × 100 mL), dried over magnesium sulfate and the solvent 
removed under reduced pressure to yield a colourless oil that crystallised upon 
cooling to - 20 °C. The solid was recrystallised from methanol yielding 21 (1.65 
g, 76%) as a colourless solid: mp 74-76 °C [lit.165 75 °C]; 
! 
"[ ]D
20 +5.0  (c 5.0, 
CHCl3); νmax (nujol)/cm-1 2920 (CH), 2580 (SH), 1740 (C=O); δH (300 MHz, 
CDCl3) 5.16-5.01 (2H, m, CH-3,4), 4.90 (1H, dd, J 9.3, 9.1 Hz, CH-2), 4.49 (1H, 
dd, J  9.1, 9.1 Hz, CH-1), 4.18 (1H, dd, J 12.6, 4.9 Hz, CH2-6a), 4.05 (1H, dd, J 
12.6, 2.4 Hz, CH2-6b), 3.70-3.67 (1H, m, CH-5), 2.03, 2.02, 1.96 1.94 (12H, 4 × 
s, CH3C(O)O); δC (75 MHz, CDCl3) 171.0, 170.5, 170.0, 169.7 (4 × CH3C(O)O), 
79.1 (C-1), 77.5 (C-5), 76.7, (C-3), 73.9, (C-2), 68.5 (C-4), 62.4 (C-6), 21.2, 21.1 
(2C), 20.1 (4 × CH3C(O)O);  m/z (ES)+ 387 (100%, [M+Na]+). 
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1-Bromopent-4-ene,69,164 53 
1
2
3
4
5
Br
 
Method 1:164 Carbon tetrabromide (8.70 g, 26.6 mmol, 1.1 eq) was added to a 
solution of 4-pentene-1-ol 51 (2.00 g, 23.8 mmol, 1.0 eq) in DCM (10 mL) and 
the solution was cooled to 0 °C before the portionwise addition of 
triphenylphosphine (6.82 g, 26.0 mmol, 1.1 eq). After 4 h stirring at room 
temperature, the solution was reduced in volume and the residue was poured 
into petroleum ether (30 mL). After 5 min the resulting precipitate was filtered 
and washed with further petroleum ether. The resulting brown oil was 
fractionally distilled to give the 53 (1.64 g, 48%) as a colourless oil. 
Method 2:69 1,5-Dibromopentene (20.0 g, 87.8 mmol, 1.0 eq) was added to a 
distillation apparatus and heated to 195 °C. HMPA (18.9 g, 105.3 mmol. 1.2 eq) 
was added dropwise over 1 h via a syringe pump and 53 (9.51 g, 73%) was 
collected in the receiver flask as a colourless oil: bp 122-125  °C [Lit.69 bp 122-
124 °C]; νmax (film)/cm-1 3100 (HC), 1640 (C=C), 630 (C-Br); δH (300 MHz, 
CDCl3) 5.82 -5.69 (1H, ddt, J 16.7, 10.6, 6.4 Hz, CH-4), 5.03-4.96 (2H, m, CH2-
5), 3.34 (2H, t, J 6.4 Hz, CH2-1), 2.18-2.09 (2H, m, CH2-3), 1.87 (2H, m, CH2-2); 
δC (75 MHz, CDCl3) 137.1 (C-4), 116.3, (C-5), 33.5, 32.4, 32.2. 
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5-Nitropent-1-ene,165 54 
NO21
2
3
4
5  
4-Bromopent-1-ene 53 (4.0 g, 27.0 mmol, 1.0 eq) was added to a stirred 
solution of sodium nitrite (2.23 g, 32.4 mmol, 1.2 eq) in dry DMF (50 mL) at 0 
°C, and reaction mixture was stirred for 3 h at ambient temperature. The 
reaction mixture was then poured into an ice-water slurry and once most of ice 
had melted the product was extracted into diethyl ether (3 × 150 mL). The 
organic extracts were then combined and washed with water (100 mL) before 
drying over magnesium sulfate and the solvent removed under reduced 
pressure.  The crude yellow oil was purified by flash column chromatography (5 
: 95, diethyl ether : petroleum ether) to give 54 (1.15 g, 37%) as a colourless oil: 
νmax (film)/cm-1 3080 (HC), 2920 (CH), 1640 (C=C), 1580 (NO2), 1350 (NO2); δH 
(300 MHz, CDCl3) 5.74 (1H, ddt, J 16.7, 10.4, 6.7 Hz, CH-2), 5.10-5.01 (2H, m, 
CH2-1), 4.36 (2H, t, J 6.8 Hz, CH-5), 2.18-2.03 (4H, m, CH2-3,4); δC (75 MHz, 
CDCl3) 136.2 (C-2), 117.1 (C-1), 75.1 (C-5), 30.6 (C-4), 26.7 (C-3). 
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2-Iodoxybenzoic Acid (IBX)73 
O
I+
O
O-HO
 
2-Iodobenzoic acid (50 g, 0.20 mol, 1.0 eq) was added to a solution of oxone 
(181.0 g, 0.29 mol, 1.5 eq) in distilled water (650 mL) and the resulting slurry 
was mechanically stirred at 73 °C for 5 h. After this time the suspension was 
cooled to 5 °C for 1.5 h. The resulting precipitate was isolated by filtration and 
washed with water (6 × 100 mL), acetone (2 × 100 mL) and allowed to dry at 
room temperature for 16 h, yielding IBX (45.9 g, 81%) as a colourless solid: δH 
(300 MHz, CDCl3) 8.13 (1H, d, J 8.0 Hz, CH-2), 8.05-7.94 (2H, m, CH-3, 5), 
7.86-7.79 (1H, m, CH-4) and 2.49 (1H, br s, OH).   
Pent-4-enal,167 56 
O
1
2
3
4
5
 
Method 1: IBX (39.6 g, 141.4 mmol, 2.0 eq) was added in a single portion to a 
solution of 4-penten-1-ol (6.1 g, 7.3 mL, 70.7 mmol, 1.0 eq) in DCM (200 mL) 
and the resulting slurry was heated under reflux for 48 h. Upon cooling the 
slurry was filtered and the residue washed with DCM (2 × 150 mL). The filtrate 
was concentrated under reduced pressure to yield 56 (4.8 g, 99%) as a 
colourless oil. 
Method 2:169 Allyl vinyl ether 58 (10.0 g, 118.9 mmol, 1.0 eq) was heated in a 
sealed tube for 15 h at 150 °C to obtain 56 (9.9 g, 99%) as a colourless oil; δH 
(300 MHz, CDCl3) 9.72 (1H, t, J 1.5 Hz, CH-1), 5.78 (1H, ddt, J 16.8, 10.3, 6.7 
Hz, CH-4), 5.05-4.93 (2H, m, CH2-5), 2.62-2.58 (2H, m, CH2-2), 2.38-2.30 (2H, 
m, CH2-3); δC (75 MHz, CDCl3) 201.5 (C-1), 136.5 (C-4), 116.9, (C-5), 43.3 (C-
2), 27.1 (C-3). 
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General procedure A: Oxime formation  
Sodium acetate (1.0 eq) and hydroxylamine hydrochloride (1.0 eq) were added 
to a solution of aldehyde (1.0 eq) in acetonitrile and water (2:1). The resulting 
biphasic solution was allowed to stir at room temperature for 16 h before the 
organic layer was separated. The aqueous layer was extracted with DCM (3 ×) 
before the organic fractions were combined and washed with saturated sodium 
hydrogen bicarbonate and brine. The organic layer was then dried over 
magnesium sulfate and the solvent removed under reduced pressure to yield 
the oxime. 
Pent-4-enal oxime, 57 
N
1
2
3
4
5 OH  
General procedure A was employed using 56 (8.00 g, 95.2 mmol, 1.0 eq), 
sodium acetate (9.40 g, 114.1 mmol, 1.2 eq) and hydroxylamine hydrochloride 
(6.6 g, 95.3 mmol, 1.0 eq ) in water (48 mL) and acetonitrile (96 mL) to obtain 
57 (6.88 g, 73%) as a pale yellow oil and as a 1 : 1 mixture of E : Z isomers: 
νmax (film)/cm-1 3280 (N-OH), 2980 (CH), 2920 (CH), 1640 (CN); δH (300 MHz, 
CDCl3) 7.43 (1H, t, J 5.8 Hz, CH-1 anti), 6.72 (1H, t, J 5.2 Hz, CH-1 syn)  5.88-
5.72 (1H, m, CH-4), 5.10-4.95 (2H, m, CH2-5), 2.52-2.33 (2H, m, CH2-3), 2.32-
2.20 (2H, m, CH2-2); δC (75 MHz, CDCl3) 149.8 (C-1 anti), 149.4 (C-1 syn), 
135.0 (C-4), 134.7(C-4), 113.8 (C-5), 113.7 (C-5), 31.9 (C-3), 30.9 (C-3), 28.8 
(C-2), 28.1 (C-2). 
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General procedure B: Thiohydroximate formation  
NaOCl (5.0 eq) was added to a solution of oxime (1.0 eq) in DCM in a 
separating funnel. The mixture was shaken and a colour change from 
colourless to vibrant blue to pale yellow was observed. The DCM layer was then 
added directly to a stirred solution of 21 (0.6 eq) in DCM before the addition of 
triethylamine (3.0 eq). The reaction was allowed to stir at room temperature until 
completion. The solution was washed with H2SO4 (0.5 M, 3 ×), water (3 ×) and 
brine and dried over magnesium sulfate. The solvent was removed under 
reduced pressure to yield the crude thiohydroximate. Purification was carried 
out using flash chromatography (with a gradient of ethyl acetate: petroleum 
ether), unless otherwise stated. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-pen-4-ene 
thiohydroximate, 47 
O
AcO
AcO
AcO
AcO N
OHS123
4 5
6
7
8
9
10
11  
General procedure B was employed using 57 (1.0 g, 10.1 mmol, 1.0 eq) in DCM 
(40 mL), NaOCl (31.0 mL, 50.5 mol, 1.6 M, 5.0 eq), 21 (2.2 g, 6.0 mmol, 0.6 eq) 
and triethylamine (3.0 g, 4.2 mL, 30.3 mmol, 3.0 eq). The reaction was allowed 
to stir for 3 h and was purified using flash chromatography (40:60, ethyl acetate: 
petroleum ether) to yield 47 (2.9 g, 63%) as a colourless solid: mp 148-152 °C: 
! 
"[ ]D
20  -17.4  (c 1.0, CHCl3); νmax (KBr)/cm-1 3320 (NOH), 3080 (CH), 2920 (CH), 
2850 (CH), 1750 (CO), 1640 (C=C), 1620 (CN); δH (300 MHz, CDCl3) 5.79 (1 H, 
ddt, J 16.7, 10.6, 6.4 Hz, CH-10), 5.23-5.17 (1H, m, CH-3), 5.06-4.93 (5H, m, 
CH2-11 and CH-1,2,4), 4.15-4.03 (2H, m, CH2-6), 3.71-3.65 (1H, m, CH-5), 
2.65-2.46 (2H, m, CH2-8), 2.39-2.32 (2H, m, CH2-9), 2.02, 1.98, 1.97, 1.94 
(12H, 4 × s, CH3C(O)O); δC (75 MHz, CDCl3) 170.2, 169.4, 169.2 (4 × 
CH3C(O)O), 156.9 (C-7), 136.6 (C-10), 115.9 (C-11), 79.9 (C-1), 76.0 (C-5), 
73.8 (C-3), 70.1 (C-2), 68.1 (C-4), 62.3 (C-6), 31.9 (C-8), 30.8 (C-9), 20.7, 20.6 
(2C), 20.5 (4 × CH3C(O)O); m/z (ES+) 484 (100%, [M+Na]+); HRMS (ES+) 
calculated [M+Na]+ C16H26NO10NaS 484.1243, found 484.1253. 
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3-Phenylpropanal oxime,168 76  
1
2
3
4
5
NHO
6
7  
General procedure A was employed using 3-phenylpropanal (1.0 g, 7.5 mmol, 
1.0 eq), hydroxylamine hydrochloride (0.52 g, 7.5 mmol, 1.0 eq), sodium 
acetate (0.73 g, 8.9 mmol, 1.2 eq), acetonitrile  (20 mL) and water (10 mL) to 
obtain 76 (0.80 g, 72%) as a pale yellow solid and 1 : 1 mixture of E : Z 
isomers: mp 86-88°C [lit.170 85.5-88°C]; νmax (KBr)/cm-1 3200 (NO), 3060 (Ar-
CH), 2860 (CH), 1660 (C=N); δH (300 MHz, CDCl3) 7.46 (1H, t, J 7.0 Hz, CH-1), 
7.35-7.27 (2H, m, 2 × CH-5), 7.25-7.18 (3H, m, 2 × CH-6, CH-7), 6.77 (1H, t, J 
3.5 Hz, CH-1 syn), 2.88-2.79 (2H, m, CH2-3), 2.77-2.68 (1H, m, CH2-2a), 2.58-
2.48 (1H, m, CH2-2b); δC (75 MHz, CDCl3) 152.2 (C-1), 151.8 (C-1), 141.0 (C-
4), 140.9 (C-4), 128.9 (C-5), 128.8 (C-6), 126.7 (C-7), 33.2 (C-3), 32.4 (C-3). 
31.6(C-2), 26.8 (C-2); m/z (ES+) 172 (100%,  [M+Na]+). 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-3-phenylpropane 
thiohydroximate,169 65 
12
3
4 5
6
7
9
10
8
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13
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AcO
AcO
AcO
AcO N
OHS
 
General procedure B was employed using using 21 (0.21 g, 0.6 mmol, 0.6 eq), 
3-phenylpropanal oxime (0.14 g, 1.0 mmol, 1.0 eq), NaOCl (3.1 mL, 1.6 M, 5.0 
mmol, 5.0 eq), triethylamine (0.42 mL, 3.0 mmol, 3.0 eq) and DCM (15 mL) to 
obtain 65 (0.23 g, 76 %) as a colourless solid; mp 196-198°C [lit.172 198 °C]; 
! 
"[ ]D
20 -17.0 (c 0.5, CHCl3); νmax (KBr)/cm-1 3310 (NOH), 3030 (C=C), 1710 
(C=O), 1600 (CN); δH (300 MHz, CDCl3), 7.28-7.10 (5H, m, CH-11,12,13), 5.20-
5.13 (1H, m, CH-3), 5.03-4.89 (3H, m, CH-1,2,4), 4.06 (1H, dd, J 12.1, 5.7 Hz, 
CH2-6a), 4.02 (1H, dd, J 12.1, 2.1 Hz, CH2-6b),  3.66-3.58 (1H, m, CH-5), 2.96-
2.64 (4H, m, CH2-8,9). 1.99, 1.96, 1.94, 1.85 (12H, s, 4 × CH3C(O)O);  δC (100 
MHz, CDCl3) 171.2, 170.8, 169.9, 169.8 (4 × CH3C(O)O), 152.2 (C-7), 140.9 (C-
10), 129.1 (2C, C-12), 128.7 (2C, C-11), 126.9 (C-13), 80.3 (C-1), 76.5 (C-5), 
74.1 (C-3), 70.5 (C-2), 68.4 (C-4), 62.6 (C-6), 34.8 (C-8), 33.5 (C-9), 21.0, 20.9 
(4 × CH3C(O)O); m/z (ES+) 534 (100%, [M+Na]+). 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-octane 
thiohydroximate,80 66 
12
3
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General procedure B was employed using octanal oxime (1.44 g, 10.1 mmol, 
1.0 eq), DCM (10 mL), NaOCl (31.0 mL, 50.5 mmol, 1.6 M, 5.0 eq), 21 (2.20 g, 
6.0 mmol, 0.6 eq) and triethylamine (3.00 g, 4.2 mL, 30.0 mmol, 3.0 eq) in DCM 
(40 mL). Purification by flash chromatography (40 : 60, ethyl acetate : petroleum 
ether) gave 66 (2.3 g, 78%) as a colourless solid; mp 122-124°C [lit.172 127°C]; 
νmax (KBr)/cm-1 3300 (OH), 2930 (CH) 1730 (CO), 1600 (C=N); δH (300 MHz, 
CDCl3) 5.40 (1H, dd, J 9.0 Hz, CH-3), 5.24 (1H, d, J 10.0 Hz, CH-1), 5.05 (2H, 
m, CH-2,4), 4.25 (1H, dd, J 12.4, 4.6 Hz, CH2-6a), 4.13 (1H, m, dd, J 2.3, 12.4 
Hz, CH2-6b), 3.98 (1H, m, CH-5), 2.55 (2H, t, J 6.1 Hz, CH2-8), 2.07, 2.04, 2.05, 
2.07 (12H, 4 × s, CH3C(O)O), 1.70-1.52 (2H, m, CH-9), 1.45-1.30 (8H, m, CH-
10,11,12,13), 0.96 (3H, m, CH3-14). m/z (ES+) 528 (100%, [M+Na]+) 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-pen-4-yne 
thiohydroximate, 67 
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General procedure A was employed using pen-4-ynal (1.02 g, 12.4 mmol, 1.0 
eq) in acetonitrile: water (2 : 1, 20 : 10 mL), sodium acetate (1.22g, 14.9 mmols, 
1.2 eq) and hydroxylamine hydrochloride (0.86 g, 12.4 mmol, 1.0 eq) to yield 
pen-4-ynal oxime (1.06 g, 88%) as a mixture of E : Z isomers and as a yellow oil 
which was used without further purification.  
General procedure B was employed using pent-4-ynal oxime (1.0 g, 10.3 mmol, 
1.0 eq), NaOCl (32.0 mL, 51.4 mmol, 5.0 eq), 21 (2.2 g, 6.2 mmol, 0.6 eq) and 
triethylamine (3.1 g, 4.27 mL, 30.9 mmol, 3.0 eq) in DCM (15 mL) to obtain the 
product as an off-white solid which was purified by flash chromatography (30 : 
70, ethyl acetate : petroleum ether) to obtain 67 (2.12 g, 77%) as white 
crystalline solid: mp 262-264 °C; 
! 
"[ ]D
20 -22.6  (c 1.0, CHCl3); νmax (nujol)/cm-1 
3290 (NOH), 2920 (CH), 1640 (CN), 1460; δH (300 MHz, CDCl3) 5.35-5.24 (1H, 
m, CH-3), 5.17-5.06 (3H, m, CH-1,2,4), 4.26-4.18 (2H, m, CH2-6), 3.83 (1H, 
ddd, J 9.3, 5.4, 2.3 Hz, CH-5), 2.93-2.73 (2H, m, CH2-8), 2.65-2.55 (2H, m, 
CH2-9), 2.14, 2.08 (6H, 2 × s, 2 × CH3C(O)O), 2.06-2.02 (7H, m, 2 × CH3C(O)O 
and CH-11); δC (75 MHz, CDCl3) 170.7, 170.2, 169.4, 169.2 (4 × CH3C(O)O), 
150.7 (C-7), 82.7 (C-10), 80.0 (C-1), 76.2 (C-11), 75.9 (C-5), 73.7 (C-3), 70.1 
(C-2), 68.1 (C-4), 62.3 (C-6), 31.7 (C-9), 29.8 (C-8), 20.8 (2C), 20.5 (2C) (4 × 
CH3C(O)O); m/z (ES+) 482 (100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ 
C19H25NO10NaS 482.1097, found 482.1101. 
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4-Bromobenzaldehyde oxime170 
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General procedure A was employed using 4-bromobenzaldehyde (5.0 g, 27.0 
mmol, 1.0 eq), sodium acetate (2.7 g, 32.4 mmol, 1.2 eq) and hydroxylamine 
hydrochloride (1.9 g, 27.0 mmol, 1.0 eq) in water and acetonitrile (1 : 2, 40 : 80 
mL).This gave 4-bromobenzaldehyde oxime (4.32 g, 79%) as a colourless solid 
and exclusively as the Z isomer: mp 110-112 °C [lit.173 111-113 °C]; νmax 
(nujol)/cm-1 3660 (NO-H), 3050 (Ar-CH), 1650 (C=N), 930 (N-O); δH (300 MHz, 
CDCl3) 7.98 (1H, s, CH-1); 7.44 (2H, d, J 8.3 Hz, CH-3,5), 7.52 (2H, d, J 8.3 Hz, 
CH-2,4); δC (75 MHz, CDCl3) 149.8 (C-5), 132.5 (C-2), 131.5 (C-3), 128.9 (C-1), 
124.7 (C-4); m/z (ES+) 200 (98%, [M+H]+, 79Br),  202 (100%, [M+H]+, 81Br). 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-4-bromophenyl 
methane thiohydroximate, 68 
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General procedure B was employed using 4-bromobenzaldehyde oxime (0.20 
g, 1.00 mmol, 1.0 eq), NaOCl (3.10 mL, 1.6 M, 5.0 mmol, 5.0 eq). 21 (0.21 g, 
0.6 mmol, 0.6 eq), triethylamine (0.3 g, 0.42 mL, 3.0 mmol, 3.0 eq) and DCM 
(15 mL) to obtain 68 (0.30 g, 92%) as a colourless solid: mp 156-160 °C; 
! 
"[ ]D
20 
+7.0 (c 1.0 in CHCl3); vmax (KBr)/cm-1 3320 (NOH), 2940 (C=C), 1750 (C=O), 
1620 (CN); δH (300 MHz, CDCl3) 7.52 (2H, d, J 8.0 Hz, 2 × CH-9), 7.39 (2H, d, J 
8.0 Hz, 2 × CH-10), 5.04-4.90 (3H, m, CH-1,2,3), 4.50-4.41 (1H, m, CH-4), 4.06 
(1H, dd, J  12.0, 5.7 Hz, CH2-6a), 3.92 (1H, dd, J  12.5, 2.3 Hz, CH2-6b), 3.16-
3.10 (1H, m, CH-5), 2.04-1.92 (12H, 3 × s, 4 × CH3C(O)O); δC (100 MHz, 
CDCl3) 171.2, 170.8, 169.9, 169.8  (4 × CH3C(O)O), 151.0 (C-7), 132.4 (C-8), 
132.1 (2C, C-9,10), 130.9 (C-11), 81.9 (C-1), 76.2 (C-5), 74.0 (C-3), 70.4 (C-2), 
68.2 (C-4), 62.3 (C-6), 21.2, 21.0 (2C), 20.9 (4 × CH3C(O)O). m/z (ES+) 584 
(98%, [M+Na]+, 79Br), 586 (100%, [M+Na]+, 81Br); HRMS (ES+) calculated 
[M+Na]+ C21H24NO10NaS79Br 584.0200, found 584.0168. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-4-pyridiylmethane 
thiohydroximate, 69 
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General procedure B was employed using 4-pyridinecarboxaldehyde oxime 
(0.12 g, 1.00 mmol, 1.0  eq), NaOCl (3.1 mL, 5.0 mmol, 5.0 eq), 21 (0.21 g, 
0.60 mmol, 0.6 eq) and triethylamine (3.0 g, 0.42 mL, 3.0 mmol, 3.0 eq) in DCM 
(15 mL) to obtain the product as an off-white solid. Purification by flash 
chromatography (30 :70, ethyl acetate : petroleum ether) gave 69 (0.18 g, 65%) 
a white crystalline solid: mp 138-142 °C; 
! 
"[ ]D
20 +12.8 (c 1.0, CHCl3); νmax 
(KBr)/cm-1 3330 (NOH), 2940(C=C), 1610 (CN); δH (500 MHz, CDCl3), 9.34 (1H, 
s, OH), 8.64 (2H, d, J 4.2 Hz, 2 × CH-10), 7.50 (2H, d, J 4.2,  Hz, 2 × CH-9), 
5.06-4.92 (3H, m, CH-1,3,2), 4.63-4.57 (1H, m, CH-4), 4.10-4.00 (1H, m, CH2-
6a), 3.92 (1H, dd, J 12.6, 2.1, Hz, CH2-6b), 3.23-3.14 (1H, m, CH-5), 2.00 (6H, 
s, 2 × CH CH3C(O)O), 1.97 (6H, s, 2 × CH3C(O)O); δC (100 MHz, CDCl3) 170.1, 
170.0, 169.9, 169.8 (4 × CH3C(O)O), 150.5 (C-7), 148.9 (2 × C-10), 135.7 (C-8), 
123.4 (2 × C-9), 81.8 (C-1), 76.4 (C-5), 74.0 (C-3), 70.6 (C-2), 68.3 (C-4), 62.5 
(C-6), 21.2 (4 × OC(O)CH3); m/z (ES+) 507 (100%, [M+Na]+); HRMS (ES+) 
calculated [M+Na]+ C20H24N2O10NaS 507.1049,  found 507.1051 
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1H-Indole-3-carbaldehyde oxime,171 72 
N
H
N
OH
1
2
3
4
5
6 7
8
9
 
General procedure A was employed using 1H-indole-3-carbaldehyde (1.00 g, 
6.9 mmol, 1.0 eq), hydroxylamine hydrochloride (0.48 g, 6.9 mmol, 1.0 eq), 
sodium acetate (0.68 g, 8.3 mmol, 1.2 eq), acetonitrile (20 mL) and water (10 
mL) to obtain 72 (0.58 g, 52%) as a pale pink solid and as a mixture of E : Z 
isomers: νmax (nujol)/cm-1 3390 (OH), 3160 (NO), 2920 (CH), 640 (CN); δH (300 
MHz, CDCl3) 10.71 (1H, br s, NH), 10.42 (1H, br s, NOH), 8.42, 8.39 (1H, 2 × s, 
CH-9), 7.83 (1H, dd, J 6.9, 1.6 Hz, CH-5), 7.73 (1H, s, CH-8), 7.51 (1H, d, J 7.6 
Hz, CH-2), 7.43-7.14 (2H, m, CH-3,4);δC (75 MHz, acetone) 145.7 (C-9),139.5 
(C-9), 131.6 (C-9), 127.6 (C-6), 123.4 (C-6), 123.0 (C-5), 121.1 (C-4), 118.9 (C-
4), 112.5 (C-2), 107.8 (C-7); m/z (ES+) 161 (100%, [M+H]+). 
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2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl azide,172 79 
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Sodium azide (0.23 g, 3.65 mmol, 1.0 eq) was added to a sealed tube 
containing a solution of 18 (1.50 g, 3.65 mmol, 1.0 eq) in acetone (9 mL) and 
water (1 mL). The resulting solution was heated to 70 °C for 16 h before 
allowing to cool to room temperature. The brown solution was poured into water 
(10 mL) and extracted with DCM (3 × 15 mL) before being dried over sodium 
sulfate and removing the solvent under reduced pressure. The pale yellow solid 
was triturated from diethyl ether before being isolated by filtration to obtain 79 
(0.95 g, 69%) as a colourless solid. The product was stored at -20 °C to avoid 
decomposition: 
! 
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20 -25.0 (c 1.0, CDCl3); δH (300 MHz, CDCl3) 5.23 (1H, dd, J 
9.5, 9.5 Hz, CH-3), 5.17 (1H, dd, J 9.3, 9.3 Hz, CH-4), 4.99 (1H, dd, J 9.3, 9.3 
Hz, CH-2), 4.68 (1H, d J 9.0 Hz, H-1) 4.30 (1H, dd J 12.6, 4.9 Hz, CH2-6a), 4.20 
(1H, dd, J 12.6, 2.3 Hz, H-6b), 3.87 (1H, ddd, J, 9.3, 4.9, 2.3 Hz, CH-5), 2.13, 
2.11, 2.06, 2.04 (12H, s, CH3C(O)O); δC (75 MHz, CDCl3) 170.6, 170.1, 169.3, 
169.2 (4 × CH3C(O)O), 88.0 (C-1), 74.0 (C-5), 72.6 (C-3), 70.7 (C-2), 67.9 (C-
4), 61.7 (C-6), 20.7 (2C), 20.6 (2C) (4 × CH3C(O)O); m/z (ES+)  396 (100%, 
[M+Na]+). 
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2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl amine,173 75 
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A solution of 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl azide 79 (100 mg, 0.268 
mmol, 1 eq) in acetone (5.3 mL), was passed though a 10% Pd/C cartridge 
using the H-Cube. The solvent was removed under reduced pressure to obtain 
75 (90 mg, 96%) as a colourless solid which did not require further purification; 
mp 110-114 °C [lit.176 113-116°C]; νmax(KBr)/cm-1 3480 (NH), 2970 (CH), 2980, 
2120, 1750 (CO), 1370, 1050; δH (300 MHz, CDCl3) 5.27 (1H, t, J 9.5 Hz CH-3) 
5.02 (1H, dd, J 9.9, 9.9 Hz, CH-2), 4.85 (1H, dd, J 9.3, 9.3 Hz, CH-4), 4.25-4.20 
(2H, m, CH2-6a and CH-1), 4.12 (1H, dd, J 12.6, 2.4 Hz, CH2-6b), 3.71 (1H, 
ddd, J 9.4, 4.9, 2.4 Hz, CH-5) 2.11, 2.09, 2.04, 2.03 (4 × 3H, s, CH3C(O)O); δC 
(75 MHz, CDCl3) 170.7, 170.3, 170.2, 169.6 (4 × CH3C(O)O), 84.9 (C-1), 72.3 
(C-3), 72.0 (C-5), 71.1 (C-2), 67.2 (C-4), 61.5 (C-6) 20.7 (2C), 20.6 (2C) (4 × 
CH3C(O)O); m/z (ES+) 348 (100%, [M+H]+). 
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S-1,2,3,4,6-penta-O-acetyl-β-D-glucopyranose,174 49 
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A slurry of D-glucose (200 g, 1.1 mmol, 1.0 eq), sodium acetate (41 g, 0.5 
mmol, 0.5) and acetic anhydride (733 mL, 7.8 mmol, 7.0 eq) was heated to 
120 °C with vigourous stirring. Upon dissolution the yellow reaction mixture was 
carefully poured onto an ice-water slurry. After 2 h of stirring 49 precipitated 
from the solution as a chalky colourless solid, which was recrystallised from 
ethanol to obtain 49 (373 g, 87%) as a colourless crystalline solid and as a 1 : 9 
mixture of α : β: νmax (KBr)/cm-1 2920 (CH), 2850, 1750 (CO); δH (300 MHz, 
CDCl3) 6.33 (1H, d, J 3.7 Hz, CH-1), 5.72 (1H,  d, J 8.2 Hz, CH-1), 5.29-5.10 
(3H, m, CH-2,3,4), 4.21 (2H, m, CH2-6), 3.85 (1H, ddd, J 9.9, 4.5, 2.2 Hz, CH-
5), 2.19-2.02 (15H, m, 5 × CH3C(O)O).  
4-(tert-Butyldimethylsilyloxy)butan-1-ol,175 89 
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Butane-1,4-diol 86 (20.0 g, 222.0 mmol, 3.2 eq) was added to a solution of 
DMAP (0.90 g, 7.4 mmol, 0.1 eq) and triethylamine (9.1 g, 12.6 mL, 90.0 mmol, 
1.3 eq) in DCM (70 mL) before the dropwise addition of TBS chloride (11.2 g, 
70.0 mmol, 1.0 eq) in DCM (30 mL). The resulting solution was allowed to stir at 
room temperature for 16 h before washing with a saturated NaHCO3 solution (3 
× 50 mL), brine (2 × 50 mL) and removing the solvent under reduced pressure. 
The resulting yellow oil was purified by flash chromatography (90 : 10, 
petroleum ether : ethyl acetate) to yield 89 (10.7 g, 75%) as a colourless oil: 
νmax (film)/cm-1 3350 (OH), 2930 (CH) 2860 (CH), 1250 (Si-CH3), 1090 (Si-OR); 
δH (300 MHz, CDCl3) 3.60-3.52 (4H, m, CH2-1,4), 3.15 (1H, br s, OH), 1.59-1.46 
(4H, m, CH2-2,3) 0.90 (9H, s, 3 × CH3-6), 0.00 (6H, s, 2 × CH3-5); δC (75 MHz, 
CDCl3) 63.7 (C-1), 63.2 (C-4), 30.7 (C-2), 30.3 (C-3), 26.4 (C-8),18.7 (C-7) -4.9 
(C-5); m/z (ES+) 227 (100%, [M+Na]+). 
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4-(tert-Butyldimethylsilyloxy)butyraldehyde,175 90 
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Method 1: A solution of 89 (1.0 g, 4.89 mmol, 1.0 eq) and DIPEA  (1.89 g, 14.69 
mmol, 3.0 eq) in DMSO:DCM (1:3, 5:15 mL) was cooled to 0 °C before the 
addition of pyridine sulfur trioxide (2.33 g, 14.69 mmol, 3.0 eq). The reaction 
mixture was allowed to stir at room temperature for two hours before diluting 
with diethyl ether (100 mL) and washing with 0.5 M HCl (3 × 50 mL), brine (2 × 
50 mL) and drying over magnesium sulfate. The solvent was removed under 
reduced pressure to yield a colourless oil (0.83 g, 83%) that was used without 
further purification.  
Method 2: To a solution of 89 (840 mg, 4.11 mmol, 1.0 eq) was added TEMPO 
(27 mg, 0.17 mmol, 0.04 eq) and the solution cooled to 0 °C. To this NaBr (68.4 
mg, 0.67 mmol, 0.16 eq), NaOCl (1.6 M, 36 mL), water (11 mL) and saturated 
sodium hydrogen carbonate solution (11 mL) were added. The biphasic solution 
was allowed to stir for 10 min before the addiiton of methanol (10 mL). The 
organic layer was separated and the aqueous phase extracted with DCM (3 × 
25 mL) and ethyl acetate (3 × 25 mL). The combined organics were dried over 
magnesium sulfate and the solvent removed under reduced pressure to give 90 
(650 mg, 74%) as a colourless oil. νmax (film)/cm-1 2950, 2890, 1720 (C=O) 1260 
(Si-CH3), 1100 (Si-OR); δH (300 MHz, CDCl3), 9.74 (1H, t, J 1.7 Hz, CH-1), 3.60 
(2H, t, J 6.0 Hz, CH2-4), 2.46 (2H, dt, J  7.1, 1.7 Hz, CH2-2), 1.84 (2H, tt, J 6.0, 
7.1 Hz, CH2-3), 0.87 (9H, s, 3 × CH3-6), 0.04 (6H, s, 2 × CH3-5); δC (75 MHz, 
CDCl3) 202.8 (C-1), 62.3 (C-4), 40.8 (C-2), 25.8, (C-3), 25.6, (C-6), 19.2 (C-7), -
5.2 (C-5).  
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4- (tert-Butyldimethylsilyloxy)butyraldehyde oxime, 92 
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General procedure A was employed using 4-(tert-butyldimethylsilyloxy) 
butyraldehyde (2.00 g, 9.9 mmol, 1.0 eq), sodium acetate (0.97 g, 11.9 mmol, 
1.2 eq), hydroxylamine hydrochloride (0.68 g, 9.9 mmol, 1.0 eq), acetonitrile (60 
mL) and water (30 mL) to yield 92 (1.65 g, 77%) as a 1:1 mixture of E:Z isomers 
and as a yellow oil; νmax (film)/cm-1 3270 (N-OH), 2930 (CH) 2880 (CH), 2850 
(CH), 1660 (CN), 1250 (Si-CH3), 1100 (Si-OR); δH (300 MHz, CDCl3) 7.47 (1H, 
t, J 6.0 Hz, CH-1anti), 6.72 (1H, t, J 5.4 Hz,CH-1syn), 3.64-3.58 (2H, m, CH-4), 
2.52-2.47 (1H, m, CH2-2a), 2.29-2.21 (1H, m, CH2-2b), 1.75 (2H, m, CH2-3) 
0.08 (9H, s, CH3-6) and 0.00 (6H, s, CH3-5); δC (75 MHz, CDCl3) 152.3 (C-1 
anti), 151.9 (C-1 syn), 62.8 (C-4), 62.4 (C-4), 29.8 (C-2), 29.3 (C-2), 26.5 (C-6), 
26.2 (C-7), 25.9 (C-7), 22.3 (C-3) -3.4 (C-5), -5.1 (C-5); m/z (ES+) 218 (100%, 
[M+H]+); HRMS (ES+) calculated [M+H]+ C10H24NO2Si 218.1567, found 
218.1576. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-4-(tert-
butyldimethylsilyloxy)butane thiohydroximate, 70 
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General procedure B was employed using 92 (1.00 g, 4.62 mmol, 1.0 eq), 
NaOCl (14.3 mL, 23.1 mmol, 5.0 eq), 21 (1.01 g, 2.78 mmol, 0.6 eq) and 
triethylamine (1.93 g, 13.9  mmol, 3.0 eq) in DCM (80 mL). 70 (1.33 g, 83%) 
was obtained as a colourless oil: νmax (film)/cm-1 3410 (N-OH), 2950 (CH) 2880 
(CH), 2850 (CH), 1750 (C=O), 1600 (CN), 1230 (Si-CH3), 1090 (Si-OR); δH (300 
MHz, CDCl3) 5.15-5.13 (1H, m, CH-1) 5.04-4.96 (2H, m, CH-2,3), 4.36-4.20 
(1H, m, CH-4), 4.12 (1H, dd, J 12.3, 5.2 Hz, CH2-6a), 4.00 (1H, dd, J 12.3, 2.3 
Hz, CH2-6b), 3.70-3.64 (1H, m, CH-5), 3.62-3.54 (2H, m, CH2-10), 2.55-2.47 
(2H, dd, J 9.5, 6.1 Hz, CH2-8), 1.97, 1.95, 1.93, 1.91 (12H, 4 × s, CH3C(O)O), 
1.83-1.71 (2H, m, CH2-9), 0.81 (9H, s, CH3-13), 0.00 (6H, s, CH3-11); δC (75 
MHz, CDCl3) 170.6, 169.8 (2C), 169.6 (4 × CH3C(O)O), 152.9 (C-7), 80.3 (C-1), 
76.5 (C-5), 74.3 (C-3), 70.4 (C-2), 68.5 (C-4), 62.5 (C-6), 62.4 (C-10), 30.7 (C-
8), 29.4 (C-12), 26.4 (C-9), 21.4, 21.1, 21.0, 20.9 (4 × CH3C(O)O), 20.1 (C-13), 
-4.8 (C-11); m/z (ES+) 602 (100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ 
C24H41NNaO11SSi 602.2067, found 602.2064. 
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General procedure C: 2,2-Dimethoxypropane protection of 
thiohydroximates 
p-Toluenesulfonic acid monohydrate (0.1 eq) and 2,2-dimethoxypropane (4.0-
5.0 eq) were added to a solution of thiohydroximate (1.0 eq) in dry DCM (30 
mL) at 0 °C. The resulting solution was allowed to warm to room temperature 
and stirred for 16 h. Sodium hydrogen carbonate  solution (1 M, 50 mL) was 
used to wash the reaction mixture before the organic layer was dried and the 
solvent was removed under reduced pressure. Purification was undertaken 
using flash chromatography. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(2-
methoxypropan-2-yl)-4-(tert-butyldimethylsilyloxy)butane 
thiohydroximate, 93 
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General procedure C was employed using 70 (0.50 g, 0.86 mmol, 1.0 eq), DCM 
(30 mL), p-toluenesulfonic acid monohydrate (0.02 g, 0.10 mmol, 0.1 eq) and 
2,2-dimethoxypropane (0.51 mL, 4.20 mmols, 4.8 eq). The solvent was reduced 
and the resulting brown syrup was purified via flash chromatography (30% Ethyl 
acetate: petroleum ether) to furnish 93 (0.51 g, 91%) as a colourless solid: mp 
65-67 °C; 
! 
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20-21.0 (c 1.0, CHCl3); νmax (KBr)/cm-1 3470 (NO), 2950 (CH), 
2860, 1750 (CO), 1580, 1440, 1370, 1090 (Si-OR); δH (300 MHz, CDCl3) 5.22–
5.14 (1H, m, CH-3), 5.05-4.96 (3H, m, CH-1,2,4) 4.15 (1H, dd J 12.6, 4.9 Hz, 
CH2-6a), 4.06 (1H, dd, J 12.6, 2.3 Hz, CH2-6b) 3.73-3.67 (1H, m, CH-5), 3.63-
3.58 (2H, m, CH2-10), 3.14 (3H, s, CH3-13), 2.50-2.56 (2H, m, CH-8), 1.99, 
1.97, 1.95, 1.93 (12H, 4 × s, CH3C(O)O), 1.84-1.72 (2H, m, CH2-9), 1.37 (6H, s, 
2 × CH3-1), 0.85 (9H, s, CH3-16), 0.00 (6H, s, CH3-14); δC (75 MHz, CDCl3) 
170.8, 170.4, 169.6, 169.4 (4 × CH3C(O)O) 151.9 (C-7), 104.6 (C-11), 80.4 (C-
1), 76.1 (C-5), 74.3 (C-3), 70.4 (C-2), 68.3 (C-4), 62.5 (C-6), 60.7 (C-10), 49.6 
(C-13), 30.9 (C-8), 29.3 (C-9) 26.4 (C-16), 24.2 (C-12), 21.4 (C-15), 21.0, 20.9, 
20.8, 20.7 (4 × CH3C(O)O), -4.9 (C-14); m/z (ES+) 674 (100%, [M+Na]+); HRMS 
(ES+) calculated [M+Na]+ C28H49NO12SSiNa 674.2642, found 674.2634. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-4-
acetyloxybutane thiohydroximate, 95 
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TBAF (1.0 M in THF, 9.5 ml, 9.5 mmol, 2.5 eq) was added to a solution of 93 
(2.50 g, 3.83 mmol, 1 eq) in THF (40 mL) at 0 oC, and resulting solution allowed 
to stir at room temperature for 3 h. The reaction was then quenched using 
saturated NH4Cl solution (30 mL) and allowed to warm to room temperature.  
The resulting yellow solution was extracted into ethyl acetate (3 × 50 mL) and 
the combined organics were washed using brine (50 mL) before the solvent 
was removed under reduced pressure and the resulting oil was purified by 
column chromatography (30 : 70, ethyl acetate : petroleum ether) to yield 95 
(0.69 g, 36%) as a colourless solid: mp 118-122°C; 
! 
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20
 -30.0 (c 1.0, CHCl3); 
νmax (KBr)/cm-1 2920 (CH), 2850, 2730, 1750 (CO); δH (300 MHz, CDCl3) 5.34-
5.09 (4H, m, CH-1,2,3,4), 4.39-4.12 (4H, m, CH2-6,10), 3.80 (1H, ddd, J 10.3, 
5.6, 2.3 Hz CH-5), 2.73-2.53 (2H, m, CH2-8), 2.17-2.02 (17H, m, 5 × CH3C(O)O, 
CH2-9); δC (75 MHz, CDCl3) 171.1, 170.6, 170.2, 169.4, 169.2 (5 × CH3C(O)O), 
151.1 (C-7), 80.9 (C-1), 76.2 (C-5), 73.9 (C-3), 70.1 (C-2), 68.0 (C-4) , 62.1 (C-
6), 61.6 (C-10), 29.3 (C-8), 26.04 (C-9), 20.9, 20.8  (5 × CH3C(O)O); m/z (ES+) 
530 (100%, [M+Na]+); HRMS  (ES+) calculated [M+Na]+ C20H29O12NNaS 
530.1306, found 530.1308. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(2-
methoxypropan-2-yl)-4-hydroxybutane thiohydroximate, 96 
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TBAF (1.0 M in THF, 9.5 ml, 9.5 mmol, 2.5 eq) was added to a solution of 93 
(2.50 g, 3.8 mmol, 1.0 eq) in THF (40 mL) at 0 °C under an inert atmosphere, 
and the resulting solution allowed to stir at 0 °C for 2 h. The reaction was then 
quenched at 0 °C using saturated NH4Cl solution (30 mL) and the resulting 
solution was allowed to warm to room temperature with stirring.  The solution 
was extracted using ethyl acetate (3 × 50 mL). The combined organics were 
further washed using brine (50 mL) and dried over magnesium sulfate. The 
solvent was removed under reduced pressure and the resulting oil was purified 
via column chromatography (40 : 60, ethyl acetate : petroleum ether) to yield 96 
(1.6 g, 80%) as a colourless solid: mp 92-94 °C; 
! 
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20 -9.7 (c 1.2, CHCl3); 
νmax (nujol)/cm-1 3430 (OH), 2920 (CH), 1750 (CO); δH (300 MHz, CDCl3) 5.20 
(1H, dd J 9.0, 9.3, CH-3), 5.07-4.93 (3H, m, CH-1,2,4), 4.17-4.06 (2H, m, CH2-
6), 3.74 (1H, ddd, J 10.2, 4.9, 2.3 Hz, CH-5), 3.70-3.58 (2H, m, CH2-10), 3.14 
(3H, s, CH3-OMe), 2.65 (2H, m, CH-8), 2.01, 1.98, 1.96, 1.95 (12H, s, 
CH3C(O)O), 1.94-1.90 (2H, m, CH-9) and 1.38 (6H, s, 2 × CH3); δC (75 MHz, 
CDCl3) 171.0, 170.6, 169.8, 169.6 (4 × CH3C(O)O), 152.3 (C-7), 104.9 (C-11), 
80.2 (C-1), 76.2 (C-5),  74.3 (C-3),  70.5 (C-2),  68.6 (C-4),  62.7 (C-6),  61.9 (C-
10),  49.8 (C-13),  30.4 (C-8), 29.5 (C-9), 24.2 (C-12a),  24.1 (C-12b),  21.1 
(2C), 20.9 (2C) (4 × CH3C(O)O); m/z (ES+) 560 (100%, [M+Na]+); HRMS (ES+) 
calculated [M+Na]+ C22H35NO12NaS 560.1778, found 560.1783. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(2-
methoxypropan-2-yl) 4-oxobutane thiohydroximate, 97 
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Method 1:IBX (156 mg, 0.55 mmol, 3.0 eq) and TEMPO (5.8 mg,  0.04 mmol, 
0.2 eq) were added to a solution of 96 (100 mg, 0.18 mmol, 1.0 eq) in DCM (4 
mL), and the resulting slurry heated under reflux for 3 h. After cooling to room 
temperature the slurry was passed though a plug of celite and washed 
repeatedly with DCM (100 mL). Solvent was reduced by 75% under a reduced 
pressure and washed with saturated sodium hydrogen carbonate (20 mL), dried 
over magnesium sulfate and then the solvent was removed under reduced 
pressure to yield 97 (98.6 mg, 99 %) as a colourless solid. No further 
purification was undertaken. The material was stored at -20 °C to prevent 
decompostion.  
Method 2: NMO (0.11 g, 0.94 mmol, 4.9 eq) and potassium carbonate 
(anhydrous, 1.0 g) were added to a solution of 105 (100 mg, 0.19 mmol, 1.0 eq) 
in DCM (50 mL),. The slurry was cooled to -78 °C and a stream of oxygen was 
bubbled though. After 5 min the oxygen was replaced by a oxygen/ozone flow 
(50 mL, 30 W) until a strong blue colour remained. Ozone was flushed from the 
system using a stream of oxygen before flushing with a stream of nitrogen. The 
slurry was then allowed to warm to room temperature and stirred for a further 30 
min before pouring the slurry into water (20 mL) and extracting with DCM (3 × 
50 mL). The combined organic fractions were dried over magnesium sulfate 
and solvent removed under reduced pressure. 97 (35 mg, 35%) was isolated 
following chromatography (50:50, ethyl acetate: petroleum ether) as a 
colourless solid. The product was stored at -20 °C to prevent decomposition.  
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mp 72-78 °C; 
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20 -23.0 (c 1.0, CHCl3); δH (300 MHz, CDCl3) 9.82 (1H, s, CH-
10), 5.29-5.21 (1H, m, CH-3), 5.10-5.01 (3H, m, CH-1,2,4), 4.15 (2H, m, CH-6), 
3.77 (1H, ddd J 10.0, 5.4, 2.5 CH-5), 3.17 (3H, s, CH3-13), 2.92-2.89 (4H, m, 
CH2-8,9)  2.05, 2.03, 2.02, 2.01, (4 × 3H, s, CH3C(O)O), 1.43 (6H, s, CH3-11); 
δC (75 MHz, CDCl3) 200.7 (C-10), 170.9, 170.5, 169.8, 169.6, (4 × CH3C(O)O) 
149.9 (C-7), 105.0 (C-11), 80.3 (C-1), 76.5 (C-5), 74.2 (C-3), 70.4 (C-2), 68.5 
(C-4), 62.6 (C-6), 49.7 (C-12), 40.3 (C-9), 29.7 (C-8), 24.1 (C-12a), 24.2 (C-
12b), 21.1 (2C), 20.9 (2C) (4 × CH3C(O)O); m/z (ES+) 558 (100%, [M+Na]+); 
HRMS (ES+) calculated [M+Na]+  C22H33NO12NaS 558.1621, found 558.1611. 
General procedure D: Sulfation of a desulfoglucosinolate with a 
potassium counterion  
A solution of desulfoglucosinolate (1.0 eq) in dry DCM was added dropwise to a 
slurry of pyridine.sulfur trioxide (5.0 eq) in anhydrous pyridine (10.0 eq). The 
resulting pink slurry was allowed to stir for 16 h. After this time the solvent was 
removed under reduced pressure before the residue was diluted with KHCO3 
(2M) allowed to stir for 30 min before the addition of diethyl ether followed by a 
further 30 mins stirring. The resulting precipitate was isolated by filtration and 
washed with KHCO3 (2 M), water, ethanol and diethyl ether. The tetra-O-acetyl 
glucosinolate was isolated as its potassium salt. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-4-(tert-
butyldimethylsilyloxy)butane thiohydroximate NO-sulfate, 
potassium salt, 104 
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General procedure D was employed using 2,3,4,6-tetra-O-acetyl-β-D-4-(tert-
butyldimethyloxy) butyl thiohydroximate (1.00 g, 1.72 mmol, 1.0 eq),  pyridine 
sulfur trioxide complex (1.4 g, 8.6 mmol, 5.0 eq), pyridine (1.4 g, 17.3 mmol, 
10.0 eq), DCM (8 mL)  to yield 104 (0.49 g, 68%) as a colourless solid following 
purification by flash chromatography (10:90, ethanol: DCM); mp 180 °C 
decomposed; νmax (nujol)/cm-1 3440 (NO), 2920 (CH), 2850 (CH), 1740 (CO), 
1650 (CN), 1220 (Si-CH3), 1060 (Si-OR).; δH (300 MHz, CD3CN) 5.24 (1H, t J 
9.6 Hz, CH-3), 5.11 (1H, d, J 9.8 Hz, CH-1), 4.99-4.88 (2H, m, CH-2,4) 4.11-
3.94 (2H, m, CH2-6), 3.86-3.77 (1H, m, CH-5), 3.63 (2H, t, J 6.3 Hz, CH-10) 
2.61-2.53 (2H, m, CH2-8), 1.93-1.87 (12H, m, CH3C(O)O), 1.81-1.72 (2H, m, 
CH2-9), 0.80 (9H, s, CH3-tBu), 0.00 (6H, s, CH3-Si); δC (75 MHz, CDCl3) 169.9, 
169.5, 169.2, 169.0, (4 × CH3C(O)O),153.3 (C-7), 79.5 (C-1), 74.3 (C-5), 72.7 
(C-3), 69.9 (C-2), 67.9 (C-4), 62.5 (C-10), 61.9 (C-6), 30.2 (C-8), 27.9 (C-9), 
25.8 (C-13) , 20.4(2C), 20.3 (2C), (4 × CH3C(O)O), 17.9 (C-12), -5.3 (C-11) : 
m/z (ES-) 658 (100%, [M-K]-); Anal. Calc. (Found C, 40.9; H, 5.7; N, 2.0. 
C24H40KO14S2Si requires C, 41.3 H, 5.8, N, 2.0%) 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(2-
methoxypropan-2-yl) pent-4-ene thiohydroximate, 105 
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General procedure C was employed using 47 (200 mg, 4.30 mmol, 1.0 eq),  
DCM (20 mL), p-toulene sulfonic acid monohydrate  (8 mg, 0.43 mmol, 0.1 eq) 
and 2,2-dimethoxypropane (0.26 mL, 21.5 mmol, 5.0 eq). The resulting solution 
was allowed to stir for 3 h before the solvent was removed under reduced 
pressure. The resulting brown syrup was purified by column chromatography 
(30:70, ethyl acetate in petroleum ether) to yield 105 (0.17g, 77%) as a 
colourless solid: mp 102-106 °C; 
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20-11.6 (c 1.0, CHCl3); δH (300 MHz, 
CDCl3) 5.86 (1H, ddt J 16.7, 10.3, 6.4 Hz, CH-10), 5.26 (1H, dd, J 9.3, 9.1 Hz, 
CH-3), 5.13-4.97 (5H, m, CH2-11 and CH-1,2,4), 4.23-4.07 (2H, m, CH2-6), 3.74 
(1H, J 10.3, 4.9, 2.3 Hz, CH-5), 3.16 (3H, s, CH3-14) 2.76-2.53 (2H, m, CH2-8), 
2.50-2.39 (2H, m, CH2-9), 2.06, 2.05, 2.04, 2.01 (4 × 3H, s, CH3C(O)O) and 
1.46 (6H, s, 2 × CH3-13); δC (75 MHz, CDCl3) 170.6, 170.2, 169.4, 169.2 (4 × 
CH3C(O)O), 151.6 (C-7), 136.7 (C-10), 115.9 (C-11), 104.8 (C-12), 80.3 (C-1), 
76.4 (C-5), 74.2 (C-3), 70.5 (C-2), 68.5 (C-4), 62.7 (C-6), 49.3 (C-14), 32.9 (C-
9), 31.3 (C-8), 24.8 (C-13), 21.1, 21.0 (2C), 20.9 (4 × CH3C(O)O); m/z (ES+) 
556 (100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ C23H35NO11NaS 
556.1841, found 556.1829 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-N-(tert-
butyldimethylsilyloxy) pent-4-ene thiohydroximate, 106 
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A solution of tert-butyldimethylsilyl chloride (0.59 g, 3.93 mmol, 1.0 eq) in dry 
DCM (20 mL) was added o a solution of 47 (2.00 g , 4.33 mmol, 1.1 eq) and 
imidazole (0.59 g, 8.66 mmol, 2.2 eq) in dry DCM (30 mL) at 0 °C and under a 
nitrogen atmosphere. The reaction was allowed to stir for 3 h at 0 °C, under an 
inert atmopshere, before being quenched using saturated sodium bicarbonate 
(mL). After allowing to warm to room temeperature. The aqueous layer was 
then extracted using DCM (3 × 20 mL) and the combined organic fractions were 
dried over magnesium sulfate. The solvent was removed under reduced 
pressure to yield a yellow oil. 106 (2.29 g, 92%) was isolated as colourless solid 
following flash chromatography (30:70, ethyl acetate : petroleum ether); mp 62-
68 °C; 
! 
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20-10.2 (c 1.0, CH3Cl); νmax (KBr)/cm-1 3340 (NO), 2910 (CH), 1730 
(C=O), 1240 (Si-R); δH (300 MHz, CDCl3) 5.72 (1H, ddt, J 16.9, 10.6, 6.4 Hz 
CH-10), 5.10 (1H, dd, J 9.3, 9.1 Hz, CH-3), 4.98-4.77 (5H, m, CH-1,2,4), 4.06-
3.98 (2H, m, CH2-6), 3.58 (1H, ddd, J 10.1, 5.7, 2.3 Hz, CH-5), 2.59-2.35 (4H, 
m, CH2-8,9), 1.90-1.85 (12H, m, CH3C(O)O), 0.76 (9H, s, CH3-14) and 0.00 
(6H, s, CH3-12); δC (75 MHz, CDCl3) 170.9, 170.6, 169.7, 169.5 (4 × 
CH3C(O)O), 155.6 (C-7), 137.5 (C-10), 116.0 (C-11), 80.3 (C-1), 77.0 (C-5), 
76.4 (C-3), 74.3 (C-2), 68.5 (C-4), 62.8 (C-6)  31.8 (C-9), 31.1 (C-8), 26.4 (C-
12), 21.5, 21.1, 21.0, 20.9 (4 × CH3C(O)O), 18.6 (C-13), -3.18 (C-12a); m/z 
(ES+) 598 (100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ C25H41NO10NaSSi 
598.2118, found 598.2122. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(tert-
butyldiphenylsilyloxy) pent-4-ene thiohydroximate, 107 
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A solution of tert-butyldiphenylsilyl chloride (1.30 g, 3.89 mmol, 1.0 eq) in dry 
DCM (20 mL) was added to a solution of 47 (2.00 g, 4.30 mmol, 1.1 eq) and 
imidazole (0.59 g, 8.60 mmol,  2.2 eq) in dry DCM (30 mL) at 0 °C. The reaction 
was allowed to stir for 4 h at 0 °C  before being quenched using satuated 
sodium hydrogen carbonate solution (20 mL). After allowing to warm to room 
temperature, the aqueous  layer was then extracted using DCM (3 × 20 mL) 
and the combined organic fractions were dried over magnesium sulfate and the 
solvent removed under reduced pressure to yield a yellow oil. Following flash 
chromatography (20:80, ethyl acetate : petroleum ether) 97 (2.63 g, 87%) was 
obtained as colourless crystalline solid; mp 68-72 °C: 
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20-12.0 (c 1.0, CHCl3); 
νmax (nujol)/cm-1 3390 (NO), 2920 (CH), 1760 (CO), 1730, 1590, 1460, 1380, 
1250 (Si-R), 1210, 1040 (Si-OR), 960, 810; δH (300 MHz, CDCl3) 7.71-7.66 (4H, 
m, CH-Ar), 7.44-7.31 (6H, m, CH-Ar), 5.76 (1H, ddt, J 16.9, 10.6, 6.4 Hz, CH-
10), 5.28 (1H, dd, J 9.3, 9.1 Hz, CH-3), 5.15-4.90 (5H, m, CH-1,2,4, CH2-11), 
4.20 (1H, dd, J 12.4, 5.8 Hz, CH2-6a), 4.16-4.09 (1H, m, CH2-6b), 3.74 (1H, 
ddd, J 10.3, 5.8, 2.3 Hz, CH-5), 2.75-2.53 (2H, m, CH2-8), 2.42-2.38 (2H, m, 
CH2-9), 2.06, 2.04, 2.03, 2.02 (12H, s, CH3C(O)O), 1.08 (9H, s, CH3-13); δC (75 
MHz, CDCl3) 170.6, 170.2, 169.4, 169.1 (4 × CH3C(O)O), 156.7 (C-7), 137.0 (C-
10), 135.5 (C-Ar), 133.3 (C-Ar, 133.2 (C-Ar), 129.7 (C-Ar), 127.6 (C-Ar), 115.6 
(C-11), 80.1 (C-1), 76.1 (C-5), 73.8 (C-3), 70.2 (C-2), 68.2 (C-4), 62.3 (C-6), 
31.5 (C-9), 30.8 (C-8), 26.9 (C-13), 20.7, 20.6 (4 × CH3C(O)O), 19.5 (C-12); m/z 
(ES+) 722 (100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ C35H45NO10NaSSi 
722.2431, found 722.2437. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(2-
methoxypropan-2-yl) 4,5-epoxypentane thiohydroximate, 110 
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Sodium hydrogen carbonate (0.38g, 4.4 mmol, 12.0 eq) was added to a solution 
of 105 (0.20 g, 0.37 mmol, 1.0 eq) in acetone: water (2 : 1, 5.0 : 2.5 mL) and 
cooled to 0 °C before the addition of oxone (0.69 g, 4.5 mmol, 12 eq). The 
resulting slurry was allowed to stir at 2 h at 0 °C before warming to room 
temperature and stirring for 16 h.  The slurry was filtered before the filtrate was 
added to DCM (20 mL) and water (10 mL). The organic layer was separated 
and washed further with brine (10 mL), dried using magnesium sulfate and the 
solvent removed at reduced pressure. 110 (0.15 g, 37%) was isolated as a 
colourless oil after column purification (50 : 50, ethyl acetate : petroleum ether) 
and as a mixture of diastereoisomers; δH (300 MHz, CDCl3) 5.62 (1H, dd, J 9.3 
Hz, CH-3), 5.28 (1H, dd J 9.3, 9.5 Hz, CH-4), 5.02 (1H, dd, J 9.0, 10.6 Hz, CH-
2), 4.87 (1H, d, J 10.6 Hz, CH-1), 4.14 (1H, dd, J 12.6, 4.8 Hz, CH2-6a), 4.02 
(1H, dd, J 12.6, 2.3 Hz, CH2-6b), 3.68-3.59 (1H, m, CH-5), 3.34 (3H, s, CH3-14), 
3.02-2.95 (3H, m, CH2-10), 3.72-2.64 (3H, m, CH2-8, CH-11a) 2.43 (1H, dd, 
CH-11b), 2.00, 1.98, 1.96 (CH3C(O)O) 1.90-1.69 (2H, m, CH2-9), 1.56 (3H, s, 
CH3-13a) 1.48 (3H, s, CH3-13b); δC (75 MHz, CDCl3) 170.30, 169.1, 168.9, (4 × 
CH3C(O)O), 151.6 (C-7), 107.1 (C-12), 86.1, 84.5 (2 × C-1), 81.0 (C-5), 73.2 (C-
3), 67.5 (C-2), 66.5 (C-4), 61.5 (C-6), 50.9, 50.8, (2 × C-10) 51.2 (C-11), 47.0, 
46.9 (2 × C-14), 31.9, 29.9, (2 × C-8), 27.1, 27.0 (2 × C-9), 24.2, 23.5 (2 × C-
13), 20.6, 20.5 (4 × CH3C(O)O); m/z (ES+) 603 [M+MeOH+Na]+ 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(tert-
butyldimethylsilyloxy) 4-hydroxy-5-acetoxypentane thiohydroximate, 
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To a solution of 106 (61 mg, 0.10 mmol, 1.0 eq) in MeCN : H2O (8 : 2 mL) at 
0°C was added RuCl3 (1 mg) and NaIO4 (33 mg, 0.15 mmol, 1.5 eq). The 
resulting solution was allowed to stir for 1 hr before being filtered through a plug 
of celite. The solvent was removed under vacuum and the resulting oil was 
purified by flash chromatography (40: 60, ethyl acetate : petroleum ether) to 
obtain a clear oil (9 mg, 13%) that was tentatively assigned as 116; δH (300 
MHz, CDCl3) 5.14-5.09 (1H, m, CH-1), 4.98-4.85 (3H, m, CH-2,3,4) 4.04-4.03 
(2H, m, CH2-6), 3.71-3.61 (3H, m, CH-5, CH2-11), 3.38-3.31 (1H, m, CH-10), 
2.61-2.32 (4H, m, CH2-8,9), 1.93-1.85 (15H, m, 5 × CH3C(O)O); m/z (ES+) 674 
(100%, [M+Na]+). 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(tert-
butyldimethylsilyloxy) 4,5-dihyroxypentane thiohydroximate, 117 
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A solution of potassium permanganate (142 mg, 0.89 mmol, 2.4 eq) in water 
(0.5 mL) was added, over 10 min, to a solution of 106 (200 mg, 0.37 mmol, 1.0 
eq)  and magnesium sulfate (162 mg,  1.34 mmol, 3.6 eq) at 0 °C in ethanol 
(3.5 mL), was added. The resulting brown slurry was allowed to stir overnight 
before being filtered though a plug of celite and washed repeatedly with 
ethanol. The solvent was removed under reduced pressure and 117 (223 mg, 
99%) was achieved as a colourless oil. No further purification was undertaken. 
! 
"[ ]D
20 -13.8 (c 1.0, CHCl3); νmax (KBr)/cm-1 3300 (OH) ; δH (300 MHz, CDCl3) 
5.14-5.09 (1H, m, CH-3), 4.98-4.85 (3H, m, CH-1,2,4), 4.10-3.98 (2H, m, CH2-
6), 3.71-3.61 (3H, m, CH-5, CH2-11), 3.38-3.31 (1H, m, CH-10), 2.71-2.53 (2H, 
m, CH-8), 1.93-1.87 (13H, m, 4 × CH3C(O)O, CH2-9a), 1.73-1.63 (1H, m, CH-
9b), 0.88 (9H, s, CH3-14), 0.00 (6H, s, CH3-12) ; δC (75 MHz, CDCl3) 170.5, 
169.9, 169.2, 169.0, (4 × CH3C(O)O), 155.1, (C-7), 79.7 (C-1), 75.9 (C-5), 73.6 
(C-3), 71.7 (C-2), 70.1 (C-10), 69.8 (C-4), 66.4 (C-11), 61.9 (C-6), 30.2 (C-8), 
28.4 (C-9), 26.4 (C-14), 21.0, 20.6, 20.3, 19.9 (4 × CH3C(O)O), 18.6 (C-13), -
4.5 (C-12); m/z (ES+) (100%, 632 [M+Na]+); HRMS calculate [M+Na]+ 
C25H43NO12NaSSi 632.2173, found 632.2173. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(tert-
butyldimethylsilyloxy) 3-carboxypropane thiohydroximate, 119 
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To a solution of 117 (30 mg, 0.05 mmol, 1.0 eq) in MeOH : H20 (1 : 0.5 mL), 
NaIO4 (27 mg, 0.01 mmol, 2.4 eq) was added and allowed at room temperature 
for 2 hr. The resultant solution was diluted with ethyl acetate (5 mL) and 
extracted with water (2 × 5 mL). The solvent was removed from the organic 
layer under vacuum to obtain a white solid (18 mg, 61%) that was tentatively 
assigned as 119; δH (300 MHz, CDCl3) 5.10-5.07 (1H, m, CH-1), 5.01-4.98 (3H, 
m, CH-2,3,4), 4.04-4.00 (2H, m, CH2-6), 3.69-3.72 (1H, m, CH-5), 2.97-2.78 
(3H, m, CH2-8,9a), 2.56-2.34 (1H, m, CH2-9b), 1.92-1.81 (12H, m, CH3COO), 
0.80 (9H, s, CH3-14), 0.00 (6H, s, CH3-12); m/z (ES+) 593 (100%, [M+Na]+); 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-pent-4-ene 
thiohydroximate NO-sulfate, potassium salt, 126 
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General procedure D was employed using pyridine⋅sulfur trioxide (0.52 g, 3.3 
mmol, 5.0 eq), pyridine (0.51 g, 0.52 mL, 6.50 mmol, 10.0 eq), 47 (0.30 g, 0.65 
mmol, 1.0 eq) and DCM (3 mL). The resulting precipitate was isolated by 
filtration and washed with KHCO3 solution (2M, 3 mL), water (3 mL), ethanol (2 
mL) and diethyl ether (3 mL) and then purified by flash chromatography (10 : 
90, ethanol : DCM) gave 126 (0.31 g, 82%) as a colourless solid:  mp 200-206 
°C dec; 
! 
"[ ]D
20- 8.0 (c 0.5, H2O); νmax (nujol)/cm-1 3420 (N-O), 2950 (CH), 1750 
(C=O), 1630 (CN), 1210 (C-O); δH (300 MHz, CD3CN) 5.93 (1H, ddt, J 17.0, 
10.4, 6.4 Hz, CH-10), 5.37-5.32 (1H, m, CH-1), 5.24 (1H, d, J 10.0 Hz, CH-3), 
5.19-5.11 (1H, m, CH-2), 5.07-4.98 (3H, m, CH2-11, CH-4), 4.17-4.05 (2H, m, 
CH2-6), 3.98-3.91 (1H, m, CH-5), 2.75-2.69 (2H, m, CH2-8), 2.47-2.39 (2H, m, 
CH2-9), 2.06, 2.05 2.04, 2.01 (12H, 4 × s, CH3C(O)O); (75 MHz, CDCl3) 170.1, 
169.3 (2C), 169.1 (4 × CH3C(O)O), 163.0 (C-7), 135.4 (C-10), 114.9 (C-11), 
80.1 (C-1), 75.9 (C-5), 72.5 (C-3), 70.1 (C-2), 68.1 (C-4), 61.9 (C-6), 31.0 (C-9), 
29.8 (C-8), 20.7, 20.6 (2C), 20.5 (4 × CH3C(O)O);  m/z (ES-) 540 (100%, [M-K]-
); HRMS (ES-) calculated [M]- C19H26NO13S2 540.0852, found 540.0846. 
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General procedure E: Sulfation of a thiohydroximate with a 
cyclohexylammonium counterion 
A solution of desulfoglucosinolate (1.0 eq) in dry DCM was added dropwise to a 
slurry of pyridine⋅sulfur trioxide (5.0 eq) in anhydrous pyridine (10.0 eq),. The 
resulting pink slurry was allowed to stir for 16 h. After this time the solvent was 
removed under reduced pressure before the residue was diluted with aqueous 
cyclohexylamine solution  (5% w/w cyclohexylamine/water). The solution was 
allowed to stir for 30 min before the addition of diethyl ether, followed by a 
further 30 min stirring. The resulting precipitate was isolated by filtration and 
washed with aqueous cyclohexylamine solution (5% w/w 
cyclohexylamine/water) water, and diethyl ether. The resulting tetra-O-acetyl 
glucosinolate, as a cyclohexylammonium salt, was isolated as a solid. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-pent-4-ene 
thiohydroximate NO-sulfate, cyclohexylammonium salt, 129 
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General procedure E was employed using 47 (0.52 g, 1.12 mmol, 1.0 eq), DCM 
(5 mL) pyridine⋅sulfur trioxide complex (0.81 g, 5.60 mmol, 5.0 eq) and pyridine 
(0.90 mL, 11.2 mmol, 10.0 eq) to obtain 129 (0.46g, 72%) as a pale yellow 
solid: mp 150-154 °C;
! 
"[ ]D
20 -11.0 (c 0.5, D2O); νmax (KBr)/cm-1 2920 (CH), 2850 
2730, 1740 (CO), 1640 (C=C), 1580, 1510, 1460, 1380, 1220, 1150, 1060, 920; 
δH (300 MHz, CDCl3) 5.80 (1H, ddt, J 17.0, 10.4, 6.4 Hz ,CH-10), 5.20 (1H, dd, 
J 9.3, 9.1 Hz, CH-3), 5.07-4.90 (5H, m, CH-1,2,4, CH2-11) 4.13-4.05 (2H, m, 
CH2-6), 3.71 (1H, ddd, J 10.3, 5.4, 2.5 Hz, CH-5), 3.12-3.09 (1H, m, CH-1”), 
2.74-2.52 (4H, m, CH2-8,9), 2.45-2.33 (4H, m, CH2-2”), 2.00, 1.99, 1.97, 1.94 (4 
× 3H, s, 4 × CH3C(O)O), 1.76-1.69 (4H, m, CH2-3”), 1.56-1.53 (2H, m, CH2-4”a), 
1.41-1.28 (1H, m, CH2-4”a); δC (75 MHz, CDCl3) 170.7, 170.1, 169.4 (4 × 
CH3C(O)O), 157.9 (C-7), 136.6 (C-10), 116.0 (C-11), 80.2 (C-1), 76.1 (C-5), 
73.7 (C-3), 69.9 (C-2), 67.8 (C-4), 62.2 (C-6), 51.2 (C-1”), 32.0 (2C, C-2”), 31.2 
(C-9), 30.7 (C-8), 24.6 (2C, C-3”), 24.3 (C-4”), 20.7, 20.7, 20.6, 20.5 (4 × 
CH3C(O)O); m/z (ES-) 540 (100%, [M-]); HRMS (ES-) calculated C19H26NO13S2 
540.0852, found 540.0842. 
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General procedure F: Wittig reaction on intact glucsoinolate  
nBuLi (1.0 eq) was added to a stirred solution of Wittig salt (1.0 eq) in THF and 
allowed to stir at -78 °C for 1 h. following this a solution of aldehyde (1.0 eq) 
was added and the allowed to warm to 0°C and stirred until no aldehyde 
remained. Ammonina chloride was added to the solution and resulting biphasic 
solution allowed to warm to room temperature. Ethyl acetate was used to 
extract and upon drying over magnesium sulfate and concentration under 
reduced pressure. The resulting material was purified by column 
chromatography. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO-(2-
methoxypropan-2-yl) 5-phenylpent-4-ene thiohydroximate, 131 
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General procedure F was employed using 97 (600 mg, 1.12 mmol, 1.0 eq), 
nBuLi (1.6M in THF, 0.738 mL, 1.18 mmol, 1.0 eq) and 
benzyltriphenylphosphonium bromide (474 mg, 1.09 mmol, 0.97 eq).  Following 
purification by flash column chromatography (30:70, ethyl acetate : petroleum 
ether) 131 (199 mg, 30%) was obtained as a colurless oil and as a mixture of 
diastereomers; 
! 
"[ ]D
20 -25.6 (c 0.3, CHCl3); νmax (KBr)/cm-1 3420 (N-O), 3120 
(CH-C=C), 2970 (CH), 1730 (CO), 1640 (C=C), 1610 (CN); δH (300 MHz, 
CDCl3) 7.39-7.27 (3H, m, CH-14,15) 7.27-7.16 (2H, m, CH-13), 6.53-6.40 (1H, 
m, CH-10), 6.30-6.19 (1H, m, CH-11), 5.33-5.23 (1H, m, CH-3), 5.17-4.90 (3H, 
m, CH-1,2,4) 4.19-4.13(1H, m, CH2-6a), 4.09-4.00 (1H, m, CH2-6b), 3.78 (1H, 
m, CH-5), 3.21 (3H, s, CH3-19), 2.84-2.56 (4H, m, CH2-8,9), 2.09, 2.06, 2.04 
(12H, s, 4 × CH3C(O)O), 1.47 (6H, s, 2 × CH3-18); δC (75 MHz, CDCl3) 170.6, 
170.5, 169.5, 169.5, 169.4, 169.2 (4 ×CH3C(O)O), 150.8, 150.4 (2 × C-7), 137.3 
(C-12), 131.2, 130.4 (2 × C-10), 128.7 (C-13), 128.4 (C-14),127.2, 127.1 (2 × C-
11), 126.0 (C-15), 104.5 (C-17) 81.2, 80.8 (2 × C-1), 76.3, 75.8 (2 × C-5), 73.8, 
73.6 (2 × C-3), 70.4, 70.1 (2 × C-2), 70.0, 69.9 (2 × C-2), 69.8, 68.6 (2 × C-4), 
62.2, 61.9 (2 × C-6), 49.4, 45.3 (2 × C-19), 32.5, 32.3 (2 × C-8), 30.3, 29.7 (2 × 
C-9), 26.2, 25.4, 23.9, 23.8 (2 × C-18), 20.8, 20.7, 20.6 (4 × CH3C(O)O); m/z 
(ES+) 632 [M+Na]+; HRMS (ES+) calculated [M+Na]+ C29H39NO11NaS 632.2142, 
found 632.2140. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-5-phenylpent-4-
ene thiohydroximate, 132 
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131 (100 mg, 0.16 mmols, 1.0 eq) was added to a solution of Dowex-50W resin 
(20 mg) in methanol (2 mL) and stirred for 5 h. 132 (84 mg, 98%) was isolated 
following filtration and removal of the solvent as a colourless oil and as 
inseperable mixture of diastereoismers; νmax (KBr)/cm-1 2960 (CH), 1760 (CO), 
1620 (CN); 
! 
"[ ]D
20 -11.5 (c 0.2 in CHCl3); δH (300 MHz, CDCl3) 7.39-7.27 (3H, m, 
2 × CH-14, CH-15), 7.27-7.16 (2H, m, 2 x CH-13), 6.51-6.39 (1H, m, CH-10), 
6.30-6.19 (1H, m, CH-11), 5.32-5.21 (1H, m, CH-3), 5.17-4.90 (3H, m, CH-
1,2,4) 4.19-4.08 (2H, m, CH2-6), 3.78-3.70 (1H, m, CH-5), 2.79-2.50 (4H, m, 
CH2-8,9), 2.07, 2.04, 2.02 (12H, s, 4 × CH3C(O)O); δC (75 MHz, CDCl3) 169.5, 
169.5, 169.4, 169.2 (4 × CH3C(O)O), 151.8, 151.4 (2 × C-7), 137.3 (C-12), 
131.3, 130.4 (2 × C-10), 129.0, 128.7 (2 × C-14), 128.4, 128.3 (2 × C-13), 
127.4, 127.1 (2 × C-11), 126.0 (C-15) 81.2, 80.8 (2 × C-1), 76.2, 75.9 (2 × C-5), 
73.7, 73.6 (2 × C-3), 70.5, 70.1, (2 × C-2), 69.9, 69.8 (2 × C-4), 68.6, 62.2 (2 × 
C-6), 32.5, 32.3 (2 × C-8), 30.3, 29.7 (2 × C-9), 20.8 (2C), 20.6 (2C) (4 × 
CH3C(O)O); m/z (ES+) 560 [M+Na]+; HRMS (ES+) calculated [M+Na]+ 
C25H31NO10NaS 560.1566, found 560.1567. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-NO(2-
methoxypropan-2-yl) oct-4-ene thiohydroximate, 133 
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General procedure G was employed using 97 (600 mg, 1.12 mmol, 1.0 eq), n-
BuLi (1.6M in THF, 0.738 mL, 1.18 mmol, 1.0 eq) and butyltriphenyl 
phosphonium bromide (447 mg, 1.18 mmol, 1.0 eq).  Following purification by 
flash column chromatography (30:70, ethyl acetate, petroleum ether) 133 (180 
mg, 28%) was obtained as a colurless oil and as a mixture of diastereomers; 
! 
"[ ]D
20- 8.2 (c 1.0, CHCl3); δH (300 MHz, CDCl3) 5.48-5.35 (2H, m, CH-3,10), 5.26 
(1H, dd, J 9.0, 8.7 Hz, CH-4), 5.10-4.98 (3H, m, CH-1, 2,11), 4.20 (1H, dd, J 
12.1, 5.6 Hz, CH2-6a) 4.12 (1H, dd, J 12.1, 2.3 Hz, CH2-6b), 3.74 (1H, ddd, J 
10.3, 5.6, 2.3 Hz, CH-5), 3.22 (3H, s, CH3-17), 2.69-2.60 (1H, m, CH2-12a), 
2.53-2.48 (1H, m, CH2-12b), 2.46-2.41 (2H, m, CH2-9), 2.06-2.01 (14H, m, 4 × 
CH3C(O)O, CH2-8), 1.49 (6H, s, 2 × CH3-16), 1.41-1.35 (2H, m, CH2-13), 0.91 
(3H, t, J 7.0 Hz, CH3-14); δC (75 MHz, CDCl3) 170.6, 170.2, 169.4, 169.2 (4 × 
CH3C(O)O), 150.8 (C-7), 131.5 (C-10), 127.6 (C-11), 104.4 (C-15), 80.0 (C-1), 
76.0 (C-5), 73.9 (C-3), 70.2 (C-2), 68.0 (C-4), 62.2 (C-6), 49.4, 41.6 (2 × C-17), 
32.5, 29.4 (2 ×C-8), 26.2, 25.2 (2 × C-9), 23.9 (C-12), 23.7 (2 × C-16), 22.8 (C-
13) 20.7, 20.5, 20.4 (4 × CH3C(O)O), 14.1, 13.8 (2 × C-14); m/z (ES+) 598 
(100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ C26H41N011NaS 598. 2298,  
found 598.2286 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z- (5-
ethoxycarbonylpent-4-ene) thiohydroximate, 135 
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A stream of oxygen was passed though a stirred slurry of 106 (100  mg, 0.17 
mmol, 1.0 eq) in DCM  (50 mL) and potassium carbonate (1.0 g) whilst cooling 
to -78 °C. After 5 min a stream of oxygen/ozone was passed though the 
solution until the blue colour remained constant. A stream of oxygen was used 
to flush excess ozone from the solution before the addition of 
triphenylphosphine (4.46 g, 1.70 mmol, 10.0 eq). After 2 min of vigorous stirring 
ethyl triphenylphosphoranylidene acetate  (0.12 g, 0.34 mmol, 2.0 eq) was 
added and solution was allowed to warm up to room temperature. The resulting 
slurry was stirred overnight before being concentrated under reduced pressure 
and filtered though a plug of celite. After washing the residue with DCM, the 
filtrate was removed under reduced pressure and the resulting brown oil was 
purified via column chromatography (30 : 70, ethyl acetate : petroleum ether 
ether) to obtain 134 (39.1 mg, 35%) as a colourless oil:  
To a solution of 134 (35 mg, 0.054 mmol, 1.0 eq) in methanol (2 mL) was added 
Dowex-50W 200 mesh resin (cat.) that had been pre washed with HCl (1M, 20 
mL) and stirred for 4 h at room temperature. The resin was removed by filtration 
and the solvent removed under reduced pressure. The yellow residue was 
purified by chromatography (50 : 50, ethyl acetate : peteroleum ether.) to yield 
135 (27 mg, 96%) as a colourless oil; 
! 
"[ ]D
20- 4.0 (c 1.0, CHCl3); νmax (KBr)/cm-1 
2950 (CH), 1730 (CO) ; δH (300 MHz, CDCl3) 8.45 (1H, br s , NOH), 6.96-6.84 
(1H, m, CH-10), 5.82 (1H, d, J 15.0 Hz, CH-11), 5.25-5.16 (1H, m, CH-3), 5.06-
4.96 (3H, m, CH-1,2,4), 4.17-4.03 (4H, m, CH2-6, 13), 3.74-3.66 (1H, m, CH-5), 
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2.74-2.48 (4H, m, CH2-8,9), 2.05-1.96 (12H, m, 4 × CH3C(O)O), 1.22 (3H, t, J 
7.5 Hz, CH3-14); δC (75 MHz, CDCl3) 170.5, 170.1, 169.4, 169.08 (4 × 
CH3C(O)O), 166 (C-12), 154.1 (C-7), 146.9 (C-10), 122.3 (C-11), 79.8 (C-1), 
76.1 (C-5), 73.8 (C-3), 70.2 (C-2), 68.2 (C-4), 62.4 (C-6), 60.4 (C-13), 30.5 (C-
8), 28.89 (C-9), 20.6 (2C), 20.7 (2C) (4 × CH3C(O)O), 14.2 (C-14) ; m/z (ES+) 
556 [M+Na]+: HRMS (ES+) calculated [M+Na]+ C22H31NO12NaS 556.1467, found 
556.1465.  
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-N-(tert-
butyldimethylsilyloxy) (3-phenethyl-4,5-dihydroisoxazole-5-
yl)propane thiohydroximate, 139 
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A solution of 3-phenylpropanal oxime (36 mg, 0.24 mmol, 1.0 eq) was added to 
a separating funnel containing NaOCl (0.7 mL, 121.5 mmol, 5.0 eq) and the 
biphasic solution was shaken and a vivid blue to yellow colour change was 
observed. The organic phase was added to a stirred solution of 106 (100 mg, 
0.17 mmol,  0.6 eq) in DCM (3mL) before the addition of triethylamine (0.1 mL, 
0.73 mmol, 3.0 eq) and the reaction mixture was stirred for 3 h. The solution 
was washed using H2SO4 (0.5 M, 2 mL) and brine before drying over 
magnesium sulfate. The solvent was removed to obtain a pale yellow oil that 
was purified using chromatography (40% ethyl acetate: petroleum ether) to 
yield 139 (154 mg, 89%) as a colourless oil and as mixture of diastereomers; 
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20-17.0 (c 1.0, CHCl3); (300 MHz; CDCl3) 7.16-7.05 (5H, m, CH-16,17,18), 
5.12 (1H, m, CH-3), 5.00-4.88 (3H, m, CH-1,2,4), 4.51-4.39 (1H, m, CH-10), 
4.08-3.96 (2H, m, CH2-6), 3.79-3.69 (1H, m, CH-5), 2.89-2.74 (3H, m, CH2-8, 
11a), 2.58-2.40 (5H, m, CH2-9, 11b, 13), 1.93-1.86 (12H, m, 4 × CH3C(O)O), 
1.82-1.71 (2H, m, CH2-14), 0.80 (9H, s,CH3-tBu), 0.00 (6H, s, CH3-Si);(75 MHz; 
CDCl3): 170.6, 170.2, 170.1, 169.5, 169.4, 169.2, 169.1 (4 × CH3C(O)O), 158.6, 
158.5 (2 × C-12), 156.1, 155.9 (2 × C-7) , 140.5, 140.4 (2 × C-15), 128.6 (2C, 2 
× C-18), 128.3 (2C, 2 × C-17), 126.4 (2C, 2 × C-16), 79.8, 79.5 (2 × C-1), 78.81, 
78.75 (2 × C-5), 75.7, 75.6 (2 × C-3),  74.0, 74.1 (2 × C-2), 70.3, 70.1 (2 × C-4), 
67.9, 67.9 (2 × C-5), 62.1 (2 × C-6), 42.6, 42.3 (2 × C-13), 32.9, 32.8 (2 × C-8), 
32.7, 32.6 (2 × C-14), 29.6, 29.5 (2 × C-10), 27.9, 27.8 (2 × C-11), 26.3 (C-21), 
26.0 (2 × C-9), 20.7, 20.6, 20.6 (4 × CH3C(O)O), 18.2 (C-20), -5.21, -5.24 (C-
   Experimental 
 179 
19); m/z (ES+) 745 (100%, [M+Na]+);HRMS (ES+) calculated [M+Na]+ 
C34H50N2O11NaSSi 745.2802, found 745.2807. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-cyclohex-3-enyl 
methane thiohydroximate, 145 
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General procedure A was employed using cyclohex-3-enecarbaldehyde (2.0 g, 
18.2 mmol, 1.0 eq), sodium acetate (1.79 g, 21.8  mmol, 1.2 eq), hydroxylamine 
hydrochloride (1.49 g, 18.2 mmol, 1.0 eq), acetonitrile (20 mL) and water (10 
mL) to yield the cyclohex-3-enecarbaldehyde oxime (1.68 g, 74%) as a yellow 
oil and as a mixture of diastereomers. This product was used without further 
purification. 
General procedure B was employed using cyclohex-3-enecarbaldehyde oxime 
(1.00 g, 8.00 mmol, 1.0 eq), NaOCl (25 mL, 1.6 M, 40.0 mmol, 5.0 eq), 21 (1.73 
g, 4.80 mmol, 0.6 eq), triethyl amine (3.35 ml, 24.00 mmol, 3.0 eq) and DCM 
(80 mL). The product was purified by chromatography (30 : 70, ethyl acetate : 
petroleum ether) to obtain 145 (1.42 g, 61%) as a colourless solid and mixture 
of diasteriomers: mp 150-154 °C; νmax(nujol)/cm-1 2910 (CH), (CO); δH (300 
MHz, CDCl3) 8.33 (1H, br s, NOH), 5.76–5.70 (2H, m, CH-10, 11), 5.33-5.26 
(1H, m, CH-1), 5.20-5.05 (3H, m, CH-2,3,4), 4.27-4.11 (2H, m, CH2-6) 3.79-3.71 
(1H, m, CH-5), 2.74-2.62 (1H, m, CH-8), 2.38-2.23 (2H, m, CH2-9) 2.22-2.14 
(2H, m, CH2-12), 2.12-2.05 (13H, m, 4 × CH3C(O)O, CH2-13a), 1.79-1.69 (1H, 
m, CH2-13b); δC (75 MHz, CDCl3) 170.7, 170.3, 170.2, 169.4, 169.3 (4 × 
CH3C(O)O), 154.6, 154.6 (2 x C-7), 126.8, 126.5 (2 × C-10), 126.0, 125.5 (2 × 
C-11), 80.6, 80.3 (2 × C-1), 76.2, 76.0 (2 × C-5), 74.5 (C-3), 70.4, 70.3 (C-2), 
68.2, 68.2 (2 × C-4), 62.2 (C-6), 39.2, 38.9 (2 × C-8), 30.7, 29.6 (2 × C-9), 28.2, 
27.2 (2 × C-12), 25.5, 25.4 (C-13), 20.7, 20.6 (4 × CH3C(O)O) ; m/z (ES+)  510 
(100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ C21H29NO10NaS 510.1410, 
found 510.1407. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-2,4-
dimethylcyclohex-3-en-1-ylmethane thiohydroximate, 148 
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General procedure A was employed using 2,4-dimethylcyclohex-3-ene 
carbaldehyde aldehyde (2.0 g, 14.5 mmol, 1.0 eq), sodium acetate (1.76 g, 21.5 
mmol, 1.2 eq), hydroxylamine hydrochloride (1.00 g, 14.5 mmols, 1.0 eq), 
acetonitrile (20 mL) and water (10 mL) to yield 2,4-dimethylcyclohex-3-ene 
carbaldehyde oxime (1.97 g, 89%) as a yellow oil and as a 1:1 mixture of E:Z 
isomers and was used without further purification.  
General procedure B was employed using 2,4-dimethylcyclohex-3-ene 
carbaldehyde oxime (1.0 g, 6.52 mmol, 1.0 eq), NaOCl (20 mL, 1.6 M, 32.63 
mmol, 5.0 eq), 21 (1.42 g, 3.91 mmol, 0.6 eq) and triethylamine (3.35 mL, 24.00 
mmol) in DCM (80 mL). The material was purified via chromatography (30 : 70, 
ethyl acetate: petroleum ether) to 148 (1.38 g, 69%) as a colourless oil and as 
an inseperable mixture of diastereomers: νmax(KBr)/cm-1 3050, 2950, 1740; δH 
(300 MHz, CDCl3) 8.35 (1 H, br s, N-OH), 5.23-5.15 (3H, m, CH-1,3,10) 5.13- 
4.98 (2H, m, CH-2,4), 4.21 (1H, dd J 12.5, 5.4 Hz, CH2-6a), 4.14 (1H, dd, J 
12.5, 2.3 Hz, CH2-6b), 3.75–3.64 (1H, m, CH-5), 2.17-2.12 (1H, m, CH-8), 2.10-
1.90 (17H, m, 4 × CH3C(O)O, CH-9, CH-12, CH2-13), 1.66 (3H, s, CH3-15), 0.96 
(3H, d J 7.0 Hz, CH3-14); δC (75 MHz, CDCl3) 170.7, 170.6, 170.3, 169.4, 169.3 
(4 × CH3C(O)O), 153.9, 153.6 (2 × C-7), 132.9, 132.5 (2 × C-11), 127.2, 126.8 
(2 × C-10), 80.9, 80.3 (2 × C-1), 76.1, 75.9 (2 × C-5), 73.9 (C-3), 70.5, 70.4 (2 × 
C-2), 68.2 (C-4), 62.3, 62.2 (2 × C-6), 47.3, 46.9 (2 × C-8), 34.3, 33.6 (2 × C-9), 
30.1, 30.0 (2 × C-12), 28.8, 28.5 (2 × C-14), 23.4 (C-15), 20.7 (C-13), 20.6, 20.2 
(2C), 20.1 (4 × CH3C(O)O); m/z (ES+) 538 (100%, [M +Na]+); HRMS (ES+) 
calculated [M+Na]+ C23H33NO10SNa 538.1723, found 538.1725. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-2,4-
dimethylcyclohex-3-enylmethane thiohydroximate NO-sulfate, 
potassium salt , 149 
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General procedure E was employed using 148 (300 mg, 0.581 mmol, 1.0 eq), 
pyridine⋅sulfur trioxide complex (460 mg, 2.90 mmol, 5.0 eq), pyridine (0.48 
mL, 5.81 mmol, 10.0 eq) and DCM (5 mL) to yield the potassium salt of 149 
(193 mg, 48%) as a pale yellow solid and mixture of diastereomers; δH (300 
MHz, D2O); 5.32 (1H, dd, J 9.7, 9.7, Hz, CH-3), 5.24 -5.19 (1H, m, CH-1), 5.10-
5.03 (2H, m, CH-2,10), 4.93 (1H, dd, J 9.9, 9.3 Hz, CH-4), 4.28-4.10 (2H, m, 
CH2-6), 3.83-3.78 (1H, m, CH-5), 2.25-2.17 (1H, m, CH-8), 2.01-1.93 (17H, m, 4 
× CH3C(O)O, CH-9, CH-12, CH2-13), 1.57 (3H, s, CH3-15), 0.87-0.84 (3H, m, 
CH3-14) δC (75 MHz, D2O) 171.2, 170.6 (2C), 170.1 (CH3C(O)O), 161.3, 161.1 
(C-7), 133.4, 132.9 (C-11), 126.2, 125.9, (C-10), 81.4 (C-1), 75.2 (C-5), 73.6 (C-
3), 71.0 (C-2), 70.8, 67.9 (2 × C-4), 61.9 (C-6), 48.3, 48.0 (2 × C-8), 33.8, 33.5 
(2 × C-9), 29.8, 29.5 (2 × C-12), 23.5 (C-15), 21.2 (C-14), 20.8 (C-13), 19.9 (4 × 
CH3C(O)O); m/z (ES-) (100%, 594 [M]-); HRMS (ES-) calculated [M-] 
C23H32NO13S2 594.1315, found 594.1320. 
General procedure G: Acetate deprotection of glucosinolates 
To a stirred solution of potassium carbonate (anhydrous) in methanol was 
added 2,3,4,6-tetra-O glucosinolate and the mixture was stirred for 16 h. The 
slurry was then filtered though a plug of cotton wool and the solvent removed 
under reduced pressure to obtain the glucosinolate. 
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S-(β-D-Glucopyranosyl) Z-2,4-dimethylcyclohex-3-enylmethane 
thiohydroximate NO-Sulfate, Potassium salt, 150 
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General procedure D was employed using 149 (200 mg, 0.31 mmol, 1.0 eq), 
potassium carbonate (anhydrous, 40 mg) and methanol (2 mL) gave 150 (128 
mg, 88%) as a clear oil and as a mixture of diasteroisomers; δH (300 MHz, D2O) 
6.47 (1H, d, J 9.8 Hz, CH-10a), 6.36 (1H, d J 9.8 Hz, CH-10b), 5.32-5.29 (1H, 
m, CH-1a), 5.02-4.88 (1H, m, CH-1b), 5.02-4.88 (3H, m, CH-2,3,4), 3.90-3.87 
(1H, m, CH-8), 3.62-3.42 (4H, m, CH2-12, 13), 3.15 (3H, CH3-15), 2.48 (3H, d, J 
6.9 Hz, CH3-14a) 2.45 (3H, d, J 6.9 Hz, CH3-14b) ; δC (75 MHz, D2O) 167.3, 
166.3,  164.2 (C-7), 137.2, 136.8  (C-11), 129.2, 129.1 (C-10), 84.9, 84.3 (C-1), 
82.6, 82.5 (C-5) , 79.6, 79.6 (C-3), 74.6, 74.5 (C-2), 71.4, 71.3 (C-4), 62.8 (C-6), 
51.5 (C-8), 26.5, 25.9 (C-9), 25.1 (C-15), 25.0 (C-12), 21.9 (C-14), 21.8 (C-13); 
m/z (ES-) (100%, 426 [M-K]-); HRMS (ES-) calculated [M]- C15H24NO9S2 
426.0893 found 426.0883. 
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Hept-6-enal,176 152 
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An aqueous solution of sodium metaperiodate (8.14 g, 38.17 mmol, 1.1 eq in 
47.5 mL water), was added over 45 min to a stirred emulsion of 7-octen-1,2-diol 
157 (5.00 g, 34.7 mmol, 1.0 eq) in water (20 mL) at room temperature. The 
resulting mixture was stirred for 2 h at room temperature before separating the 
organic phase. The organic phase was dried over sodium sulfate and the 
solvent removed under reduced pressure to yield hept-6-enal (2.84 g). The 
aqueous fraction was then saturated with sodium chloride and extracted into 
DCM (3 × 40 mL), dried over magnesium sulfate and concentrated under 
reduced pressure to yield give the second batch of 152 (0.73 g).  The two 
fractions were combined to give hept-6-enal (3.57 g, 92%) as a colourless oil; 
δH (300 MHz, CDCl3) 9.67 (1H, t, J 1.8 Hz, CH-1), 5.70 (1H, ddt, J 17.2, 10.6, 
6.4 Hz, CH-6), 4.96-4.84 (2H, m, CH2-7), 2.35 (2H, dt, J 7.3, 1.5 Hz, CH2-2), 
1.94 (2H, dt, J  7.3, 1.5 Hz, CH2-5), 1.62-1.50 (2H, m, CH2-3), 1.40-1.29 (2H, m, 
CH2-4); δC (75 MHz, CDCl3) 202.4 (C-1), 138.2 (C-6) 114.7 (C-7), 43.6 (C-2), 
33.4 (C-5), 28.2 (C-3),  21.4(C-4); m/z  (ES)+ 121 (100%, [M+Na]+). 
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Hept-6-enal oxime, 153 
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General procedure A was employed using hept-6-enal (3.80 g, 34.3 mmol, 1.0 
eq), sodium acetate (3.39 g, 41.1 mmol, 1.2 eq), hydroxylamine hydrochloride 
(2.38 g, 34.2 mmol, 1.0 eq) in water (48 mL) and acetonitrile (96 mL). The 
procedure afforded 153 (3.39 g, 78%) as a colurless oil and a 1:1 mixture of E:Z 
isomers: νmax (film)/cm-1 3280, 2930 (CH), 2620, 1640 (C=C), 1620 (CN); δH 
(300 MHz, CDCl3) 9.98 (1H, br s, N-OH), 7.41 (1H, t, J 6.0 Hz, CH-1 anti), 6.70 
(1H, t, J 5.4 Hz, CH-1 syn), 5.84-5.69 (1H, m, CH2-6), 5.02-4.90 (2H, m, CH2-7), 
2.42-2.34 (1H, m, CH2-2a), 2.21-2.15 (1H, m, CH2-2b), 2.09- 2.01 (2H, m, CH2-
5), 1.55-1.35 (4H, m, CH2-3,4); δC (75 MHz, CDCl3) 152.6 (C-1 anti), 152.1 (C-1 
syn), 138.5 (C-6), 114.7 (C-7), 33.4 (C-5), 29.3 (C-4), 28.5 (C-2), 28.2 (C-2), 
25.9 (C3) and 25.4 (C-3); m/z (CI)+ 128 (100%, [M+H]+); HRMS (CI+) calculated 
[M+H]+ C7H14NO 128.1075, found 128.1078.  
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-hept-6-ene 
thiohydroximate, 154 
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General procedure B was employed using hept-6-enal oxime 153 (1.28 g, 10.1 
mmol, 1.0 eq), DCM (10 mL), NaOCl (31.0 mL, 50.5 mol, 1.6 M, 5.0 eq), 21 
(2.20 g, 6.0 mmol, 0.6 eq) and triethylamine (3.00 g, 4.2 mL, 30.3 mmol, 3.0 eq) 
in DCM (100 mL). Purification by flash chromatography (40:60, ethyl acetate: 
petroleum ether) gave 154 (2.08 g, 71%) as a colourless solid: mp 122-126 °C; 
! 
"[ ]D
20-14.6 (c 0.5, CHCl3); νmax (KBr)/cm-1 3320 (NOH), 3080 (CH), 2920 (CH), 
2850 (CH), 1750 (CO), 1640 (C=C), 1610 (CN); δH (300 MHz, CDCl3) 5.72 (1H, 
ddt, J 16.7, 10.6, 6.4 Hz, CH-12), 5.19 (1H, m, CH-3), 5.05-4.86 (5H, m, CH2-13 
and CH-1,2,4), 4.16-4.02 (2H, m, CH2-6), 3.65-3.60 (1H, m, CH-5), 2.45-2.39 
(2H, m, CH2-11), 2.05-1.93 (14H, m, 4 × CH3 and CH2-8), 1.65-1.53 (2 H, m, 
CH2-9), 1.44-1.34 (2H, m, CH-10); δC (75 MHz, CDCl3)  171.0, 170.6, 169.8, 
169.6, (4 × CH3C(O)O), 152.7 (C-7), 138.6 (C-12), 115.4 (C-13), 80.4 (C-1), 
76.4 (C-5), 74.2 (C-3), 70.5 (C-2), 68.5 (C-4), 62.5 (C-6), 33.8 (C-11), 32.8 (C-
8), 28.8 (C-9), 26.9 (C-10), 21.1, 21.0 (2C), 20.9 (4 × CH3C(O)O); m/z (ES+) 
512 (100%, [M+Na]+); Anal. Calc. (Found C, 51.4; H, 6.1; N, 2.7. C21H31NO10S 
requires C, 51.5; H, 6.3; N, 2.9%.)  
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-hept-6-ene 
thiohydroximate NO-sulfate, potassium salt, 155 
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General procedure D was employed using 154 (0.78 g, 1.6 mmol, 1.0 eq), 
pyridine (1.3 g, 1.2 mL, 16.0 mmol 10.0 eq), pyridine⋅sulfur trioxide complex 
(1.3 g, 8.0 mmol, 5 eq) and DCM (80 mL) to obtain 155 (0.54 g, 59%) as a 
colourless solid: mp >150 °C decomposed; 
! 
"[ ]D
20 -10.0 (c 1.0, H2O); νmax 
(KBr)/cm-1 3500 (N-O), 2930 (CH), 2850, 2720, 1750 (C=O), 1630 (CN), 1250 
(CO), 1050; δH (300 MHz, D2O) 5.72 (1H, ddt, J 16.7, 10.6, 6.4 Hz, CH-12), 
5.34-5.29 (1H, m, CH-3), 5.05-4.86 (5H, m, CH2-13 and CH-1,2,4), 4.28 (1H, m, 
CH2-6a), 4.12-4.00 (2H, m, CH-5, CH2-6b), 3.98-3.92 (1H, m, CH-5), 2.61-2.56 
(2H, m, CH2-11), 2.05-1.93 (14H, m, 4 × CH3 and CH2-8), 1.65-1.55 (2 H, m, 
CH2-9), 1.44-1.34 (2H, m, CH-10); δC (75 MHz, CDCl3) 173.5, 172.9, 172.6, 
172.3, (4 × CH3C(O)O), 162.6 (C-7), 139.3 (C-12), 114.0 (C-13), 79.5 (C-1), 
75.1 (C-5), 73.8 (C-3), 69.9 (C-2), 67.7 (C-4), 61.9 (C-6), 32.6 (C-11), 32.0 (C-
8), 30.2 (C-11) 27.2 (C-9), 26.2 (C-10), 20.0 (2C), 19.9, 19.8 (4 × CH3C(O)O); 
m/z (ES-) 568 (100%, [M-K]-); HRMS (ES-) calculated [M]- C21H30NO13S2 
568.1159, found 568.1152. 
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S-(β-D-Glucopyranosyl) Z-hept-6-ene thiohydroximate NO-Sulfate, 
potassium salt, 156 
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General procedure G was employed using 155 (200  mg, 0.33 mmol, 1.0 eq), 
potassium carbonate (anhydrous, 40 mg) and methanol (2 mL) to obtain 156 
(105 mg, 73%) as a colourless amphorous solid; 
! 
"[ ]D
20 -4.6 (c 0.5, H2O); νmax 
(nujol)/cm-1 3400 (NO), 2850 (CH), 1560 (C=C), 1250; δH (500 MHz, D2O) 5.84-
5.69 (1H, m, CH-12), 4.92-4.89 (2H, m, CH-13), 3.83 (1H, d, J 12.0 Hz, CH-1), 
3.70-3.57 (3H, m, CH-2,3,4), 3.39-3.28 (4H, m, CH-1,5, CH2-6), 2.59 (2H, t, J 
7.5 Hz, CH2-8), 2.04-1.94 (2H, m, CH2-11), 1.63-1.42 (2H, m, CH2-9), 1.43-1.37 
(2H, m, CH2-10); δC (125 MHz, D2O) 164.7 (C-7), 139.6 (C-12), 114.6 (C-13), 
81.8 (C-1), 79.8 (C-5), 77.0 (C-3), 72.3 (C-2), 69.4 (C-4), 60.8 (C-6), 32.9 (C-
11), 29.8 (C-8), 27.7 (C-9), 25.4 (C-10); m/z (ES-) 400 (100%, [M-K]-); HRMS 
(ES-) calculated [M]- C13H22NO9S2 400.0736, found 400.0730. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-hept-4-ene 
thiohydroximate, 157 
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General procedure A was employed for using cis-heptenal aldehyde (5.0 g, 
44.6 mmol, 1.0 eq), sodium acetate (3.36 g, 44.57 mmol, 1.0 eq), 
hydroxylamine hydrochloride (4.48 g, 53.5 mmol, 1.0  eq), acetonitrile (20 mL) 
and water (10 mL) to yield the cis-hept-enal oxime 158 (4.70 g, 83%) as a 
yellow oil and a 1:1 mixture of E:Z isomers.  
General procedure B was employed using cis-hept-enal oxime 158 (1.0 g, 7.9 
mmol, 1.0 eq) NaOCl (24.5 mL, 1.6 M, 39.3 mmol, 5.0 eq), 21 (1.72 g, 4.7 
mmol, 0.6 eq) and triethylamine (1.89 mL, 23.5 mmol, 3.0 eq) in DCM (60 mL). 
The product was purified via chromatography (30:70, ethyl acetate : petroleum 
ether) to obtain 157 (1.96 g, 85%) as a colourless solid: mp 130-132 °C;
! 
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20  -
12.4 (c 1.0, CHCl3); νmax (KBr)/cm-1 3430 (N-O), 3100 (CH), 2970 (CH), 1730 
(CO), 1650 (C=C), 1610 (CN); δH (300 MHz, CDCl3) 8.97 (1H, br s, N-OH), 
5.50- 5.46 (1H, m, CH-10), 5.38-5.32 (2H, m, CH-11, CH-3), 5.10-5.04 (3H, m, 
CH-1,2,4) and 4.20 (1H, dd, J 12.0, 5.4 Hz, CH2-6a), 4.13 (1H, dd J 12.3, 2.0 
Hz, CH2-6b), 3.76-3.65 (1H, m, CH-5), 2.68-2.50 (2H, m, CH2-8), 2.48-2.34 (2H, 
m, CH2-9), 2.13-1.97 (14H, m, CH2-12, 4 × CH3C(O)O), 0.97 (3H, t, J 7.5 Hz, 
CH3-13); δC (75 MHz, CDCl3); 170.7, 170.3 , 169.4, 169.2 (4 × CH3C(O)O), 151. 
8 (C-7), 133.6 (C-10) 126.5 (C-11), 79.9 (C-1), 76.0 (C-5), 73.8 (C-3), 70.1 (C-
2), 68.1 (C-4), 62.2 (C-6), 32.5 (C-8), 24.7 (C-9), 20.7 (C-12), 20.6, 20.5 (4 × 
CH3C(O)O), 14.3 (C-13); m/z (ES+) 512 (100%, [M+Na]+); HRMS (ES+) 
calculated [M+Na]+ C21H31NO10NaS 512.1566, found 512.1570. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-hept-4-ene 
thiohydroximate NO-sulfate, Cyclohexylammonium salt, 160 
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General procedure E was employed using S-(2,3,4,6-tetra-O-acetyl-β-D-
glucopyranosyl) Z-(cis-hept-enal) thiohydroximate (1.0 g, 2.04 mmol, 1.0 eq), 
pyridine.sulfur trioxide complex (1.63 g, 10.2 mmol, 5.0 eq), pyridine (1.60 g, 
1.64 mL, 20.4 mmol, 10.0 eq) and DCM (5mL)  to yield 160 (1.03 g, 75%)  as a 
pale yellow solid: mp 152-156 °C; 
! 
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20 -18.3 (c 0.5, CHCl3); νmax (KBr)/cm-1 
3330 (N-O), 3000 (HC), 2970 (CH), 1760 (CO), 1650 (C=C), 1610 (CN); δH (300 
MHz, CDCl3)  5.52-5.40 (1H, m, CH-10), 5.38 (1H, m, CH-11), 5.26 (1H, dd J 
9.3, 9.3 Hz, CH-3), 5.12-4.96 (3H, m, CH-1,2,4), 4.22-4.09 (2H, m ,CH2-6), 
3.81-3.76 (1H, m CH-5), 2.76 (1H, m, CH-8a), 2.60-2.56 (1H, m, CH-8b), 2.50-
2.38 (2H, m, CH2-9) 2.01- 1.89 (16H, m, 4 × CH3C(O)O, CH2-2’a, CH2-12), 
1.65-1.53 (2H, m, CH2-2’b), 1.40-1.16 (6H, m, 2×CH2-3’, CH2-4’), 0.97 (3H, t, J 
7.5 Hz, CH-7); δC (75 MHz, CDCl3) 170.7, 170.3, 170.0, 169.8 (4 × CH3C(O)O), 
155.9 (C-7), 133.8 (C-10), 128.5 (C-11), 80.2 (C-1), 76.4 (C-5), 74.2 (C-3), 71.0 
(C-2), 70.8 (C-2), 69.1 (C-4), 60.6 (C-6) 51.9 (C-1’), 32.9 (2C, C-2’), 32.5 (C-8), 
30.7 (2C, C-9, 12), 25.0 (2C, C-3’), 24.6 (C-4’), 20.7, 20.6 (2C), 20.5 (4 × 
CH3C(O)O) and 14.3 (C-13); m/z (ES-) 568 [M-C6H14N]-; HRMS (ES-) calculated 
[M]- C21H30NO13S2 568.1159, found 568.1155. 
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S-(β-D-Glucopyranosyl) Z-hept-4-ene thiohydroximate NO-sulfate, 
Cyclohexylammonium salt, 161 
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OSO3-S +NH3
 
General procedure D was employed using 160 as a cyclohexylammonium salt 
(100 mg, 0.15 mmol, 1.0 eq), potassium carbonate (anhydrous, 40 mg) and 
methanol (6 mL) to obtain 161 (60 mg, 81%) as a colourless amphorous 
solid:
! 
"[ ]D
20 -13.0 (c 1.0 , CDCl3); νmax (KBr)/cm-1 3400 (OH); δH(300 MHz, CDCl3) 
5.49-5.38 (1H, m, CH2-10), 5.34-5.24 (1H, m, CH-11), 4.90 (1H, d, J 9.3 Hz, 
CH-1), 3.76-3.62 (1H, m, CH-5), 3.58 (1H, dd, J 12.7, 5.6 Hz, CH-6a), 3.48-3.28 
(4H, m, CH-2,3,4,6b), 3.04-2.92 (1H, m, CH-1”), 2.61 (3H, m, CH2-8a, 9), 2.41-
2.31 (1H, m, CH2-8b), 1.97-1.90 (2H, m, CH2-12), 1.87-1.80 (2H, m, 2 × CH2-
2”a), 1.73-1.62 (2H, m, 2 × CH2-2”b), 1.56-1.43 (2H, m, CH2-4”), 1.19-1.15 (4H, 
m, 2 × CH2-3”), 0.81 (3H, t, J 7.6 Hz, CH3-13); δC (75 MHz, CDCl3) 164.3 (C-7), 
134.5 (C-10), 126.4 (C-11), 81.8 (C-1), 80.0 (C-5), 77.1 (C-3), 71.9 (C-2), 69.1 
(C-4), 60.6 (C-6), 50.5 (C-1’), 33.3 (2C, C-2’), 32.0 (2C, C-9, C-12), 25.0 (2C, C-
3’), 24.8 (2C, C-4’), 13.0 (C-13); m/z (ES-) 400 (100%, [M]-); HRMS (ES-) 
calculated [M]- C13H22NO9S2 400.0736, found 400.0746  
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3-Benzyldiacetoneglucose,177 177 
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 Sodium hydride (60% wt in mineral oil, 1.6 g, 42.2 mmol, 1.1 eq) was added to 
a solution of diacetone-D-glucose (10.0 g, 38.4 mmol, 1.0 eq), in DMF (100 mL) 
at 0 °C. The resulting suspension was allowed to stir for 20 min before the 
addition of benzyl bromide (5.02 mL, 4.22 mmol, 1.1 eq) and further stirring for 
3 hr. The reaction mixture was poured into water (200 mL) and extracted with 
ethyl acetate (3 × 100 mL). The organic layer was dried over magnesium sulfate 
and the solvent removed under reduced pressure. The resulting product was 
purified via column chromatography (5:95, ethyl acetate:petroleum ether) to 
yield 177 (10.4 g, 78%) as a colourless oil: 
! 
"[ ]D
20-20.5 (c 1.1, CHCl3) [Lit.180 -
25.2 (c 2.87, CHCl3)]; δH (300 MHz, CDCl3) 7.32-7.27 (3H, m, 2 × CH-13 CH-
15), 7.24-7.16 (2H, m, 2 × CH-14), 5.82 (1H, d, J 3.8 Hz, CH-1), 4.70-4.64 (2H, 
m, CH2-11), 4.60-4.57 (1H, m, CH-2), 4.29 (1H, m, CH-4), 4.05 (2H, m , CH2-
3,5), 3.96-3.91 (2H, m, CH-6), 1.41, 1.35, 1.29, 1.22 (12H, 4 × s, 4 × CH3); δC 
(75 MHz, CDCl3) 138.1 (C-12), 128.8 (C-13), 128.2 (C-14), 128.0 (C-15), 112.1 
(C-7), 109.9 (C-9), 105.7 (C-1), 83.0 (C-2), 82.1 (C-3), 81.7 (C-4), 73.0 (C-11), 
67.8 (C-6), 27.2 (CH3), 27.1 (CH3), 26.7 (CH3), 25.8 (CH3); m/z (ES+) 373 
(100%, [M+Na]+) 
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3-Benzyloxyglucose,178 173  
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Pre-activated Dowex-50W 200 resin (2.00 g) was added to a solution of 177 
(5.00 g, 14.2 mmol, eq) in water (40 mL) and the resulting slurry heated under 
reflux for 16 h. Upon cooling, the resin was filtered and the solvent removed 
under reduced pressure to yield 173 (3.66 g, 95%) as a colourless solid and a 
2:3 mixture of α:β anomers: mp 118-122 °C [Lit.181 137-140 ]; 
! 
"[ ]D
20+ 24.0 (c 1.0, 
H2O); δH (300 MHz, D2O) 7.23-7.46 (5H, m, CH-9,10,11), 5.10 (1H, d, J 3.7 Hz, 
CH-1α), 4.77 (1H, d, J 8.6 Hz, CH2-7a), 4.75 (1H, d, J 8.6 Hz, CH2-7b), 4.53 
(1H, d, J 8.6 Hz, CH-1β), 3.81 (3H, m, CH-2,3,4), 3.52-3.18 (3H, m, CH-5, CH2-
6); m/z (ES+) 271 (100%, [M+H]+). 
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3-O-Benzyl-1,2,4,6-tetra-O-acetyl glucose,179 174 
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To a solution of 3-Bn-Glucose (0.30 g, 1.11 mmol, 1.0 eq) in acetic anhydride  
(0.6 mL, 0.63 mmol, 5.7 eq) was added sodium acetate (0.18 g, 2.22 mmol, 2.0 
eq). The resulting slurry was heated to 100 °C with stirring until the solution had 
become yellow and transparent. Heating was removed and the solution poured 
on to an ice water slurry (ca. 20 mL). After 2 h of stirring the resulting percipate 
was isolated by filtration and the recystrallised from ethanol to yield 3-O-benzyl-
1,2,4,6-tetra-O-acetyl glucose (0.26 g, 54%) as a pale yellow solid: m.p 100-106 
°C [Lit.182 107 °C ]; 
! 
"[ ]D
20+ 6.3 (c 1.0, CHCl3); νmax (KBr)/cm-1 3030, 2940 (CH), 
1720 (C=O); δH (300 MHz, CDCl3) 7.34-7.27 (3H, m, 2 × CH-10, CH-11), 7.21-
7.19 (2H, d, J  7.9 Hz, 2 × CH-9), 6.29 (1H, d, J 3.5 Hz, CH-1α), 5.62 (1H, d, J 
8.2 Hz, CH-1β), 5.17-5.09 (2H, m, CH-2,4), 4.58 (2H, s, CH2-7), 4.18 (1H, dd ,J 
12.5, 5.5 Hz, CH2-6a)  4.06 (1H, dd, J 12.5, 2.3 Hz, CH2-6b),  3.75-3.67 (2H, m, 
CH-3,5), 2.07-1.94 (12H, 3 × s, 3 × CH3C(O)O); m/z  (ES+) 461 (100%, 
[M+Na]+); HRMS (ES+) calculated [M+Na]+ C21H26O10Na 461.1424, found 
461.1414. 
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2,4,6-Tetra-O-acetyl-3-benzyl-1-thio-β-D-glucopyranose, 175 
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A solution of 3-O-benzyl-1,2,4,6-tetra-O-acetyl glucose (456 mg, 1.04 mmol, 1.0 
eq) and thiourea (98 mg, 1.2 mmol, 1.2 eq) and BF3.OEt2 (0.324 g, 2.6 mmol, 
2.5 eq) in acetonitrile was heated under reflux for 3 h. After this time a solution 
of sodium metabisulfite (197 mg, 1.04 mmol, 1.0 eq) in water (10 mL) was 
added and the biphasic solution was heated for a further 3 h at reflux. Upon 
cooling the organic layer was separated and the aqueous layer was extracted 
with ethyl acetate (3 × 50 mL). The organic fractions were combined and 
washed with saturated sodium hydrogen carbonate (2 × 50 mL), brine (2 × 50 
mL) and dried over magnesium sulfate. Following flash column chromatography 
(40:60, ethyl acetate: petroleum ether) 175 (296 mg, 62%) was obtained as a 
pale yellow solid; 
! 
"[ ]D
20+17.3 (c 1.0, CHCl3); νmax (KBr)/cm-1 2920 (CH), 2570 
(SH), 1730 (C=O); δH (300 MHz, CDCl3) 7.36-7.28 (3H, m, 2 × CH-9, CH-11), 
7.24-7.21 (2H, m, 2 × CH-10), 5.13 (1H, dd, J 10.1, 9.4 Hz, CH-1), 5.01 (1H, dd, 
J 9.5, 9.5 Hz, CH-4), 4.44 (1H, dd, J 9.3, 9.4, CH-2), 4.16 (1H, dd, J 12.5, 5.4 
Hz, CH2-6a), 4.10 (1H, dd, J 12.5, 2.3 Hz, CH2-6b), 3.67 (1H, t, J 9.3Hz, CH-3), 
4.62 (2H, m, CH2-7), 3.60 (1H, ddd, J 9.5, 5.4, 2.3, Hz, CH-5), 2.31 (1H, d, J 
10.1 Hz, SH), 2.08, 2.03, 1.95 (9H, 3 × s, 3 × CH3C(O)O); δC (75 MHz, CDCl3) 
170.9, 169.7, 169.4 (3 × CH3C(O)O), 138.2 (C-8), 128.5 (C-10), 127.7 (C-9), 
127.4 (C-11), 81.3 (C-3), 79.5 (C-1), 76.8 (C-5), 75.2 (C-2), 74.3 (C-7), 69.5 (C-
4), 62.5 (C-6), 20.9, 20.8, 20.7 (3 × CH3C(O)O); m/z 435 (100%, [M+Na]+); 
HRMS (ES+) calculated [M+Na]+ calculated C19H24O8NaS 435.1090, found 
435.1094. 
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S-(2,4,6-Tetra-O-acetyl-3-O-benzyl-β-D-glucopyranosyl) pent-4-ene 
thiohydroximate, 195 
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General procedure B was employed using 2,4,6-tetra-3-benzyl-O-acetyl-1-thio-
β-D-glucopyranose 21 (2.0 g, 4.07 mmol, 0.6 eq), pent-4-enal oxime (0.69 g, 
6.79 mmol, 1.0 eq), NaOCl (1.6 M, 63.8 mL, 102 mmol, 5.0 eq), DCM (40 mL), 
and NEt3 (2.78 mL, 20.4 mmol, 3.0 eq). Purification was undertaken using flash 
chromatography (40 : 60, ethyl acetate : petroleum ether) to obtain 195 (1.79 g, 
86%) as a colourless solid; 
! 
"[ ]D
20-15.6 (c 1.1 in CHCl3); νmax (nujol)/cm-1 3230 
(NOH), 2920 (CH), 1750 (CO); δH (300 MHz; CDCl3)  8.46 (1H, br s, N-OH), 
7.40-7.31 (3H, m, 2 × CH-15, CH-16), 7.25-7.20 (2H, m, 2 × CH-14), 5.88 (1H, 
ddt, J  17.0, 10.4, 6.5 Hz, CH-10), 5.18-5.04 (4H, m, CH-2,4,11), 4.97 (1H, d, J  
10.1 Hz, CH-1), 4.66-4.59 (2H, m, CH2-12), 4.19-4.12 (2H, m, CH2-6), 3.80, 
(1H, t, J 9.3 Hz, CH-3), 3.68 (1H, m, CH-5), 2.76-2.55 (2H, m, CH2-8), 2.48-2.40 
(2H, m, CH2-9), 2.08-2.0 (9H, 3 × s, CH3C(O)O). δC (75 MHz, CDCl3) 170.7, 
169.4, 169.1 (3 × CH3C(O)O), 152.0 (C-7), 137.0 (C-13), 128.5, 128.0, 127.8 (3 
× CH-Ar), 115.8 (C-11), 81.4 (C-3), 80.2 (C-1), 76.4 (C-5), 74.3 (C-4), 71.3 (C-
12), 69.5 (C-6), 62.7 (C-5), 31.8 (C-9), 30.8 (C-8), 20.8 (CH3C(O)O); m/z (ES+) 
532 (100%, [M+Na]+); HRMS (ES+) calculated [M+Na]+ C24H31NO9NaS 
532.1617, found 532.1627. 
   Experimental 
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S-(2,4,6-Tetra-O-acetyl-3-O-benzyl-β-D-glucopyranosyl) pent-4-ene 
thiohydroximate NO-sulfate, cyclohexylammonium salt, 197 
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General procedure E was employed using 195 (1.00 g, 1.96 mmol, 1.0 eq) 
pyridine-sulfoxide complex (1.55 g, 9.8 mmol, 5.0 eq), pyridine (1.55 mL, 19.6 
mmol, 10.0 eq), DCM (10 mL) gave the cyclohexylammonium salt of 197 (0.71 
g, 53%) as a colourless solid: 
! 
"[ ]D
20-22.3 (c 0.5, CHCl3); δH (500 MHz, CDCl3) 
7.35-7.27 (3H, m, CH-Ar ), 7.24-7.21 (2H, m, CH-Ar), 5.87-5.77 (1H, m, CH-10), 
5.13-4.93 (5H, m, CH2-11, CH-1,2,4), 4.63-4.57 (2H, m, CH2-12), 4.13-4.09 (2H, 
m, CH2-6), 3.76 (1H, dd, J 9.3, 9.3 Hz, CH-3), 3.70-3.64 (1H, m, CH-5), 3.17-
3.04 (1H, m, CH-1’), 2.75-2.51 (2H, m, CH2-8), 2.49-2.29 (4H, m, CH2-9, 2’a), 
2.04, 1.99, 1.96 (3 × 3H, s, 3 × CH3C(O)O), 1.75-1.66 (2H, m, CH2-2’b), 1.60-
1.33 (2H, m, CH2-3’a), 1.28-1.06 (4H, m, CH2-3’b, 4’); δC (MHz, CDCl3) 170.7, 
169.4, 169.2 (3 × CH3C(O)O), 152.0 (C-7), 137.5 (C-Ar), 136.8 (C-10), 128.5, 
128.0, 127.8 (C-16), 115.8 (C-11), 81.4 (C-3), 80.2 (C-1), 76.4 (C-5), 74.3 (C-
12), 71.3 (C-4), 69.5 (C-2), 62.7 (C-6), 50.6 (C-1’), 32.0 (C-9), 31.8 (C-8), 30.5 
(2C, C-2’), 24.2 (2C, C-3’), 23.8 (C-4’), 20.9, 20.8, 20.8 (3 x CH3C(O)O) ; m/z 
(ES-) (100%, 588 [M]-); HRMS calculated [M]- C24H30NO12S2 588.1209, found 
588.120. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-pent-4-
ene thiohydroximate, 47 
 
 
Table 1.  Crystal data and structure refinement for scnb2. 
Identification code  scnb2 
Empirical formula  C19 H27 N O10 S 
Formula weight  461.48 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1 
Unit cell dimensions a = 5.508(5) Å α= 80.23(3)°. 
 b = 12.454(9) Å β= 88.81(3)°. 
 c = 17.858(16) Å γ = 83.27(3)°. 
Volume 1198.8(17) Å3 
Z 2 
Density (calculated) 1.278 Mg/m3 
Absorption coefficient 0.186 mm-1 
F(000) 488 
Crystal size 0.2000 x 0.2000 x 0.0500 mm3 
Theta range for data collection 1.86 to 25.29°. 
Index ranges -4<=h<=6, -14<=k<=14, -21<=l<=21 
    
 212 
Reflections collected 7512 
Independent reflections 5625 [R(int) = 0.0784] 
Completeness to theta = 25.29° 96.8 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.8355 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5625 / 15 / 560 
Goodness-of-fit on F2 1.068 
Final R indices [I>2sigma(I)] R1 = 0.1019, wR2 = 0.2684 
R indices (all data) R1 = 0.1157, wR2 = 0.2974 
Absolute structure parameter -0.12(17) 
Extinction coefficient 0.042(8) 
Largest diff. peak and hole 0.779 and -0.373 e.Å-3 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 
103) 
for scnb2.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-hept-6-
ene thiohydroximate, 154 
 
 
Table 1.  Crystal data and structure refinement for scnb1 
 
Identification code  scnb2 
Empirical Formula  C21H31NO10S 
Formula Weight489.54 
Crystal Color, Habit colourless, plate 
Crystal Dimensions 0.200 X 0.200 X 0.050 mm 
Crystal System  monoclinic 
Lattice Type  Primitive 
No. of Reflections Used for Unit 
Cell Determination (2θ range)  17386 ( 6.9 - 137.1o ) 
Lattice Parameters  a =   5.4897(3) Å 
  b =  18.1296(9) Å 
  c =  25.8737(13) Å 
  β =  96.499(2) o 
  V = 2558.6(3) Å3 
Space Group  P21 (#4) 
Z value  4 
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Dcalc  1.271 g/cm3 
F000  1040.00 
µ(CuKα)  15.796 cm-1 
Diffractometer  
Radiation  CuKα (λ = 1.54178 Å) 
  graphite monochromated 
Take-off Angle  2.8o 
Detector Aperture  2.0 - 2.5 mm horizontal 
  2.0 mm vertical 
Crystal to Detector Distance  21 mm 
Temperature  -100.0oC 
Scan Type  ω-2θ 
2θmax  136.1o 
No. of Reflections Measured  Total: 28579 
  Unique: 7925 (Rint = 0.0360) 
  Friedel pairs: 3557 
Corrections  Lorentz-polarization 
   Absorption 
   (trans. factors: 0.787 - 0.924) 
Structure Solution  Direct Methods 
Refinement  Full-matrix least-squares on F2 
Function Minimized  Σ w (Fo2 - Fc2)2  
Last Squares Weights  w = 1/ [ σ2(Fo2) + (0.1122 . P)2  
   + 1.6952 .  P ] 
   where P = (Max(Fo2,0) + 2Fc2)/3 
2θmax cutoff  136.1o 
Anomalous Dispersion  All non-hydrogen atoms 
No. Observations (All reflections)  7925 
No. Variables  595 
Reflection/Parameter Ratio  13.32 
Residuals: R1 (I>2.00σ(I))  0.0661 
Residuals: R (All reflections)  0.0688 
Residuals: wR2 (All reflections)  0.1905 
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Goodness of Fit Indicator  1.105 
Flack Parameter   0.06(3) 
Max Shift/Error in Final Cycle  0.145 
Maximum peak in Final Diff. Map  0.61 e‑/Å3 
Minimum peak in Final Diff. Map  -0.31 e‑/Å3 
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S-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl) Z-pent-4-
ene thiohydroximate NO-Sulfate, cyclohexylammonium 
salt, 129 
 
Table 1.  Crystal data and structure refinement for scnb3. 
Identification code  scnb3 
Empirical formula  C26 H41 Cl3 N2 O13 S2 
Formula weight  760.08 
Temperature  173(2) K 
Wavelength  1.54178 Å 
Crystal system  Triclinic 
Space group  P1 
Unit cell dimensions a = 7.511(2) Å α= 97.675(13)°. 
 b = 11.105(3) Å β= 95.260(12)°. 
 c = 22.271(6) Å γ = 91.563(13)°. 
Volume 1831.8(8) Å3 
Z 2 
Density (calculated) 1.378 Mg/m3 
Absorption coefficient 3.856 mm-1 
F(000) 796 
Crystal size 0.250 x 0.120 x 0.010 mm3 
Theta range for data collection 4.02 to 66.96°. 
Index ranges -8<=h<=8, -13<=k<=12, -26<=l<=26 
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Reflections collected 15617 
Independent reflections 8136 [R(int) = 0.1423] 
Completeness to theta = 66.96° 74.9 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.9367 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8136 / 564 / 829 
Goodness-of-fit on F2 2.845 
Final R indices [I>2sigma(I)] R1 = 0.2461, wR2 = 0.5878 
R indices (all data) R1 = 0.2654, wR2 = 0.6077 
Absolute structure parameter 0.00 
Largest diff. peak and hole 1.679 and -1.182 e.Å-3 
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